
<html lang="en"     class="pb-page"  data-request-id="ddd535df-c58b-46d8-81fd-3ca9c37f4f0a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2019.62.issue-17;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00751;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design" /></meta><meta name="dc.Creator" content="Van-Hai  Hoang" /></meta><meta name="dc.Creator" content="Van T. H.  Ngo" /></meta><meta name="dc.Creator" content="Minghua  Cui" /></meta><meta name="dc.Creator" content="Nguyen Van  Manh" /></meta><meta name="dc.Creator" content="Phuong-Thao  Tran" /></meta><meta name="dc.Creator" content="Jihyae  Ann" /></meta><meta name="dc.Creator" content="Hee-Jin  Ha" /></meta><meta name="dc.Creator" content="Hee  Kim" /></meta><meta name="dc.Creator" content="Kwanghyun  Choi" /></meta><meta name="dc.Creator" content="Young-Ho  Kim" /></meta><meta name="dc.Creator" content="Hyerim  Chang" /></meta><meta name="dc.Creator" content="Stephani Joy Y.  Macalino" /></meta><meta name="dc.Creator" content="Jiyoun  Lee" /></meta><meta name="dc.Creator" content="Sun  Choi" /></meta><meta name="dc.Creator" content="Jeewoo  Lee" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 14, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00751" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00751" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00751" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00751" /></link>
        
    
    

<title>Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00751" /></meta><meta property="og:title" content="Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0019.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD. Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients. On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivatives were developed. The structure–activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogues, and several selected compounds demonstrated desirable therapeutic activity in an AD mouse model. The conformational analysis of a representative inhibitor indicated that the inhibitor appeared to maintain the Z–E conformation at the active site, as it is critical for its potent activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00751"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00751">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00751&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00751&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00751&amp;href=/doi/10.1021/acs.jmedchem.9b00751" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 8011-8027</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00720" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00723" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Van-Hai Hoang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Van-Hai Hoang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Van-Hai++Hoang">Van-Hai Hoang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7462-9598" title="Orcid link">http://orcid.org/0000-0001-7462-9598</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Van T. H. Ngo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Van T. H. Ngo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Theoretical and Computational Biophysics & Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 75307, Vietnam</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Van+T.+H.++Ngo">Van T. H. Ngo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minghua Cui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minghua Cui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Leading Research Laboratory of Molecular Modeling & Drug Design, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minghua++Cui">Minghua Cui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nguyen Van Manh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nguyen Van Manh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nguyen+Van++Manh">Nguyen Van Manh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Phuong-Thao Tran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Phuong-Thao Tran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi 10000, Vietnam</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Phuong-Thao++Tran">Phuong-Thao Tran</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4855-2544" title="Orcid link">http://orcid.org/0000-0003-4855-2544</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jihyae Ann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jihyae Ann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jihyae++Ann">Jihyae Ann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hee-Jin Ha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hee-Jin Ha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hee-Jin++Ha">Hee-Jin Ha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hee Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hee Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hee++Kim">Hee Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kwanghyun Choi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kwanghyun Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kwanghyun++Choi">Kwanghyun Choi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Young-Ho Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Young-Ho Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Young-Ho++Kim">Young-Ho Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hyerim Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hyerim Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Leading Research Laboratory of Molecular Modeling & Drug Design, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hyerim++Chang">Hyerim Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephani Joy Y. Macalino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephani Joy Y. Macalino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Leading Research Laboratory of Molecular Modeling & Drug Design, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephani+Joy+Y.++Macalino">Stephani Joy Y. Macalino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiyoun Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiyoun Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Global Medical Science, Sungshin University, Seoul 01133, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiyoun++Lee">Jiyoun Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sun Choi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sun Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Leading Research Laboratory of Molecular Modeling & Drug Design, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#16656378757e797f5673617e77387775387d64"><span class="__cf_email__" data-cfemail="e99a9c878a818680a98c9e8188c7888ac7829b">[email protected]</span></a>. Phone: 82-2-3277-4503. Fax: 82-2-3277-2851 (S.C.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sun++Choi">Sun Choi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7669-7954" title="Orcid link">http://orcid.org/0000-0002-7669-7954</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jeewoo Lee</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeewoo Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ed8788889a8282ad9e8398c38c8ec3869f"><span class="__cf_email__" data-cfemail="b1dbd4d4c6dedef1c2dfc49fd0d29fdac3">[email protected]</span></a>. Phone: 82-2-880-7846. Fax: 82-2-888-0649 (J.L.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeewoo++Lee">Jeewoo Lee</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7832-6719" title="Orcid link">http://orcid.org/0000-0002-7832-6719</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00751&amp;href=/doi/10.1021%2Facs.jmedchem.9b00751" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 8011–8027</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 May 2019</li><li><span class="item_label"><b>Published</b> online</span>14 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00751" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00751</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8011%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVan-Hai%2BHoang%252C%2BVan%2BT.%2BH.%2BNgo%252C%2BMinghua%2BCui%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D17%26contentID%3Dacs.jmedchem.9b00751%26title%3DDiscovery%2Bof%2BConformationally%2BRestricted%2BHuman%2BGlutaminyl%2BCyclase%2BInhibitors%2Bas%2BPotent%2BAnti-Alzheimer%25E2%2580%2599s%2BAgents%2Bby%2BStructure-Based%2BDesign%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8027%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00751"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2168</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00751" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Van-Hai&quot;,&quot;last_name&quot;:&quot;Hoang&quot;},{&quot;first_name&quot;:&quot;Van&quot;,&quot;last_name&quot;:&quot;T. H. Ngo&quot;},{&quot;first_name&quot;:&quot;Minghua&quot;,&quot;last_name&quot;:&quot;Cui&quot;},{&quot;first_name&quot;:&quot;Nguyen&quot;,&quot;last_name&quot;:&quot;Van Manh&quot;},{&quot;first_name&quot;:&quot;Phuong-Thao&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Jihyae&quot;,&quot;last_name&quot;:&quot;Ann&quot;},{&quot;first_name&quot;:&quot;Hee-Jin&quot;,&quot;last_name&quot;:&quot;Ha&quot;},{&quot;first_name&quot;:&quot;Hee&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Kwanghyun&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Young-Ho&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Hyerim&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Stephani&quot;,&quot;last_name&quot;:&quot;Joy Y. Macalino&quot;},{&quot;first_name&quot;:&quot;Jiyoun&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Sun&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Jeewoo&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8011-8027&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00751&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD. Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients. On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivatives were developed. The structure–activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogues, and several selected compounds demonstrated desirable therapeutic activity in an AD mouse model. The conformational analysis of a representative inhibitor indicated that the inhibitor appeared to maintain the Z–E conformation at the active sit&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00751&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00751" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00751&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00751" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00751&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00751" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00751&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00751&amp;href=/doi/10.1021/acs.jmedchem.9b00751" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00751" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00751" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26pmid%3D31411468%26genre%3Darticle%26aulast%3DHoang%26date%3D2019%26atitle%3DDiscovery%2Bof%2BConformationally%2BRestricted%2BHuman%2BGlutaminyl%2BCyclase%2BInhibitors%2Bas%2BPotent%2BAnti-Alzheimer%25E2%2580%2599s%2BAgents%2Bby%2BStructure-Based%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D17%26spage%3D8011%26epage%3D8027%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/jmcmar.2019.62.issue-17/20190912/jmcmar.2019.62.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD. Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients. On the basis of a putative active conformation of the prototype inhibitor <b>1</b>, a series of N-substituted thiourea, urea, and α-substituted amide derivatives were developed. The structure–activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogues, and several selected compounds demonstrated desirable therapeutic activity in an AD mouse model. The conformational analysis of a representative inhibitor indicated that the inhibitor appeared to maintain the Z–E conformation at the active site, as it is critical for its potent activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with cognitive and behavioral dysfunction that ultimately leads to severe dementia. A variety of therapeutic strategies have been developed to provide symptomatic relief; however, no disease-modifying therapies have yet emerged because the causes and pathogenesis of AD have not been completely elucidated. One of the leading theories of AD pathogenesis is “the amyloid hypothesis,” which has now been put into question because clinical trials have largely failed to confirm it.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Most of the tested drugs are small molecules and antibodies targeting Aβ-producing enzymes and Aβ aggregates, and they seemingly show little efficacy or unacceptable toxicity. Nevertheless, there is a general consensus that anti-amyloid therapy is still a viable approach for early-stage patients, given that the accumulation of the Aβ peptides begins decades before any symptoms appear.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Moreover, there are numerous types of Aβ fibrils and oligomers that are either neurotoxic<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> or possibly neuroprotective;<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> thus, targeting specific forms of Aβ species may provide effective treatment options in addition to other potential alternatives.</div><div class="NLM_p">The N-truncated Aβ peptides generated from the N-terminal hydrolysis of Aβ are the main constituents of amyloid plaques, represented as Aβ<sub><i>n</i>-40/42</sub>, where <i>n</i> ranges from 2 to 11.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> Interestingly, more than 50% of the total Aβ plaques in the AD brain comprise pyroglutamate Aβ (pE-Aβ), Aβ<sub>N3pE3-40/42</sub> and Aβ<sub>N3pE11-40/42</sub>, which are produced by cyclization of the N-terminal glutamates (E), E3 and E11, in Aβ.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> The pE-Aβs appear to be present only in AD brain, not normal brain, and aggregate quickly and irreversibly into soluble toxic oligomers that form inert amorphous fibrils over a long period of time. In addition, pE-Aβs function as key initiators of AD pathogenesis by acting as seeds for aggregation of Aβ<sub>1-40/42</sub> and tau,<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> suggesting that the pE-Aβs may serve as a potential target to augment current anti-amyloid strategies.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">The pE-Aβ peptides are generated by glutaminyl cyclase (QC), which is mainly found in the hippocampus and cortex of mammalian brain.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> Importantly, QC is overexpressed in the brains of AD patients and animal models,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> and the knock-out of QC rescued cognitive function in AD model mice.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> It has also been reported that small-molecule inhibitors of QC efficiently reduced the brain levels of pE-Aβ and Aβ plaques<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and improved memory deficits in AD mice.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> These studies suggested that inhibition of brain QC activity may bring about beneficial effects for AD patients.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Several research groups have developed QC inhibitors that are based on imidazole (<b>1</b>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and benzimidazole core structures (<b>2</b>, <b>3</b>)<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The most prominent candidate is PQ912 (<b>3</b>), developed by Probiodrug, which showed improvement in synaptic and neurological functions in AD patients without significant toxicity in clinical trials.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> More recently, Rubinsztein and colleagues introduced an <i>N</i>-methyltriazole-based inhibitor (<b>4</b>, <b>SEN177</b>), which was discovered through three-dimensional (3D)-pharmacophore model-based in silico methods.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Similarly, Wu and colleagues reported a diphenyl-group-conjugated imidazole inhibitor (<b>5</b>), which significantly decreased the amount of pE-Aβ<sub>3-42</sub> in a cell-based model and improved the behavior in AD model mice.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Naturally occurring inhibitors<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> and other small-molecule inhibitors developed by the fragment-based approach<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> have also been reported, demonstrating moderate in vitro activity. It should be noted that while these QC inhibitors reduced brain levels of pE-Aβ<sub>3-42</sub> and improved cognitive functions, it is still in debate whether these inhibitors directly affected the QC activity in brain. Brooks and colleagues reported that compound <b>1a</b> did not appear to cross the blood–brain barrier (BBB) in mice, suggesting that the therapeutic effect of QC inhibition may be associated with peripheral mechanisms.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a><named-content content-type="anchor" rid="fig2" type="simple"></named-content><named-content content-type="anchor" rid="fig3" type="simple"></named-content></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported QC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previously reported QC inhibitors are designed based on the N-terminal (Glu-Phe) structure of its substrate Aβ<sub>3-42</sub>, containing the three principle pharmacophores including a zinc-binding group (A), hydrogen bonding donor (B), and phenyl group (C), respectively, in inhibitor <b>1</b>. In addition to this basic scaffold, our research group previously reported a series of QC inhibitors with a new extended pharmacophore based on the N-terminal tripeptide (Glu-Phe-Arg) of Aβ<sub>3E-42</sub>. The additional pharmacophore mimicking Arg (D) was tethered to the phenyl group of compound <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The extended pharmacophore helped improve the potency, ranging from 5- to 40-fold enhancement compared to <b>1</b>. In vivo experiments also indicated that compound <b>6</b> significantly reduced the brain concentrations of pE-Aβ and total Aβ while restoring cognitive functions in an AD animal model. Our molecular modeling studies revealed that the Arg mimetic 2-aminopyridine group (shown in magenta) appeared to form strong interactions with the carboxylate group of Glu327 at the QC-binding site, supporting our hypothesis that the additional pharmacophore provides an extra binding interaction. Since the 2-aminopyridine group in compound <b>6</b> can freely rotate at the active site, there may be a favorable conformation that will generate more potent inhibitors. The X-ray structure of the <i>h</i>QC-PBD150 (<b>1a</b>) complex<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> showed that the ligand resided at the <i>h</i>QC active site with a bent conformation, the so-called Z–E conformation. We performed the docking analysis of the prototype inhibitor <b>1</b> using the same X-ray crystal structure of <i>h</i>QC, and compound <b>1</b> in the similar Z–E orientation appeared to form favorable interactions at the active site as shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked pose of <b>1</b> in the Z–E conformation in <i>h</i>QC. <b>1</b> is displayed as sticks with purple carbon atoms, and Zn<sup>2+</sup> is shown as the magenta ball. The interacting residues are shown as thin sticks with their carbon atoms shown in light blue. Hydrogen bonds are depicted as black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on these observations, we hypothesized that a rigidification strategy to generate the bent conformation of <b>1</b> might improve its binding potency. Therefore, we decided to incorporate a conformational blocker to the thiourea/urea nitrogen that is proximal to the dimethoxyphenyl group to induce the formation of Z–E conformers as described in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy to facilitate Z–E conformation by N-substitution on thiourea/urea analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this work, we synthesized a series of N-substituted thiourea/urea analogues of <b>1</b> and investigated their structure–activity relationships (SARs) by performing in vitro enzyme activity assays. We added alkyl groups of different sizes and added various aromatic and heteroaromatic functional groups to search for additional binding interactions. Several potent inhibitors were selected based on in vitro activity, and in vivo efficacy was further evaluated by measuring their ability to reduce the formation of Aβ<sub>3(pE)-42</sub> in acute and transgenic AD mice models. Finally, we performed molecular docking studies to identify the specific binding interactions of the most potent compound and examined our hypothesis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The N-substituted thiourea and urea compounds were obtained by the coupling reaction between N-substituted 3,4-dimethoxyaniline fragments and the imidazole, 1-(3-azidopropyl)-5-methyl-1<i>H</i>-imidazole or 3-(5-methyl-1<i>H</i>-imidazol-1-yl)propan-1-amine.</div><div class="NLM_p">The syntheses of N-substituted 3,4-dimethoxyaniline derivatives were accomplished by the two different synthetic pathways where either 3,4-dimethoxyaniline (<b>7</b>) or its 2-nitrobenzenesulfonamide (<b>33</b>) was directly N-substituted (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). In the first pathway, most of the N-substituted 3,4-dimethoxyaniline derivatives (<b>8</b>, <b>9</b>, and <b>11</b>–<b>29</b>) were synthesized by reductive amination of <b>7</b> using corresponding aldehydes or ketones, respectively (method <b>A</b>). In the case of <i>N</i>-cyclopropyl derivative <b>10</b>, cyclopropanone was generated in situ from 1-ethoxy-1-(trimethylsilyloxy)cyclopropane under reflux in acidic conditions.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The <i>N</i>-phenyl derivative <b>30</b> was obtained by the Buchwald–Hartwig amination using iodobenzene (method <b>B</b>). <i>N</i>-Thiazol-2-yl derivative <b>31</b> was prepared using 2-chlorothiazole through the nucleophilic aromatic substitution reaction under acidic conditions (method <b>C</b>). <i>N</i>-Oxazol-2-yl derivative <b>32</b> was prepared by the modified Robinson–Gabriel method<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> in which the phenyl carbamate of <b>7</b> was reacted with aminoacetaldehyde dimethyl acetal and then the resulting urea was cyclized in situ under acidic conditions (method <b>D</b>). In the second pathway, N-substituted aniline derivatives were synthesized through 2-nitrobenzenesulfonamide derivative <b>33</b>, prepared by reacting <b>7</b> with 2-nitrobenzenesulfonyl chloride.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The N-alkylation of <b>33</b> was conducted by either direct alkylation with corresponding alkyl halides for the syntheses of <b>34</b> and <b>35</b> or Mitsunobu reaction with the corresponding alcohols for the syntheses of <b>36</b>–<b>43</b>. The protected sulfonamide group was readily cleaved by a nucleophilic aromatic substitution with thiophenol in basic media.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of N-Substituted 3,4-Dimethoxyaniline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (method <b>A</b>) aldehyde or ketone, NaBH<sub>3</sub>CN, AcOH, MeOH, 40 °C, 4 h; 1-ethoxy-1-(trimethylsilyloxy)cyclopropane, AcOH/MeOH (1:1), NaBH<sub>3</sub>CN, reflux, overnight; (method <b>B</b>) iodobenzene, Pd(OAc)<sub>2</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, reflux, overnight for <b>30</b>; (method <b>C</b>) 2-chlorothiazole, TsOH, EtOH, reflux, overnight for <b>31</b>; (method <b>D</b>) (i) PhOCOCl, NEt<sub>3</sub> then (CH<sub>3</sub>O)<sub>2</sub>CHCH<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (r.t.), overnight and (ii) c-HCl, MeOH, r.t., 2 h for <b>32</b>; (b) 2-nitrobenzenesulfonyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 4 h; (c) alkyl halide, Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), r.t., 2 h; (d) hydroxyalkyl derivatives, Ph<sub>3</sub>P, diethyl azodicarboxylate, CH<sub>2</sub>Cl<sub>2</sub>, r.t., overnight; (e) thiophenol, K<sub>2</sub>CO<sub>3</sub>, MeCN, r.t., overnight.</p></p></figure><div class="NLM_p">The syntheses of thiourea and urea compounds were accomplished by coupling N-substituted 3,4-dimethoxyaniline (<b>8</b>–<b>43</b>) prepared in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> with either one of the two imidazole fragments (<b>44</b>, <b>45</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). 3-(5-Methyl-1<i>H</i>-imidazol-1-yl)propan-1-amine <b>44</b> was obtained by following the previously described method,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and its azide surrogate <b>45</b>, 1-(3-azidopropyl)-5-methyl-1<i>H</i>-imidazole, was prepared from <b>44</b> using the diazo transfer reagent, imidazole-1-sulfonyl azide hydrochloride, under CuSO<sub>4</sub> catalysis in basic media.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Aza-Wittig coupling reactions<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> between the synthesized N-substituted 3,4-dimethoxyaniline fragments and <b>45</b> under carbon disulfide provided the N-substituted thiourea compounds <b>46</b>–<b>61</b>. Meanwhile, the use of carbon dioxide instead of carbon disulfide afforded N-substituted urea compounds (<b>62</b>–<b>79</b>, <b>81</b>, <b>87</b>, <b>88</b>, <b>90</b>–<b>96</b>, and <b>98</b>) (method <b>E</b>) and Boc-protected penultimate intermediates, which were hydrolyzed to final amine compounds <b>80</b>, <b>82</b>–<b>85</b>, and <b>97</b> (method <b>F</b>). <i>N</i>-Phenyl urea derivative <b>86</b> was obtained by the coupling reaction using triphosgene between the two amines, <b>30</b> and <b>44</b> (method <b>G</b>). <i>N</i>-Piperidin-4-yl urea derivative <b>89</b> was obtained from <i>N</i>-benzylpiperidin-4-yl urea <b>94</b> by hydrogenation in acidic conditions (method <b>H</b>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of N-substituted Thiourea and Urea Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1<i>H</i>-imidazole-1-sulfonyl azide hydrogen chloride, CuSO<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, MeOH, r.t., overnight; (b) CS<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight; (c) (method <b>E</b>) CO<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight; (method <b>F</b>) (i) CO<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight and (ii) CF<sub>3</sub>CO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, r.t., overnight; (method <b>G</b>) triphosgene, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, r.t. then <b>44</b>, reflux; (method <b>H</b>) (i) CO<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight and (ii) Pd/C, c-HCl, H<sub>2</sub>, MeOH, r.t.</p></p></figure><div class="NLM_p">The syntheses of α-substituted amide derivatives were carried out by following the pathway described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. 2-(3,4-Dimethoxyphenyl)acetonitrile <b>99</b> was alkylated with the corresponding alkyl halides, which were then hydrolyzed to respective acids in basic aqueous medium at high temperature. The resulting acids were condensed with amine <b>44</b> using the 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) reagent to afford the final compounds, <b>100</b>–<b>108</b>, respectively.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of α-Substituted Amide Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, alkyl halide, tetrahydrofuran (THF) or DMF, r.t. to 60 °C; (b) NaOH, H<sub>2</sub>O, EtOH, reflux, 24 h; (c) <b>44</b>, EDC·HCl, 1-hydroxybenzotriazole (HOBt), NEt<sub>3</sub>, r.t., overnight.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro Activity</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Structure–Activity Relationships of QC Inhibitors</h4><div class="NLM_p">The QC inhibitory activities of final compounds were determined using a fluorogenic substrate, <span class="smallcaps smallerCapital">l</span>-glutamine 7-amido-4-methylcoumarin (Gln-AMC), and pyroglutamyl peptidase (pGAP) as an auxiliary enzyme, as described previously.<a onclick="showRef(event, 'ref38 ref45'); return false;" href="javascript:void(0);" class="ref ref38 ref45">(38,45)</a> These results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, together with the IC<sub>50</sub> values of the previously reported inhibitors <b>1</b>–<b>5</b> for comparison.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values for Inhibition of <i>h</i>QC by N-Substituted Thiourea Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values indicate the mean of at least three experiments, and the numbers in parentheses refer to the standard deviation.</p></div></div><div></div></div><div class="NLM_p">First, we investigated the SAR of the N-substituted thiourea derivatives, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The incorporation of alkyl groups, such as methyl (<b>46</b>), ethyl (<b>47</b>), and isopropyl (<b>48</b>) groups, increased the potencies by 2-, 3-, and 10-fold, respectively, compared to <b>1</b>. As the size of the conformation-blocking alkyl group increased, the QC inhibition also improved, likely due to the formation of the Z–E conformer, the active conformation. Isobutyl (<b>49</b>) and cyclopentylmethyl (<b>50</b>) derivatives also exhibited similar degrees of potency, suggesting that the improvement in activity arises from the favorable conformational conversion, rather than from the increased lipophilicity. When cyclic alkyl groups, including cyclopropyl (<b>51</b>), cyclobutyl (<b>52</b>), cyclopentyl (<b>53</b>), and cyclohexyl (<b>54</b>), were incorporated into the same position, the cyclopropyl derivative (<b>51</b>) displayed a similar activity to that of <b>1</b>, whereas cyclobutyl and cyclopentyl derivatives exhibited improved potencies up to 6-fold as the size of substituent increased progressively. The incorporation of an aromatic ring generally yielded much improved potency, as demonstrated by compounds <b>55</b>–<b>61</b> with IC<sub>50</sub> values in the low nanomolar range. Notably, the <i>N</i>-4-fluorobenzyl derivative (<b>58</b>) displayed excellent inhibition, with an IC<sub>50</sub> value of 1.3 nM: much more potent than its parent compound <b>1</b>.</div><div class="NLM_p">Next, we investigated the SAR of the urea derivatives as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The unsubstituted urea (<b>62</b>) was found to be much less potent than its thiourea surrogate <b>1</b>. However, we observed a similar trend in the thiourea derivatives once an alkyl group was introduced to the urea nitrogen. The QC inhibition increases upon addition of the <i>N</i>-alkyl groups with increasing size as follows: acyclic (<i>N</i>-methyl (<b>63</b>) < <i>N</i>-ethyl (<b>64</b>) < <i>N</i>-isopropyl (<b>65</b>) < <i>N</i>-isobutyl (<b>66</b>) < <i>N</i>-cyclopentylmethyl (<b>67</b>)) and cyclic alkyl substituents (<i>N</i>-cyclopropyl (<b>68</b>) < <i>N</i>-cyclobutyl (<b>69</b>) < <i>N</i>-cyclopentyl (<b>70</b>) < <i>N</i>-cyclohexyl (<b>71</b>)). In particular, <i>N</i>-cyclopentylmethyl (<b>67</b>) and <i>N</i>-cyclohexyl (<b>71</b>) derivatives exhibited 26- and 36-fold enhancements in potency compared to <b>62</b>, indicating that the effect of the conformational restriction was found to be more marked in the series of urea than that of thiourea. Among the <i>N</i>-benzylic urea derivatives (<b>72</b>–<b>76</b>), the <i>N</i>-4-fluorobenzyl derivative (<b>75</b>) also showed the most potent activity in this series, having the IC<sub>50</sub> value of 3.9 nM. <i>N</i>-Pyridinyl derivatives (<b>77</b>–<b>82</b>) displayed a similar extent of inhibition with a range of IC<sub>50</sub> = 8.7–32.5 nM.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for Inhibition of <i>h</i>QC by <i>N</i>-Alkyl/Aryl-Substituted Urea Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0013.gif" alt="" id="GRAPHIC-d7e1361-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The values indicate the mean of at least three experiments, and the numbers in parentheses refer to the standard deviation.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values for Inhibition of <i>h</i>QC by <i>N</i>-Piperidinyl Urea Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0015.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0016.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values indicate the mean of at least three experiments, and the numbers in parentheses refer to the standard deviation.</p></div></div><div></div></div><div class="NLM_p">Previously, we have found that the 2-aminopyridine moiety in <b>6</b> provided an additional binding interaction with the enzyme.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Therefore, we incorporated this group on the nitrogen with various spacer lengths. Surprisingly, <i>N</i>-2-aminopyridinyl derivatives <b>84</b> and <b>85</b> with a four-carbon linker displayed excellent inhibition, having the IC<sub>50</sub> values of 3.6 and 1.6 nM, respectively. Because both of these compounds contained a flexible linker, we believe that their potent activities may arise from a strong ionic interaction between the 2-aminopyridyl group and the carboxylate of Glu327 rather than conformational restriction based on our docking study (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_001.pdf" class="ext-link">Figure S1</a>). <i>N</i>-Phenyl and N-heterocyclic derivatives in this series (<b>86</b>–<b>88</b>) showed only modest inhibitions.</div><div class="NLM_p">Based on the finding that the <i>N</i>-cyclohexyl urea derivative (<b>71</b>) was one of the most potent inhibitors, we decided to study additional analogues containing bioisosteric piperidine surrogates, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. The <i>N</i>-piperidin-4-yl (<b>89</b>) and <i>N</i>-(1-methylpiperidin-4-yl) (<b>90</b>) derivatives exhibited potent inhibitions, with IC<sub>50</sub> values of 8.2 and 6.1 nM, respectively, comparable to that of <b>71</b>. Incorporation of bulkier groups, such as ethyl (<b>91</b>) and acetyl (<b>92</b>) groups, on the nitrogen of piperidine led to marked reductions in potency. On the other hand, phenyl (<b>93</b>) and benzyl (<b>94</b>–<b>96</b>) groups at the same position did not affect potency significantly. <i>N</i>-Piperazinylethyl (<b>97</b>) and morpholinylethyl (<b>98</b>) derivatives showed moderate inhibitions (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Values for Inhibition of <i>h</i>QC by α-Substituted Amide Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0017.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0018.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The values indicate the mean of at least three experiments, and the numbers in parentheses refer to the standard deviation.</p></div></div><div></div></div><div class="NLM_p last">Finally, we examined α-substituted amide derivatives as the bioisosteres of the <i>N</i>-alkyl urea moiety. The unsubstituted amide (<b>100</b>) showed modest activity comparable to that of the urea compound <b>62</b>. However, incorporation of alkyl groups at the α-position led to a progressive improvement in potency as conformational restriction was enhanced (<b>100</b> < <b>101</b> (methyl) < <b>102</b> (dimethyl) < <b>103</b> (cyclopropyl)). The ring expansion at the same position (<b>104</b>–<b>106</b>) did not improve potency any further. α-Benzyl amide analogues (<b>107</b> and <b>108</b>) showed only moderate inhibition. In general, α-substituted amide analogues appeared to be less potent than N-substituted urea analogues.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Toxicity Study</h4><div class="NLM_p">On the basis of the in vitro QC inhibition, we selected the 24 most potent compounds having IC<sub>50</sub> values less than 10 nM for further evaluation. For in vitro toxicity study, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, we first examined the cell viability of each compound in a hippocampal neuronal cell line (HT-22) and found that a total of 11 compounds were nontoxic at 10 μM. We also examined the human ether-a-go-go-related gene (hERG) potassium channel inhibition of each compound and found that 16 compounds exhibited less than 50% inhibition at the same concentration.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Toxicity Studies of Selected QC Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char=".">in vitro IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">cell viability at 10 μM (% of control)</th><th class="colsep0 rowsep0" align="center" char=".">hERG FP (% inhibition at 10 μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="left">88.4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">46.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">39.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">60.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="left">86.7</td><td class="colsep0 rowsep0" align="char" char=".">11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="left">81.7</td><td class="colsep0 rowsep0" align="char" char=".">31.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="left">78.3</td><td class="colsep0 rowsep0" align="char" char=".">59.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="left">80.4</td><td class="colsep0 rowsep0" align="char" char=".">71.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="left">91.7</td><td class="colsep0 rowsep0" align="char" char=".">77.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="left">88.2</td><td class="colsep0 rowsep0" align="char" char=".">86.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">83.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">86.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="left">89.3</td><td class="colsep0 rowsep0" align="char" char=".">34.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">32.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>66</b></td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">23.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>67</b></td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">29.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="left">88.6</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>75</b></td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="left">90.7</td><td class="colsep0 rowsep0" align="char" char=".">40.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>77</b></td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">33.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>84</b></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">48.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>85</b></td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">82.2</td><td class="colsep0 rowsep0" align="char" char=".">40.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>89</b></td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="left">88.3</td><td class="colsep0 rowsep0" align="char" char=".">26.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>90</b></td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char=".">46.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>94</b></td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="left">92.4</td><td class="colsep0 rowsep0" align="char" char=".">73.5</td></tr></tbody></table></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Activity</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Acute AD Model</h4><div class="NLM_p">To assess in vivo efficacy, we tested all 24 compounds that were selected from our in vitro activity study in the acute mouse model of AD. In this study, we injected 5 μg of human Aβ<sub>3-40</sub>, together with each compound (25 mg/kg), into Institute of Cancer Research (ICR) mice (male, 6 week old) by intracerebroventricular (icv) injection. We determined the activity of each compound on the next day by measuring the levels of human Aβ<sub>N3pE-40</sub> in the brain extracts of each of the mice. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, four compounds (<b>77</b>, <b>84</b>, <b>89</b>, and <b>90</b>) suppressed greater than 20% of the formation of Aβ<sub>N3pE-40</sub> compared to the vehicle control. While the tested compounds mostly demonstrated similar in vitro activities, their in vivo activities appear to vary. We believe that this apparent discrepancy can be attributed to the use of different substrates and enzyme species for in vitro assays (glutaminyl-AMC tested against human QC) and in vivo studies (human Aβ<sub>3-40</sub> tested in mice), as well as compound-specific characteristics such as solubility, enzyme reaction kinetics, and metabolic rate. To examine whether these compounds exert their activity by penetrating the blood–brain barrier (BBB), we again performed the same experiment by injecting the three effective compounds (<b>77</b>, <b>84</b>, and <b>90</b>) via intraperitoneal (ip) injection while human Aβ<sub>3-40</sub> was injected by icv injection prior to the ip administration. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, all three compounds exhibited significant Aβ<sub>N3pE-40</sub> lowering effects (>20% inhibition) that were also comparable to the activities observed in the icv administered experiments, suggesting that these compounds are likely to cross the BBB. However, since these experiments are an indirect measure comparing biological effects after the administration, possible peripheral association with QC inhibitory effect should be considered in future mechanistic studies.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. QC Inhibition in Acute Model Studies in Vivo<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">% inhibition of Aβ<sub>N3pE-40</sub> formation</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char=".">in vitro IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">(icv injected)</th><th class="colsep0 rowsep0" align="center">(ip injected)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="left">2.96</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="left">1.17</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="left">4.01</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="left">15.28</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="left">6.66</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="left">5.31</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">11.58</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>66</b></td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>67</b></td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="left">2.96</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>75</b></td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>77</b></td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="left">25.98</td><td class="colsep0 rowsep0" align="left">22.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>84</b></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="left">24.38</td><td class="colsep0 rowsep0" align="left">22.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>85</b></td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">13.70</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>89</b></td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="left">26.26</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>90</b></td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="left">35.46</td><td class="colsep0 rowsep0" align="left">26.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>94</b></td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="left">19.40</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">5 μL of human Aβ<sub>3-40</sub> in phosphate-buffered saline (PBS) (1 μg/μL) was injected into the deep cortex/hippocampus of 5 week old ICR mice (25 g, <i>n</i> = 4, male) using a stereotaxic frame to induce acute Aβ toxicity. Test compounds were administered via icv or ip injection. Sandwich enzyme-linked immunosorbent assay (ELISA) was performed for the quantification of the brain Aβ<sub>N3pE-40</sub>. NE: not effective, NT: not tested.</p></div></div></div><div class="NLM_p last">Additionally, we determined mouse and human liver microsomal stabilities of these three compounds. The remaining percentage values of intact compounds after 30 min for <b>77</b>, <b>84</b>, and <b>90</b> were found to be 12.8, 21.6, and 89% for mouse and 44, 43.1, and 100% for human, respectively, indicating that <b>90</b> was the most stable in metabolism. We further tested compound <b>90</b> for selectivity against isoQC, an isozyme of QC with a differential substrate specificity.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Compound <b>90</b> was found to have an IC<sub>50</sub> value of 304 nM for isoQC, which was more than 50-fold greater than that for QC, indicating that <b>90</b> is highly specific for QC. We also determined the IC<sub>50</sub> value of <b>90</b> in mouse QC as 28.4 nM, indicating that <b>90</b> is an <i>h</i>QC-selective inhibitor.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> AD Model</h4><div class="NLM_p">To assess the desired therapeutic effects of <b>90</b> in AD, we performed long-term in vivo studies in 5XFAD transgenic mice. It has been reported that 5XFAD mice generate severe AD-related pathologies with massive increases of Aβ and pyroform Aβ in the brain;<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> this model is thus suitable to study Aβ-induced neurodegeneration. Compound <b>90</b> was administered by ip injection to 32 week old 5XFAD mice at a dose of 25 mg/kg every day for 4 weeks. After finishing the 4 week administration, the brain concentrations of Aβ<sub>N3pE-40/42</sub> and Aβ<sub>40/42</sub> were measured by sandwich ELISA. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, compound <b>90</b> significantly reduced the brain concentrations of Aβ<sub>N3pE-40</sub> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and Aβ<sub>N3pE-42</sub> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) by 57.9 and 50.5%, respectively, compared to the vehicle control. Compound <b>90</b> also reduced the Aβ<sub>40</sub> and Aβ<sub>42</sub> levels (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C,D) substantially, by 36.6 and 35.1% without significant toxicity, indicating that the inhibition of QC not only reduced the amount of pE-Aβ in brains but also contributed to the overall reduction in Aβ levels as previously reported.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of the formation of human Aβ<sub>N3pE-40/42</sub> and Aβ<sub>1-40/42</sub> in 5XFAD mice. Brain concentrations of (a) Aβ<sub>N3pE-40</sub>, (b) Aβ<sub>N3pE-42</sub>, (c) Aβ<sub>40</sub>, and (c) Aβ<sub>42</sub>. Data were analyzed by unpaired <i>t</i>-test or one-way analysis of variance (ANOVA) (*: <i>p</i> < 0.05, **: <i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Computational Study</h3><div class="NLM_p">Our initial hypothesis of this study is that since the bent conformation of compound <b>1</b> with a Z–E orientation is the most active conformation, the N-substituted thiourea/urea analogues with a conformational blocker will favor the Z–E conformation and thus improve the overall potency. Both in vitro and in vivo activity tests showed enhanced activity compared to that of the unsubstituted analogues, which is consistent with our hypothesis. To better understand how our conformational restriction strategy worked to improve QC inhibition, we performed comprehensive computational analysis.</div><div class="NLM_p">We first performed conformational analysis for the prototype inhibitors <b>1</b> and <b>62</b>. The unsubstituted thiourea <b>1</b> displayed the Z–E form as the dominant conformation, whereas the unsubstituted urea <b>62</b> had both Z–Z and Z–E conformations, with Z–Z as the major form. We also employed an incremental conformation search by calculating the dihedral angles of the urea/thiourea groups. The plot showing the relationship between energy and conformation revealed that lower energy was observed for <b>62</b> when its urea group was in the Z–Z form, suggesting that <b>62</b> was more stable in the Z–Z conformation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). On the other hand, the corresponding thiourea group of <b>1</b> was more stable in the Z–E conformation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Given that the bioactive conformation of the QC inhibitor favors the Z–E form and that <b>62</b> has a mixture of Z–Z/Z–E conformations, this analysis explains why compound <b>62</b> displays 5 times less inhibitory activity than that of <b>1</b>.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plots of energy vs incremental conformational changes from calculated dihedral angles: (A) thiourea in <b>1</b>, (B) urea in <b>62</b>, and (C) <i>N</i>-piperidinyl urea in <b>90</b>. The <i>X</i> axis represents the dihedral angle (C–C–N–C) found near the 5-methyl imidazole ring, while the <i>Y</i> axis represents the dihedral angle (N–C–N–C) near the dimethoxy phenyl group. Dihedral angle (in degrees) close to 0 denotes the E-form and close to 180/–180 denotes the Z-form. The plots show that low-energy conformations occupied mostly the Z–E form in thiourea <b>1</b> and N-substituted urea <b>90</b>. In contrast, diversity (both Z–Z and Z–E) of low-energy conformations exist for the urea compound, <b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using the most stable conformers from the conformational analysis, we optimized and calculated the total free energy of both <b>1</b> (Z–E) and <b>62</b> (Z–Z). Only minimal changes were observed after optimization, as both structures maintained the stable conformations. The resulting total free energies of <b>1</b> and <b>62</b> are −1390.33 and −1067.37 kcal/mol, respectively. These values indicate that the structure of compound <b>1</b> is more stable than that of <b>62</b>, whose higher energy may result from the unconstrained dihedral angle of its urea group, leading to a mixed conformational population. Among the synthesized compounds in which different substituents were added to the proximal nitrogen of urea/thiourea, <b>90</b> exhibited excellent inhibitory activity toward <i>h</i>QC, with 5- and 26-fold increased activity compared to that of <b>1</b> and <b>62</b>, respectively. The conformational analysis of <b>90</b> demonstrated that the Z–E form was its sole conformation with high stability, consistent with our design strategy (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). The most stable conformer of <b>90</b> has a total free energy of −1357.68 kcal/mol, which is comparable to that of <b>1</b>. This analysis supported our hypothesis that the design strategy restricted to the bioactive Z–E form provided more potent inhibitors against <i>h</i>QC.</div><div class="NLM_p">To investigate the binding interactions of <b>90</b>, the protonated piperidine form of <b>90</b> at pH 7.4 was used for Glide quantum mechanics (QM)-polarized ligand docking (QPLD). The results indicated that <b>90</b> was docked very well at the active site of <i>h</i>QC<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> with Z–E conformation as anticipated. The binding interactions examined were as follows: the 5-methyl imidazole group chelated with zinc and formed H-bonding interaction with the indole NH of Trp329. Additionally, it produced hydrophobic interactions with Leu249 and Trp207. The oxygen of urea formed a H-bonding interaction with Gln304. The 3,4-dimethoxy phenyl group displayed hydrophobic interactions with Ile321, Pro324, and Phe325, in which the phenyl ring presented π–π interactions with Phe325. The N-substituted piperidinyl group not only restricted the conformation but also showed hydrophobic interactions with Tyr299, Ile303, and Val302 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docked result of <b>90</b> in <i>h</i>QC. (A) Binding interactions of <b>90</b> at the active site of <i>h</i>QC. <b>90</b> is displayed as sticks with cyan carbon atoms, and Zn<sup>2+</sup> is shown as a purple ball. The interacting residues are shown as thin sticks with their carbon atoms shown in light blue. Hydrogen bonds are depicted as black dashed lines. (B) Two-dimensional representation of the interactions of <b>90</b> with the active site residues of the <i>h</i>QC. Hydrophobic interactions are marked in light brown. Hydrogen bonds are shown as red-dotted arrows with directionality. The π–π stacking interaction is marked by a blue disc and arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this work, we developed a series of N-substituted thiourea and urea surrogates of <b>1</b> as conformationally restricted analogues that favor a bent conformation (Z–E conformation). Our in-depth SAR analyses indicated that conformational restriction by the proximal N-substituent was able to improve the potency with respect to QC inhibition by up to 20-fold for thiourea, 100-fold for urea, and 8-fold for amide. Among the library of compounds, <i>N</i>-4-fluorobenzyl thiourea (<b>58</b>) and urea (<b>75</b>) analogues exhibited excellent QC inhibition, with the IC<sub>50</sub> values of 1.3 and 3.9 nM, respectively. For further evaluation of the selected inhibitors with IC<sub>50</sub> values of less than 10 nM, we measured the levels of Aβ<sub>N3pE-40</sub> in an acute model and examined their cytotoxicities, hERG inhibitions, and metabolic stabilities. Among the selected inhibitors, <b>90</b> showed the most promising efficacy and druggable profile and thus was evaluated in the AD model for in vivo efficacy. After 4 weeks of administration, <b>90</b> significantly reduced the brain concentrations of pyroform Aβ and total Aβ in the 5XFAD mouse model. The conformational analysis of the two prototype inhibitors <b>1</b> and <b>62</b> indicated that unsubstituted thiourea <b>1</b> displayed mostly a bioactive Z–E conformation, whereas unsubstituted urea <b>62</b> existed in a mixed conformation with a major Z–Z form, explaining why <b>62</b> is much less potent than <b>1</b>. The docking analysis of <b>90</b> indicated that the Z–E conformer is the dominant form and displayed the three key interactions in the active site, supporting our hypothesis that the introduction of a conformational blocker favors the active conformation. Although recent clinical failures in anti-amyloid therapies might have disappointed researchers in the related field, amyloid-targeting drugs can still be beneficial for early-stage AD patients, and they offer advantages for combination therapy by lowering the levels of toxic Aβ species.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We demonstrated that highly potent and selective QC inhibitors with promising in vitro and in vivo activities can be rationally designed, which may open a new avenue for alternative therapeutic strategies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General</h3><div class="NLM_p last">All chemical reagents were commercially available. A Buchi B-540 apparatus was used to determine melting points, which are uncorrected. Silica gel flash column chromatography was performed on silica gel 60, 230–400 mesh, Merck. The PLC plates used in the present study were PLC silica gel 60 F<sub>254</sub>, 1 mm, Merck. Proton NMR spectra were recorded on JEOL JNM-LA 300 at 300 MHz, Bruker Analytik, DE/AVANCE Digital 400 at 400 MHz, a Bruker Analytik, DE/AVANCE Digital 500 at 500 MHz, and JEOL JNM-ECA-600 at 600 MHz. Chemical shifts are calculated in ppm units, with Me<sub>4</sub>Si as a reference standard. A VG Trio-2 gas chromatography–mass spectrometry (MS) instrument and a 6460 Triple Quad liquid chromatography (LC)–MS instrument were used to determine mass spectra. All final compounds were purified to >95% purity using high-performance liquid chromatography (HPLC) on an Agilent 1120 Compact LC (G4288A) instrument using an Agilent TC-C18 column (4.6 mm × 250 mm, 5 μm) and an Agilent Eclipse Plus C18 column (4.6 mm × 250 mm, 5 μm).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for Reductive Amination (Procedure <b>A</b>)</h3><div class="NLM_p last">To a mixture of 3,4-dimethoxyaniline <b>7</b> (1.0 equiv) and ketone or aldehyde (1.0 equiv) in MeOH was added acetic acid (5.0 equiv), followed by NaBH<sub>3</sub>CN (3.0 equiv). After stirring at 40 °C for 4 h, the reaction mixture was basified by NaHCO<sub>3</sub> solution and then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was concentrated in vacuo and purified by silica gel column chromatography (EtOAc/<i>n</i>-hexane, 1:4–1:1) to obtain the secondary amine <b>8</b>–<b>29</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for N-Alkylation (Procedure <b>B</b>)</h3><div class="NLM_p last">A mixture of sulfonamide <b>33</b> (1.0 equiv), alkyl halide derivative (1.0 equiv), and excess cesium carbonate in DMF was stirred at 60 °C for 1 h or at room temperature for 2 h. The reaction mixture was quenched with water and extracted three times with EtOAc. The combined organic layer was washed with water and brine, concentrated in vacuo, and used for the next step without further purification.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for Mitsunobu-Type Reaction (Procedure <b>C</b>)</h3><div class="NLM_p last">To a mixture of sulfonamide (1.0 equiv), alcohol (1.5 equiv), and Ph<sub>3</sub>P (1.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> was slowly added ethyl azodicarboxylate (1.5 equiv). The reaction mixture was stirred overnight at room temperature, washed with water, and concentrated in vacuo. The residue was purified by silica gel column chromatography (EtOAc/<i>n</i>-hexane 1/1) to afford the desired product.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for Desulfurization (Procedure <b>D</b>)</h3><div class="NLM_p last">To a mixture of sulfonamide (1.0 equiv) and excess potassium carbonate in CH<sub>3</sub>CN was added thiophenol (2.0 equiv). The reaction mixture was stirred overnight at room temperature, added to dilute NaOH solution, and extracted several times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was washed with water, dried over MgSO<sub>4</sub>, and purified by silica gel column chromatography (EtOAc/<i>n</i>-hexane 1/4 for <b>34</b>–<b>36</b>, 1/1 for <b>37</b>–<b>43</b>). (Caution: the experiment should be carried out in a fume hood. The aqueous solution should be collected and detoxified with hydrogen peroxide.)</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure for Boc-Protection (Procedure <b>E</b>)</h3><div class="NLM_p last">To an ice-cooled solution of amine (1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> were added 4-dimethylaminopyridine (0.1 equiv) and di-<i>tert</i>-butyl dicarbonate (1.2 equiv for monoprotection, 2.5 equiv for diprotection) in CH<sub>2</sub>Cl<sub>2</sub>. The reaction mixture was stirred at room temperature overnight, quenched with water, and extracted several times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was washed with 10% aqueous NaHCO<sub>3</sub> solution, water, and brine and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated in vacuo, and the residue was purified by silica gel column chromatography (EtOAc/<i>n</i>-hexane 1/4).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for Boc-Deprotection Reaction (Procedure <b>F</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-Boc-protected amine in CH<sub>2</sub>Cl<sub>2</sub> was added trifluoroacetic acid (10 equiv). The reaction mixture was stirred overnight, concentrated in vacuo, and purified by ion-exchange resin (strongly basic form) to provide a free amine.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for Aza-Wittig Coupling Reaction</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Procedure <b>G</b></h4><div class="NLM_p last">To a stirred solution of N-substituted 3,4-dimethoxyaniline (1.0 equiv) and azide <b>45</b> (1.1 equiv) in toluene was added triphenylphosphine (1.2 equiv). The reaction mixture was degassed and aerated with carbon dioxide. After stirring at 80 °C for 4–8 h under a carbon dioxide atmosphere, the mixture was concentrated in vacuo and purified by silica gel column chromatography (methanol (MeOH)/dichloromethane 1:1 (v/v) 1/13 for <b>62</b>–<b>88</b>, 1/9 for <b>90</b>–<b>98</b>) to yield the desired product.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Procedure <b>H</b></h4><div class="NLM_p last">A solution of azide <b>45</b> (1.0 equiv) and triphenylphosphine (1.2 equiv) in toluene was stirred 30 min under a nitrogen atmosphere, and a solution of carbon disulfide (1.1 equiv) in toluene was then added. The mixture was stirred for 1 h, and N-substituted 3,4-dimethoxyaniline (1.0 equiv) was added. After stirring at 40 °C overnight, the mixture was concentrated in vacuo and purified by silica gel column chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub> 1/19) to yield the desired product.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for C-Alkylation (Procedure <b>I</b>)</h3><div class="NLM_p last">To a cooled suspension of sodium hydride (1.1 equiv) in anhydrous THF was added a solution of 2-(3,4-dimethoxyphenyl)acetonitrile <b>99</b> (1.0 equiv) in anhydrous THF at 0 °C. After stirring for 10 minutes, a solution of alkyl halide (1.05 equiv) was added to the mixture. The reaction mixture was stirred at room temperature or at 60 °C until the starting material was consumed. After completion, the reaction mixture was quenched with water and extracted twice with EtOAc. The combined organic layer was washed with water and brine and concentrated in vacuo. The residue was purified by silica gel column chromatography (EtOAc/<i>n</i>-hexane 1/3) to afford an α-substituted acetonitrile.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure for Hydrolysis of Nitrile Group (Procedure <b>J</b>)</h3><div class="NLM_p last">To a solution of nitrile in MeOH was added the same amount of water and excess NaOH. The reaction mixture was refluxed for 24 h and then cooled to room temperature. The mixture was washed with EtOAc twice, acidified with dilute solution of HCl, and extracted several times with EtOAc. The combined organic layer was washed with water and concentrated in vacuo to yield an α-substituted acid, which was used for the next step without further purification.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for EDC Coupling Reaction (Procedure <b>K</b>)</h3><div class="NLM_p">To a solution of amine <b>44</b> (1.0 equiv) in CH<sub>2</sub>Cl<sub>2</sub> were stepwise added triethylamine (3.0 equiv), 1-hydroxybenzotriazole (HOBt) (1.2 equiv), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide·HCl (EDC·HCl) (1.2 equiv), and α-substituted acid (1.1 equiv) at room temperature. After stirring overnight, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed several times with water. The organic layer was dried over MgSO<sub>4</sub>, concentrated in vacuo, and purified by silica gel column chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub> 1/14) to provide an amide product.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(3,4-Dimethoxyphenyl)-1-methyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>46</b>)</h4><div class="NLM_p last">From compound <b>34</b>, procedure <b>H</b>, yield 52%, white solid, mp 80–81 °C: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (s, 1H), 6.90 (d, <i>J</i> = 8.48 Hz, 1H), 6.74 (dd, <i>J</i> = 8.37, 2.13 Hz, 1H), 6.70 (s, 1H), 6.65 (d, <i>J</i> = 2.16 Hz, 1H), 5.40 (br, NH), 3.89 (s, 3H), 3.84 (s, 3H), 3.82 (t, <i>J</i> = 7.16 Hz, 2H), 3.61 (s, 3H), 3.56 (q, <i>J</i> = 6.64 Hz, 2H), 2.12 (d, <i>J</i> = 0.96 Hz, 3H), 1.96 (quintet, <i>J</i> = 7.12 Hz, 2H); high-resolution mass spectrometry (HRMS) (electrospray ionization (ESI)) calcd for C<sub>17</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 349.1693, found: 349.1697.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(3,4-Dimethoxyphenyl)-1-ethyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>47</b>)</h4><div class="NLM_p last">From compound <b>35</b>, procedure <b>H</b>, yield 29%, white solid, mp 51–52 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) 7.77 (s, 1H), 6.90 (d, <i>J</i> = 8.43 Hz, 2H), 6.77 (s, 1H), 6.69 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.60 (d, <i>J</i> = 2.37 Hz, 1H), 5.39 (t, <i>J</i> = 6.60 Hz, 1H), 4.16 (q, <i>J</i> = 6.69 Hz, 2H), 3.90 (t, <i>J</i> = 7.68 Hz, 2H), 3.88 (s, 3H), 3.82 (s, 3H), 3.58 (q, <i>J</i> = 6.57 Hz, 2H), 2.15 (s, 3H), 2.02 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.17 (t, <i>J</i> = 7.14 Hz, 3H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 363.1849, found: 363.1847.</div></div><div id="sec4_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(3,4-Dimethoxyphenyl)-1-isopropyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>48</b>)</h4><div class="NLM_p last">From compound <b>8</b>, procedure <b>H</b>, yield 78%, white solid, mp 59–60 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47 (s, 1H), 6.92 (d, <i>J</i> = 8.61 Hz, 1H), 6.73 (s, 1H), 6.63 (dd, <i>J</i> = 8.43, 2.19 Hz, 1H), 6.52 (d, <i>J</i> = 2.22 Hz, 1H), 5.86 (quintet, <i>J</i> = 6.78 Hz, 1H), 5.21 (t, <i>J</i> = 5.67 Hz, 1H), 3.90 (s, 3H), 3.84 (s, 3H), 3.81 (t, <i>J</i> = 7.14 Hz, 2H), 3.58 (q, <i>J</i> = 6.39 Hz, 2H), 2.13 (d, <i>J</i> = 0.90 Hz, 3H), 1.98 (quintet, <i>J</i> = 7.32 Hz, 2H), 1.08 (s, 3H), 1.06 (s, 3H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 377.2006, found: 377.2008.</div></div><div id="sec4_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(3,4-Dimethoxyphenyl)-1-isobutyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>49</b>)</h4><div class="NLM_p last">From compound <b>9</b>, procedure <b>H</b>, yield 65%, white solid, mp 76–77 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.70 (s, 1H), 6.91 (d, <i>J</i> = 8.43 Hz, 1H), 6.78 (s, 1H), 6.72 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.62 (d, <i>J</i> = 2.40 Hz, 1H), 5.47 (t, <i>J</i> = 6.09 Hz, NH), 4.08 (t, <i>J</i> = 6.66 Hz, 2H), 3.89 (s, 3H), 3.88 (d, <i>J</i> = 7.89 Hz, 2H), 3.84 (s, 3H), 3.58 (q, <i>J</i> = 6.96 Hz, 2H), 2.16 (s, 3H), 1.98 (quintet, <i>J</i> = 7.32 Hz, 2H), 1.87–1.78 (m, 1H), 0.93 (d, <i>J</i> = 6.60 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 391.2162, found 391.2171.</div></div><div id="sec4_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(Cyclopentylmethyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>50</b>)</h4><div class="NLM_p last">From compound <b>36</b>, procedure <b>H</b>, yield 25%, white solid, mp 87–88 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48 (s, 1H), 6.87 (d, <i>J</i> = 8.61 Hz, 1H), 6.70 (s, 1H), 6.67 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.58 (d, <i>J</i> = 2.40 Hz, 1H), 5.36 (t, <i>J</i> = 5.85 Hz, 1H), 4.12 (d, <i>J</i> = 6.96 Hz, 2H), 3.84 (s, 3H), 3.80 (s, 3H), 3.78 (t, <i>J</i> = 7.32 Hz, 2H), 3.54 (q, <i>J</i> = 7.68 Hz, 2H), 2.09 (s, 3H), 2.06–1.99 (m, 1H), 1.83 (quintet, <i>J</i> = 6.78 Hz, 2H), 1.57–1.42 (m, 4H), 1.21–1.18 (m, 2H), 0.80–0.76 (m, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 417.2319, found 417.2323.</div></div><div id="sec4_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-Cyclopropyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>51</b>)</h4><div class="NLM_p last">From compound <b>10</b>, procedure <b>H</b>, yield 34%, white solid, 159 °C (decomposition): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.49 (d, <i>J</i> = 1.08 Hz, 1H), 6.86 (d, <i>J</i> = 8.43 Hz, 1H), 6.59 (d, <i>J</i> = 2.22 Hz, 1H), 6.57 (s, 1H), 6.52 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 3.87 (t, <i>J</i> = 7.14 Hz, 2H), 3.75 (s, 3H), 3.71 (s, 3H), 3.58 (t, <i>J</i> = 6.96 Hz, 2H), 3.09–3.02 (m, 1H), 2.12 (d, <i>J</i> = 0.90 Hz, 3H), 1.96 (quintet, <i>J</i> = 6.96 Hz, 2H), 0.80–0.68 (m, 2H), 0.51–0.46 (m, 2H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 375.1849, found 375.1846.</div></div><div id="sec4_11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-Cyclobutyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>52</b>)</h4><div class="NLM_p last">From compound <b>11</b>, procedure <b>H</b>, yield 52%, white solid, mp 126–127 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.40 (s, 1H), 6.93 (d, <i>J</i> = 8.43 Hz, 1H), 6.71 (s, 1H), 6.62 (dd, <i>J</i> = 8.40, 2.19 Hz, 1H), 6.51 (d, <i>J</i> = 2.01 Hz, 1H), 5.70 (quintet, <i>J</i> = 7.89 Hz, 1H), 5.25 (t, <i>J</i> = 5.67 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H), 3.80 (t, <i>J</i> = 7.32 Hz, 2H), 3.55 (q, <i>J</i> = 6.42 Hz, 2H), 2.20–2.16 (m, 2H), 2.12 (s, 3H), 1.93 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.72–1.39 (m, 4H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 389.2006, found 389.2014.</div></div><div id="sec4_11_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-Cyclopentyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>53</b>)</h4><div class="NLM_p last">From compound <b>12</b>, procedure <b>H</b>, yield 68%, white solid, mp 57–59 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 6.91 (d, <i>J</i> = 8.40 Hz, 1H), 6.75 (s, 1H), 6.62 (dd, <i>J</i> = 8.22, 2.19 Hz, 1H), 6.53 (d, <i>J</i> = 2.19 Hz, 1H), 5.76–5.64 (m, 1H), 5.24 (t, <i>J</i> = 5.31 Hz, 1H), 3.90 (s, 3H), 3.84 (t, <i>J</i> = 7.50 Hz, 2H), 3.83 (s, 3H), 3.59 (br, 2H), 2.14 (s, 3H), 1.98–1.91 (m, 4H), 1.56–1.44 (m, 4H), 1.23–1.94 (m, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 403.2162, found 403.2167.</div></div><div id="sec4_11_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-Cyclohexyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>54</b>)</h4><div class="NLM_p last">From compound <b>13</b>, procedure <b>H</b>, yield 69%, white solid, mp 62–64 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.56 (s, 1H), 6.98 (d, <i>J</i> = 8.43 Hz, 1H), 6.79 (s, 1H), 6.60 (dd, <i>J</i> = 8.40, 2.19 Hz, 1H), 6.51 (d, <i>J</i> = 2.19 Hz, 1H), 5.40–5.27 (m, 1H), 5.17 (t, <i>J</i> = 5.52 Hz, 1H), 3.90 (s, 3H), 3.83 (s, 3H), 3.83 (t, <i>J</i> = 7.05 Hz, 2H), 3.59 (brm, 2H), 2.15 (s, 3H), 1.96–1.92 (m, 4H), 1.71 (d, <i>J</i> = 12.63 Hz, 2H), 1.56 (d, <i>J</i> = 13.71 Hz, 1H), 1.47–1.36 (m, 2H), 1.04–0.81 (m, 3H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 417.2319, found 417.2327.</div></div><div id="sec4_11_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-Benzyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>55</b>)</h4><div class="NLM_p last">From compound <b>21</b>, procedure <b>H</b>, yield 50%, white solid, mp 157–159 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.70 (s, 1H), 7.28–7.22 (m, 5H), 6.79 (d, <i>J</i> = 8.61 Hz, 1H), 6.77 (s, 1H), 6.50 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.29 (d, <i>J</i> = 2.37 Hz, 1H), 5.53 (t, <i>J</i> = 5.67 Hz, 1H), 5.43 (s, 2H), 3.89 (t, <i>J</i> = 7.14 Hz, 2H), 3.84 (s, 3H), 3.63–3.59 (m, 5H), 2.17 (s, 3H), 2.01 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 425.2006, found 425.2013.</div></div><div id="sec4_11_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(3,4-Dimethoxyphenyl)-1-(3-fluorobenzyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>56</b>)</h4><div class="NLM_p last">From compound <b>23</b>, procedure <b>H</b>, yield 62%, white solid, mp 95–96 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.31 (s, 1H), 7.20 (qd, <i>J</i> = 8.25, 6.24 Hz, 1H), 7.08–7.03 (m, 2H), 6.92 (td, <i>J</i> = 8.61, 2.37 Hz, 1H), 6.80 (d, <i>J</i> = 8.58 Hz, 1H), 6.71 (s, 1H), 6.50 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.35 (d, <i>J</i> = 2.37 Hz, 1H), 5.47 (t, <i>J</i> = 5.67 Hz, 1H), 5.42 (s, 2H), 3.85 (s, 3H), 3.82 (t, <i>J</i> = 7.14 Hz, 2H), 3.68 (s, 3H), 3.61 (q, <i>J</i> = 6.78 Hz, 2H), 2.13 (d, <i>J</i> = 0.90 Hz, 3H), 1.97 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 443.1912, found 443.1921.</div></div><div id="sec4_11_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(3-Chlorobenzyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>57</b>)</h4><div class="NLM_p last">From compound <b>25</b>, procedure <b>H</b>, yield 43%, white solid, mp 90–91 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (s, 1H), 7.29 (s, 1H), 7.21–7.18 (m, 3H), 6.82 (d, <i>J</i> = 8.43 Hz, 1H), 6.73 (s, 1H), 6.52 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.35 (d, <i>J</i> = 2.19 Hz, 1H), 5.48 (t, <i>J</i> = 6.06 Hz, NH), 5.40 (s, 2H), 3.85 (s, 3H), 3.84 (t, <i>J</i> = 7.14 Hz, 2H), 3.69 (s, 3H), 3.62 (q, <i>J</i> = 6.57 Hz, 2H), 2.15 (s, 3H), 2.01 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 459.1616, found 459.1620.</div></div><div id="sec4_11_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(3,4-Dimethoxyphenyl)-1-(4-fluorobenzyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>58</b>)</h4><div class="NLM_p last">From compound <b>22</b>, procedure <b>H</b>, yield 55%, white solid, mp 54–56 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.59 (s, 1H), 7.26 (dd, <i>J</i> = 8.43, 5.49 Hz, 2H), 6.92 (t, <i>J</i> = 8.61 Hz, 2H), 6.79 (d, <i>J</i> = 7.89 Hz, 1H), 6.75 (s, 1H), 6.46 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.31 (d, <i>J</i> = 2.22 Hz, 1H), 5.50 (t-like, 1H), 5.39 (s, 2H), 3.86 (t, <i>J</i> = 7.14 Hz, 2H), 3.85 (s, 3H), 3.67 (s, 3H), 3.61 (q, <i>J</i> = 6.96 Hz, 2H), 2.16 (s, 3H), 1.97 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 443.1912, found 443.1909.</div></div><div id="sec4_11_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(4-Chlorobenzyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>59</b>)</h4><div class="NLM_p last">From compound <b>24</b>, procedure <b>H</b>, yield 34%, white solid, mp 71–72 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.34 (s, 1H), 7.26–7.21 (m, 4H), 6.82 (d, <i>J</i> = 8.43 Hz, 1H), 6.73 (s, 1H), 6.50 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.36 (d, <i>J</i> = 2.37 Hz, 1H), 5.51 (t, <i>J</i> = 5.70 Hz, NH), 5.41 (s, 2H), 3.99 (s, 3H), 3.99 (t, <i>J</i> = 8.25 Hz, 2H), 3.87 (s, 3H), 3.65 (q, <i>J</i> = 7.32 Hz, 2H), 2.17 (s, 3H), 2.08 (quintet, <i>J</i> = 6.60 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 459.1616, found 459.1615.</div></div><div id="sec4_11_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(pyridin-3-yl-methyl)thiourea (<b>60</b>)</h4><div class="NLM_p last">From compound <b>26</b>, procedure <b>H</b>, yield 78%, white solid, mp 58–60 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.41 (d, <i>J</i> = 2.19 Hz, 1H), 8.40 (dd, <i>J</i> = 4.95, 1.47 Hz, 1H), 7.88 (dt, <i>J</i> = 8.04, 2.19 Hz, 1H), 7.55 (d, <i>J</i> = 0.90 Hz, 1H), 7.36 (dd, <i>J</i> = 7.86, 4.38 Hz, 1H), 6.93 (d, <i>J</i> = 8.40 Hz, 1H), 6.66 (s, 1H), 6.59 (d, <i>J</i> = 2.37 Hz, 1H), 6.52 (dd, <i>J</i> = 8.43, 2.73 Hz, 1H), 5.52 (s, 2H), 3.90 (t, <i>J</i> = 7.14 Hz, 2H), 3.80 (s, 3H), 3.70 (s, 3H), 3.59 (t, <i>J</i> = 6.78 Hz, 2H), 2.19 (d, <i>J</i> = 0.93 Hz, 3H), 1.99 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 426.1958, found 426.1969.</div></div><div id="sec4_11_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(pyridin-4-yl-methyl)thiourea (<b>61</b>)</h4><div class="NLM_p last">From compound <b>29</b>, procedure <b>H</b>, yield 59%, white solid, mp 61–62 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 6.06, 1.65 Hz, 2H), 7.83 (s, 1H), 7.25 (t, <i>J</i> = 4.38, 1.44 Hz, 2H), 6.82 (d, <i>J</i> = 8.40 Hz, 1H), 6.79 (s, 1H), 6.56 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.43 (d, <i>J</i> = 2.37 Hz, 1H), 5.68 (t, <i>J</i> = 5.31 Hz, NH), 5.42 (s, 2H), 3.94 (t, <i>J</i> = 6.96 Hz, 2H), 3.85 (s, 3H), 3.71 (s, 3H), 3.66 (q, <i>J</i> = 6.78 Hz, 2H), 2.18 (d, <i>J</i> = 0.90 Hz, 3H), 2.08 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 426.1958, found 426.1930.</div></div><div id="sec4_11_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>62</b>)</h4><div class="NLM_p last">From compound <b>7</b>, procedure <b>G</b>, yield 56%, white solid, mp 100–101 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.59 (s, 1H), 7.42 (s, 1H), 7.17 (d, <i>J</i> = 2.40 Hz, 1H), 6.77–6.74 (m, 2H), 6.67 (dd, <i>J</i> = 8.61, 2.37 Hz, 1H), 5.76 (t, <i>J</i> = 4.95 Hz, NH), 3.94 (t, <i>J</i> = 6.75 Hz, 2H), 3.85 (s, 3H), 3.83 (s, 3H), 3.23 (q, <i>J</i> = 6.21 Hz, 2H), 2.19 (s, 3H), 1.98 (quintet, <i>J</i> = 6.60 Hz, 2H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 319.1765, found 319.1780.</div></div><div id="sec4_11_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(3,4-Dimethoxyphenyl)-1-methyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>63</b>)</h4><div class="NLM_p last">From compound <b>34</b>, procedure <b>G</b>, yield 32%, white solid, mp 103–104 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.31 (s, 1H), 6.86 (d, <i>J</i> = 8.43 Hz, 1H), 6.77 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.70–6.69 (m, 2H), 6.65 (d, <i>J</i> = 2.16 Hz, 1H), 4.34 (t, <i>J</i> = 5.85 Hz, NH), 3.87 (s, 3H), 3.85 (s, 3H), 3.82 (t, <i>J</i> = 7.32 Hz, 2H), 3.20 (s, 3H), 3.19 (q, <i>J</i> = 6.60 Hz, 2H), 2.12 (d, <i>J</i> = 0.75 Hz, 3H), 1.86 (quintet, <i>J</i> = 7.12 Hz, 2H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 333.1921, found 333.1929.</div></div><div id="sec4_11_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-(3,4-Dimethoxyphenyl)-1-ethyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>64</b>)</h4><div class="NLM_p last">From compound <b>35</b>, procedure <b>G</b>, yield 35%, white solid, mp 110–111 °C: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29 (s, 1H), 6.83 (d, <i>J</i> = 8.25 Hz, 1H), 6.70–6.66 (m, 2H), 6.62 (d, <i>J</i> = 2.22 Hz, 1H), 4.18 (t, <i>J</i> = 5.88 Hz, NH), 3.84 (s, 3H), 3.80 (s, 3H), 3.78 (t, <i>J</i> = 7.14 Hz, 2H), 3.65 (q, <i>J</i> = 7.14 Hz, 2H), 3.14 (q, <i>J</i> = 6.60 Hz, 2H), 2.08 (d, <i>J</i> = 0.90 Hz, 3H), 1.83 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.05 (t, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 347.2078, found 347.2079.</div></div><div id="sec4_11_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(3,4-Dimethoxyphenyl)-1-isopropyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>65</b>)</h4><div class="NLM_p last">From compound <b>8</b>, procedure <b>G</b>, yield 73%, white solid, mp 60–61 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.40 (s, 1H), 6.83 (d, <i>J</i> = 8.43 Hz, 1H), 6.68 (s, 1H), 6.65 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.55 (d, <i>J</i> = 2.19 Hz, 1H), 4.81 (quintet, <i>J</i> = 6.78 Hz. 1H), 4.04 (t, <i>J</i> = 5.85 Hz, 1H), 3.85 (s, 3H), 3.80 (s, 3H), 3.76 (t, <i>J</i> = 7.14 Hz, 2H), 3.12 (q, <i>J</i> = 6.39 Hz, 2H), 2.08 (d, <i>J</i> = 0.90 Hz, 3H), 1.87 (quintet, <i>J</i> = 7.14 Hz, 2H), <i>0</i>.99 (s, 3H), 0.97 (s, 3H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 361.2234, found 361.2237.</div></div><div id="sec4_11_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(3,4-Dimethoxyphenyl)-1-isobutyl-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>66</b>)</h4><div class="NLM_p last">From compound <b>9</b>, procedure <b>G</b>, yield 64%, white solid, mp 55–56 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.45 (s, 1H), 6.86 (d, <i>J</i> = 8.43 Hz, 1H), 6.76 (dd, <i>J</i> = 8.25, 2.37 Hz, 1H), 6.73 (s, 1H), 6.67 (d, <i>J</i> = 2.19 Hz, 1H), 4.29 (t, <i>J</i> = 6.03 Hz, 1H), 3.88 (s. 3H), 3.84 (s, 3H), 3.82 (t, <i>J</i> = 7.32 Hz, 2H), 3.46 (d, <i>J</i> = 7.50 Hz, 2H), 3.18 (q, <i>J</i> = 6.60 Hz, 2H), 2.13 (d, <i>J</i> = 0.90 Hz, 3H), 1.88 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.74–1.62 (m, 1H), 0.89 (d, <i>J</i> = 6.78 Hz, 6H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 375.2391, found 375.2426.</div></div><div id="sec4_11_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(Cyclopentylmethyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)-propyl)urea (<b>67</b>)</h4><div class="NLM_p last">From compound <b>36</b>, procedure <b>G</b>, yield 33%, white solid, mp 55–56 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (s, 1H), 6.83 (d, <i>J</i> = 8.43 Hz, 1H), 6.71 (m, 2H), 6.63 (d, <i>J</i> = 2.37 Hz, 1H), 4.23 (t, <i>J</i> = 5.85 Hz, 1H), 3.84 (s, 3H), 3.80 (s, 3H), 3.78 (t, <i>J</i> = 7.32 Hz, 2H), 3.54 (d, <i>J</i> = 7.68 Hz, 2H), 3.14 (q, <i>J</i> = 6.60 Hz, 2H), 2.09 (s, 3H), 1.97 (quintet, <i>J</i> = 6.96 Hz, 1H), 1.83 (quintet, <i>J</i> = 6.78 Hz, 2H), 1.57–1.42 (m, 4H), 1.21–1.18 (m, 2H), 0.80–0.76 (m, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 401.2547, found 401.2560.</div></div><div id="sec4_11_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-Cyclopropyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>68</b>)</h4><div class="NLM_p last">From compound <b>10</b>, procedure <b>G</b>, yield 28%, white solid, mp 84–85 °C: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.93 (s, 1H), 7.62–7.60 (m, 2H), 6.67 (s, 1H), 6.66 (d, <i>J</i> = 6.70 Hz, 1H), 5.00 (s, 1H), 3.95 (t, <i>J</i> = 6.95 Hz, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 3.25 (q, <i>J</i> = 6.25 Hz, 2H), 2.96–2.93 (m, 1H), 2.19 (s, 3H), 1.97–1.94 (m, 2H), 0.82–0.78 (m, 2H), 0.55–0.52 (m, 2H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>37</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 359.2078, found 359.2082.</div></div><div id="sec4_11_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-Cyclobutyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>69</b>)</h4><div class="NLM_p last">From compound <b>11</b>, procedure <b>G</b>, yield 50%, white solid, mp 77–78 °C: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.51 (s, 1H), 6.89 (d, <i>J</i> = 8.40 Hz, 1H), 6.74 (s, 1H), 6.67 (dd, <i>J</i> = 8.35, 2.15 Hz, 1H), 6.58 (d, <i>J</i> = 2.10 Hz, 1H), 4.94 (quintet, <i>J</i> = 7.90 Hz, 1H), 4.11 (t, <i>J</i> = 5.60 Hz, 1H), 3.90 (s, 3H), 3.85 (s, 3H), 3.82 (t, <i>J</i> = 7.15 Hz, 2H), 3.13 (q, <i>J</i> = 6.35 Hz, 2H), 2.13 (s, 3H), 2.11–2.07 (m, 2H), 1.83 (quintet, <i>J</i> = 6.70 Hz, 2H), 1.77–1.69 (m, 2H), 1.58–1.49 (m, 1H), 1.45–1.39 (m, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 373.2234, found 373.2236.</div></div><div id="sec4_11_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-Cyclopentyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>70</b>)</h4><div class="NLM_p last">From compound <b>12</b>, procedure <b>G</b>, yield 79%, white solid, mp 50–51 °C: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.61 (s, 1H), 6.86 (d, <i>J</i> = 8.40 Hz, 1H), 6.77 (s, 1H), 6.68 (dd, <i>J</i> = 8.30, 1.90 Hz, 1H), 6.60 (d, <i>J</i> = 1.85 Hz, 1H), 4.79–4.73 (m, 1H), 4.08 (t, <i>J</i> = 5.50 Hz, 1H), 3.89 (s, 3H), 3.85 (s, 3H), 3.85 (t, <i>J</i> = 8.50 Hz, 2H), 3.14 (q, <i>J</i> = 6.35 Hz, 2H), 2.15 (s, 3H), 1.85–1.81 (m, 4H), 1.50–1.48 (m, 4H), 1.29–1.23 (m, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 387.2391, found 387.2387.</div></div><div id="sec4_11_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-Cyclohexyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>71</b>)</h4><div class="NLM_p last">From compound <b>13</b>, procedure <b>G</b>, yield 48%, white solid, mp 53–55 °C: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.66 (s, 1H), 6.85 (d, <i>J</i> = 8.40 Hz, 1H), 6.78 (s, 1H), 6.67 (dd, <i>J</i> = 8.35, 2.05 Hz, 1H), 6.58 (d, <i>J</i> = 2.10 Hz, 1H), 4.36 (tt, <i>J</i> = 11.90, 3.20 Hz, 1H), 4.05 (t, <i>J</i> = 5.60 Hz, 1H), 3.89 (s, 3H), 3.87–3.85 (m, 5H), 3.14 (q, <i>J</i> = 6.25 Hz, 2H), 2.16 (s, 3H), 1.87–1.80 (m, 4H), 1.72–1.69 (m, 2H), 1.56–1.54 (m, 1H), 1.40–1.34 (m, 2H), 1.01 (qd, <i>J</i> = 12.4, 3.15 Hz, 2H), 0.89 (qt, <i>J</i> = 13.1, 3.40 Hz, 1H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 401.2547, found 401.2554.</div></div><div id="sec4_11_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-Benzyl-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>72</b>)</h4><div class="NLM_p last">From compound <b>21</b>, procedure <b>G</b>, yield 51%, white solid, mp 112–113 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 7.27–7.19 (m, 5H), 6.77 (d, <i>J</i> = 8.61 Hz, 1H), 6.76 (s, 1H), 6.58 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.39 (d, <i>J</i> = 2.40 Hz, 1H), 4.77 (s, 2H), 4.34 (t, <i>J</i> = 5.85 Hz, 1H), 3.86 (t, <i>J</i> = 7.14 Hz, 2H), 3.84 (s, 3H), 3.67 (s, 3H), 3.19 (q, <i>J</i> = 6.60 Hz, 2H), 2.15 (d, <i>J</i> = 0.75 Hz, 3H), 1.87 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 409.2234, found 409.2237.</div></div><div id="sec4_11_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(3,4-Dimethoxyphenyl)-1-(3-fluorobenzyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>73</b>)</h4><div class="NLM_p last">From compound <b>23</b>, procedure <b>G</b>, yield 56%, white solid, mp 123–125 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.28 (s, 1H), 7.16 (qd, <i>J</i> = 7.86, 5.67 Hz, 1H), 6.94–6.84 (m, 3H), 6.73 (d, <i>J</i> = 8.43 Hz, 1H), 6.67 (s, 1H), 6.54 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.39 (d, <i>J</i> = 2.19 Hz, 1H), 4.72 (s, 2H), 4.28 (t, <i>J</i> = 5.88 Hz, 1H), 3.81 (s, 3H), 3.77 (t, <i>J</i> = 7.14 Hz, 2H), 3.67 (s, 3H), 3.15 (q, <i>J</i> = 6.39 Hz, 2H), 2.09 (s, 3H), 1.82 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 427.2140, found 427.2155.</div></div><div id="sec4_11_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(3-Chlorobenzyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>74</b>)</h4><div class="NLM_p last">From compound <b>25</b>, procedure <b>G</b>, yield 54%, white solid, mp 53–54 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.32 (s, 1H), 7.17–7.13 (m, 3H), 7.06–7.03 (m, 1H), 6.75 (d, <i>J</i> = 8.43 Hz, 1H), 6.67 (s, 1H), 6.55 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.39 (d, <i>J</i> = 2.40 Hz, 1H), 4.70 (s, 2H), 4.29 (t, <i>J</i> = 5.67 Hz, NH), 3.81 (s, 3H), 3.77 (t, <i>J</i> = 7.32 Hz, 2H), 3.67 (s, 3H), 3.18 (q, <i>J</i> = 6.78 Hz, 2H), 2.09 (s, 3H), 1.86 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 443.1844, found 443.1899.</div></div><div id="sec4_11_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 1-(3,4-Dimethoxyphenyl)-1-(4-fluorobenzyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>75</b>)</h4><div class="NLM_p last">From compound <b>22</b>, procedure <b>G</b>, yield 52%, white solid, mp 87–88 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.59 (s, 1H), 7.16 (dd, <i>J</i> = 8.04, 5.49 Hz, 2H), 6.93 (t, <i>J</i> = 7.86 Hz, 2H), 6.78 (d, <i>J</i> = 8.43 Hz, 1H), 6.76 (s, 1H), 6.54 (dd, <i>J</i> = 8.43, 1.47 Hz, 1H), 6.40 (d, <i>J</i> = 1.83 Hz, 1H), 4.73 (s, 2H), 4.33 (t, <i>J</i> = 5.85 Hz, 1H), 3.85 (s, 3H), 3.85 (t, <i>J</i> = 7.14 Hz, 2H), 3.71 (s, 3H), 3.18 (q, <i>J</i> = 6.60 Hz, 2H), 2.15 (s, 3H), 1.86 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 427.2140, found 427.2147.</div></div><div id="sec4_11_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-(4-Chlorobenzyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>76</b>)</h4><div class="NLM_p last">From compound <b>24</b>, procedure <b>G</b>, yield 25%, white solid, mp 54–55 °C: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (s, 1H), 7.24 (d, <i>J</i> = 8.44 Hz, 2H), 7.15 (d, <i>J</i> = 8.36 Hz, 2H), 6.78 (d, <i>J</i> = 8.52 Hz, 1H), 6.71 (s, 1H), 6.57 (dd, <i>J</i> = 8.52, 2.40 Hz, 1H), 6.42 (s, 1H), 4.73 (s, 2H), 4.30 (t, <i>J</i> = 5.72 Hz, NH), 3.85 (s, 3H), 3.83 (t, <i>J</i> = 7.08 Hz, 2H), 3.72 (s, 3H), 3.21 (q, <i>J</i> = 6.52 Hz, 2H), 2.12 (s, 3H), 1.89 (quintet, <i>J</i> = 6.88 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 443.1844, found 443.1851.</div></div><div id="sec4_11_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(pyridin-3-yl-methyl)urea (<b>77</b>)</h4><div class="NLM_p last">From compound <b>26</b>, procedure <b>G</b>, yield 76%, white solid, mp 94–95 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.41 (dd, <i>J</i> = 4.95, 1.65 Hz, 1H), 8.35 (d, <i>J</i> = 1.65 Hz, 1H), 7.74 (dt, <i>J</i> = 7.89, 1.83 Hz, 1H), 7.55 (s, 1H), 7.38 (dd, <i>J</i> = 7.89, 4.77 Hz, 1H), 6.91 (d, <i>J</i> = 8.58 Hz, 1H), 6.66 (d, <i>J</i> = 2.40 Hz, 1H), 6.65 (s, 1H), 6.60 (dd, <i>J</i> = 8.61, 2.55 Hz, 1H), 4.85 (s, 2H), 3.90 (t, <i>J</i> = 7.14 Hz, 2H), 3.81 (s, 3H), 3.72 (s, 3H), 3.16 (t, <i>J</i> = 6.60 Hz, 2H), 2.18 (d, <i>J</i> = 1.11 Hz, 3H), 1.86 (quintet, <i>J</i> = 7.08 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 410.2187, found 410.2189.</div></div><div id="sec4_11_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-(3,4-Dimethoxyphenyl)-1-((6-fluoropyridin-3-yl)methyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>78</b>)</h4><div class="NLM_p last">From compound <b>27</b>, procedure <b>G</b>, yield 54%, white solid, mp 59–60 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.99 (s, 1H), 7.85 (dt, <i>J</i> = 8.25, 2.55 Hz, 1H), 7.36 (s, 1H), 6.91 (dd, <i>J</i> = 8.43, 2.94 Hz, 1H), 6.84 (d, <i>J</i> = 8.43 Hz, 1H), 6.74 (s, 1H), 6.57 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.50 (d, <i>J</i> = 2.37 Hz, 1H), 4.80 (s, 2H), 4.36 (t, <i>J</i> = 6.24 Hz, NH), 3.90 (s, 3H), 3.84 (t, <i>J</i> = 7.14 Hz, 2H), 3.80 (s, 3H), 3.25 (q, <i>J</i> = 6.78 Hz, 2H), 2.16 (d, <i>J</i> = 0.75 Hz, 3H), 1.94 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 428.2092, found 428.2088.</div></div><div id="sec4_11_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-((6-Chloropyridin-3-yl)methyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>79</b>)</h4><div class="NLM_p last">From compound <b>28</b>, procedure <b>G</b>, yield 87%, white solid, mp 72–73 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 2.37 Hz, 1H), 7.65 (dd, <i>J</i> = 8.07, 2.40 Hz, 1H), 7.31–7.24 (m, 2H), 6.80 (d, <i>J</i> = 8.43 Hz, 1H), 6.70 (s, 1H), 6.52–6.74 (m, 2H), 4.75 (s, 2H), 4.32 (t, <i>J</i> = 5.88 Hz, NH), 3.85 (s, 3H), 3.82 (t, <i>J</i> = 7.14 Hz, 2H), 3.76 (s, 3H), 3.20 (q, <i>J</i> = 6.42 Hz, 2H), 2.12 (d, <i>J</i> = 0.90 Hz, 3H), 1.89 (quintet, <i>J</i> = 6.78 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>ClN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 444.1797, found 444.1792.</div></div><div id="sec4_11_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-((6-Aminopyridin-3-yl)methyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>80</b>)</h4><div class="NLM_p last">From compound <b>39</b>, procedure <b>G</b> then <b>F</b>, yield 67%, white solid, mp 155–157 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.71 (d, <i>J</i> = 2.01 Hz, 1H), 7.36 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 7.26 (d, <i>J</i> = 0.93 Hz, 1H), 7.72 (d, <i>J</i> = 8.61 Hz, 1H), 6.65 (s, 1H), 6.47 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.40 (d, <i>J</i> = 2.37 Hz, 1H), 6.37 (d, <i>J</i> = 8.43 Hz, 1H), 4.58 (s, 2H), 4.31 (s, 2H), 4.21 (t, <i>J</i> = 5.85 Hz, 1H), 3.80 (s, 3H), 3.76 (t, <i>J</i> = 7.14 Hz, 2H), 3.69 (s, 3H), 3.12 (q, <i>J</i> = 6.24 Hz, 2H), 2.06 (d, <i>J</i> = 0.90 Hz, 3H), 1.79 (quintet, <i>J</i> = 7.32 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>29</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 425.2296, found 425.2296.</div></div><div id="sec4_11_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(pyridin-4-yl-methyl)urea (<b>81</b>)</h4><div class="NLM_p last">From compound <b>29</b>, procedure <b>G</b>, yield 54%, white solid, mp 79–80 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.46 (dd, <i>J</i> = 4.41, 1.65 Hz, 2H), 7.29 (s, 1H), 7.13 (dd, <i>J</i> = 4.38, 1.47 Hz, 2H), 6.75 (d, <i>J</i> = 8.40 Hz, 1H), 6.66 (s, 1H), 6.57 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.45 (d, <i>J</i> = 2.37 Hz, 1H), 4.73 (s, 2H), 4.36 (t, <i>J</i> = 5.85 Hz, NH), 3.80 (s, 3H), 3.77 (t, <i>J</i> = 7.14 Hz, 2H), 3.69 (s, 3H), 3.19 (q, <i>J</i> = 6.75 Hz, 2H), 2.08 (d, <i>J</i> = 0.90 Hz, 3H), 1.87 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub> [M + H ]<sup>+</sup> 410.2187, found 410.2181.</div></div><div id="sec4_11_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-((2-Aminopyridin-4-yl)methyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>82</b>)</h4><div class="NLM_p last">From compound <b>40</b>, procedure <b>G</b> then <b>F</b>, yield 52%, white solid, mp 105–107 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.89 (d, <i>J</i> = 5.13 Hz, 1H), 7.29 (s, 1H), 6.73 (d, <i>J</i> = 8.43 Hz, 1H), 6.66 (s, 1H), 6.57 (dd, <i>J</i> = 8.43, 2.00 Hz, 1H), 6.47 (d, <i>J</i> = 2.40 Hz, 1H), 6.44 (dd, <i>J</i> = 5.28, 1.26 Hz, 1H), 6.36 (s, 1H), 4.60 (s, 2H), 4.44 (s, 2H), 4.31 (t, <i>J</i> = 5.85 Hz, 1H), 3.80 (s, 3H), 3.77 (t, <i>J</i> = 7.14 Hz, 2H), 3.70 (s, 3H), 3.16 (q, <i>J</i> = 6.21 Hz, 2H), 2.08 (d, <i>J</i> = 0.75 Hz, 3H), 1.82 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 425.2296, found 425.2293.</div></div><div id="sec4_11_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-(2-(2-Aminopyridin-4-yl)ethyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>83</b>)</h4><div class="NLM_p last">From compound <b>41</b>, procedure <b>G</b> then <b>F</b>, yield 83%, white solid, mp 223–224 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.74 (d, <i>J</i> = 5.13 Hz, 1H), 7.52 (s, 1H), 6.99 (d, <i>J</i> = 8.43 Hz, 1H), 6.74 (dd, <i>J</i> = 8.25, 2.37 Hz, 1H), 6.64 (s, 1H), 6.63 (d, <i>J</i> = 2.37 Hz, 1H), 6.45–6.41 (m, 2H), 3.89–3.81 (m, 7H), 3.76 (s, 3H), 3.14 (t, <i>J</i> = 6.78 Hz, 2H), 2.75 (t, <i>J</i> = 6.93 Hz, 2H), 2.17 (d, <i>J</i> = 0.93 Hz, 3H), 1.89 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>30</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 439.1837, found 439.1847.</div></div><div id="sec4_11_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-(4-(2-Aminopyridin-4-yl)butyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>84</b>)</h4><div class="NLM_p last">From compound <b>42</b>, procedure <b>G</b> then <b>F</b>, yield 94%, white solid, mp 150–151 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.71 (d, <i>J</i> = 5.31 Hz, 1H), 7.53 (s, 1H), 6.98 (d, <i>J</i> = 8.43 Hz, 1H), 6.77 (d, <i>J</i> = 2.37 Hz, 1H), 6.72 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.64 (s, 1H), 6.41 (d, <i>J</i> = 5.31 Hz, 1H), 6.38 (s, 1H), 3.87 (t, <i>J</i> = 7.14 Hz, 2H), 3.85 (s, 3H), 3.80 (s, 3H), 3.63 (t, <i>J</i> = 7.32 Hz, 2H), 3.11 (t, <i>J</i> = 6.60 Hz, 2H), 2.48 (t, <i>J</i> = 7.14 Hz, 2H), 2.16 (d, <i>J</i> = 0.93 Hz, 3H), 1.83 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.64–1.46 (m, 4H); HRMS (ESI) calcd for C<sub>25</sub>H<sub>35</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 467.2765, found 467.2767.</div></div><div id="sec4_11_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-(4-(2-(2-Aminoethylamino)pyridin-4-yl)butyl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>85</b>)</h4><div class="NLM_p last">From compound <b>43</b>, procedure <b>G</b> then <b>F</b>, yield 89%, white solid, mp 64–65 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.87 (d, <i>J</i> = 5.13 Hz, 1H), 7.28 (s, 1H), 6.79 (d, <i>J</i> = 8.40 Hz, 1H), 6.65 (d, <i>J</i> = 2.37 Hz, 1H), 6.63 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.58 (d, <i>J</i> = 2.22 Hz, 1H), 6.31 (d, <i>J</i> = 4.02 Hz, 1H), 6.14 (s, 1H), 4.69 (br, 1H), 4.16 (t, <i>J</i> = 6.06 Hz, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 3.75 (t, <i>J</i> = 6.96 Hz, 2H), 3.58 (t, <i>J</i> = 6.93 Hz, 2H), 3.27 (q, <i>J</i> = 5.67 Hz, 2H), 3.10 (q, <i>J</i> = 6.24 Hz, 2H), 2.87 (t, <i>J</i> = 5.70 Hz, 2H), 2.42 (t, <i>J</i> = 7.14 Hz, 2H), 2.07 (s, 3H), 1.78 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.56–1.42 (m, 4H); HRMS (ESI) calcd for C<sub>27</sub>H<sub>40</sub>N<sub>7</sub>O<sub>3</sub> [M + H]<sup>+</sup> 510.3187, found 510.3186.</div></div><div id="sec4_11_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-phenylurea (<b>86</b>)</h4><div class="NLM_p last">The solution of <b>30</b> (1.0 equiv) in toluene was cooled to 0 °C and added with pyridine (1.0 equiv) followed by triphosgene (0.34 equiv). The reaction mixture was stirred for 2 h at 70 °C and cooled down to 0 °C. After adding amine <b>44</b> (1.0 equiv) and pyridine (1.0 equiv), the reaction mixture was refluxed overnight. The mixture was washed with NaHCO<sub>3</sub> solution, water, and brine and concentrated in vacuo. The residue was purified by silica gel chromatography to afford <b>86</b>. Yield 51%, white solid, mp 117–118 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46 (s, 1H), 7.33–7.22 (m, 4H), 7.13 (t, <i>J</i> = 7.14 Hz, 1H), 6.85–6.80 (m, 2H), 6.78 (s, 1H), 6.73 (s, 1H), 4.63 (t, <i>J</i> = 5.85 Hz, 1H), 3.87 (t, <i>J</i> = 7.32 Hz, 2H), 3.86 (s, 3H), 3.80 (s, 3H), 3.23 (q, <i>J</i> = 6.24 Hz, 2H), 2.15 (s, 3H), 1.95 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 395.2078, found 395.2080.</div></div><div id="sec4_11_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(oxazol-2-yl)urea (<b>87</b>)</h4><div class="NLM_p last">From compound <b>32</b>, procedure <b>G</b>, yield 61%, white solid, mp 139–140 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.81 (t, <i>J</i> = 5.44 Hz, 1H), 7.42 (s, 1H), 7.07–7.05 (m, 2H), 6.94–6.82 (m, 2H), 6.72 (s, 1H), 6.53 (d, <i>J</i> = 3.30 Hz, 1H), 3.91–3.82 (m, 8H), 3.37 (q, <i>J</i> = 6.03 Hz, 2H), 2.15 (d, <i>J</i> = 0.90 Hz, 3H), 1.99 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 386.1823, found 386.1839.</div></div><div id="sec4_11_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(thiazol-2-yl)urea (<b>88</b>)</h4><div class="NLM_p last">From compound <b>31</b>, procedure G, yield 62%, white solid, mp 140–141 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.58 (d, <i>J</i> = 1.08 Hz, 1H), 7.27 (d, <i>J</i> = 3.66 Hz, 1H), 7.11 (d, <i>J</i> = 8.43 Hz, 1H), 7.02 (d, <i>J</i> = 3.87 Hz, 1H), 6.93–6.87 (m, 2H), 6.65 (s, 1H), 4.00 (t, <i>J</i> = 6.96 Hz, 2H), 3.95 (s, 3H), 3.81 (s, 3H), 3.26 (t, <i>J</i> = 6.66 Hz, 2H), 2.21 (d, <i>J</i> = 1.08 Hz, 3H), 2.01 (quintet, <i>J</i> = 6.75 Hz, 2H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>S 402.1594, found 402.1599.</div></div><div id="sec4_11_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(piperidin-4-yl)urea (<b>89</b>)</h4><div class="NLM_p last">A suspension of <b>94</b>, Pd/C (10 mol %), and two drops of concd HCl in MeOH was hydrogenated under a balloon of hydrogen for 1 h. The mixture was filtered off (Celite) and washed with MeOH. The combined filtrate was concentrated in vacuo, and the residue was purified by PLC (silica gel, MeOH/CH<sub>2</sub>Cl<sub>2</sub> 1/9) to provide <b>89</b>. Yield 93%, white solid, mp 119–121 °C; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.52 (s, 1H), 7.02 (d, <i>J</i> = 8.25 Hz, 1H), 6.73 (dd, <i>J</i> = 8.46, 2.37 Hz, 1H), 6.64 (s, 1H), 3.87 (t, <i>J</i> = 7.14 Hz, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 3.11 (t, <i>J</i> = 6.75 Hz, 2H), 3.01 (d, <i>J</i> = 12.27 Hz, 2H), 2.68–2.60 (m, 2H), 2.17 (d, <i>J</i> = 0.93 Hz, 3H), 1.84–1.79 (m, 4H), 1.29 (qd, <i>J</i> = 12.09, 4.32 Hz, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 402.2500, found 402.2491.</div></div><div id="sec4_11_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(1-methylpiperidin-4-yl)urea (<b>90</b>)</h4><div class="NLM_p last">From compound <b>14</b>, procedure <b>G</b>, yield 65%, white solid, mp 85–86 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.54 (s, 1H), 7.02 (d, <i>J</i> = 9.15 Hz, 1H), 6.75–6.71 (m, 2H), 6.64 (s, 1H), 4.36–4.28 (m, 1H), 3.89–3.84 (m, 5H), 3.81 (s, 3H), 3.10 (t, <i>J</i> = 6.78 Hz, 2H), 2.88 (d, <i>J</i> = 11.73 Hz, 2H), 2.20 (s, 3H), 2.17 (d, <i>J</i> = 0.93 Hz, 3H), 2.14 (t, <i>J</i> = 5.13 Hz, 2H), 1.86–1.79 (m, 4H), 1.52–1.36 (m, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>34</sub>N<sub>5</sub>O<sub>3</sub> 416.2656, found 416.2655.</div></div><div id="sec4_11_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-(3,4-Dimethoxyphenyl)-1-(1-ethylpiperidin-4-yl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>91</b>)</h4><div class="NLM_p last">From compound <b>15</b>, procedure <b>G</b>, yield 51%, white solid, mp 76–77 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.26 (s, 1H), 6.79 (d, <i>J</i> = 8.43 Hz, 1H), 6.65 (s, 1H), 6.62 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.52 (d, <i>J</i> = 2.37 Hz, 1H), 4.43–4.34 (m, 1H), 4.04 (t, <i>J</i> = 6.06 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 3.76 (t, <i>J</i> = 7.32 Hz, 2H), 3.12 (q, <i>J</i> = 6.39 Hz, 2H), 2.93–2.89 (br, 2H), 2.35 (q, <i>J</i> = 7.14 Hz, 2H), 2.07 (d, <i>J</i> = 0.90 Hz, 3H), 2.03–1.96 (m, 2H), 1.82–1.72 (m, 4H), 1.44–1.33 (m, 2H), 0.99 (t, <i>J</i> = 7.14 Hz, 3H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub> 430.2813, found 430.2813.</div></div><div id="sec4_11_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-(1-Acetylpiperidin-4-yl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>92</b>)</h4><div class="NLM_p last">From compound <b>16</b>, procedure <b>G</b>, yield 84%, white solid, mp 58–59 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 1H), 6.81 (d, <i>J</i> = 8.43 Hz, 1H), 6.66 (s, 1H), 6.58 (dd, <i>J</i> = 8.25, 2.22 Hz, 1H), 6.48 (d, <i>J</i> = 2.37 Hz, 1H), 4.63–4.55 (m, 2H), 4.02 (t, <i>J</i> = 4.41 Hz, 1H), 3.89 (s, 3H), 3.79 (s, 3H), 3.74 (t, <i>J</i> = 7.14 Hz, 2H), 3.79–3.72 (m, 1H), 3.13–3.05 (m, 3H), 2.53 (t, <i>J</i> = 10.8 Hz, 1H), 2.07 (s, 3H), 1.94 (s, 3H), 1.82–1.76 (m, 4H), 1.20–1.12 (m, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>34</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 444.2605, found 444.2612.</div></div><div id="sec4_11_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(1-phenylpiperidin-4-yl)urea (<b>93</b>)</h4><div class="NLM_p last">From compound <b>17</b>, procedure <b>G</b>, yield 56%, white solid, mp 87–88 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.55 (s, 1H), 7.22–7.16 (m, 2H), 6.87–6.84 (m, 3H), 6.82–6.77 (m, 2H), 6.71 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.59 (d, <i>J</i> = 2.19 Hz, 1H), 4.55–4.50 (m, 1H), 4.11 (t, <i>J</i> = 5.55 Hz, NH), 3.88 (s, 3H), 3.85 (s, 3H), 3.82 (t, <i>J</i> = 7.14 Hz, 2H), 3.65–3.61 (br, 2H), 3.17 (q, <i>J</i> = 6.21 Hz, 2H), 2.84–2.76 (m, 2H), 2.15 (d, <i>J</i> = 0.90 Hz, 3H), 1.87–1.82 (m, 4H), 1.51–1.41 (m, 2H); HRMS (ESI) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub> 478.2813, found 478.2823.</div></div><div id="sec4_11_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(1-Benzylpiperidin-4-yl)-1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>94</b>)</h4><div class="NLM_p last">From compound <b>18</b>, procedure <b>G</b>, yield 78%, white solid, mp 53–55 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.29 (d, <i>J</i> = 0.75 Hz, 1H), 7.25–7.16 (m, 5H), 6.84 (d, <i>J</i> = 8.40 Hz, 1H), 6.94 (s, 1H), 6.64 (dd, <i>J</i> = 8.40, 2.19 Hz, 1H), 6.55 (d, <i>J</i> = 2.19 Hz, 1H), 4.43 (tt, <i>J</i> = 12.09, 4.05 Hz, 1H), 4.03 (t, <i>J</i> = 5.67 Hz, 1H), 3.88 (s, 3H), 3.83 (s, 3H), 3.77 (t, <i>J</i> = 7.14 Hz, 2H), 3.42 (s, 2H), 3.12 (q, <i>J</i> = 6.60 Hz, 2H), 2.85 (d, <i>J</i> = 11.37 Hz, 2H), 2.11 (d, <i>J</i> = 0.90 Hz, 3H), 2.07 (t, <i>J</i> = 10.26 Hz, 2H), 1.81 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.76–1.72 (m, 2H), 1.38 (qd, <i>J</i> = 12.09, 3.66 Hz, 2H); HRMS (ESI) calcd for C<sub>28</sub>H<sub>38</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 492.2969, found 492.2973.</div></div><div id="sec4_11_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-(3,4-Dimethoxyphenyl)-1-(1-(4-fluorobenzyl)piperidin-4-yl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)urea (<b>95</b>)</h4><div class="NLM_p last">From compound <b>19</b>, procedure <b>G</b>, yield 45%, white solid, mp 48–49 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 1H), 7.17 (dd, <i>J</i> = 8.43, 5.49 Hz, 2H), 6.91 (t, <i>J</i> = 8.61 Hz, 2H), 6.80 (d, <i>J</i> = 8.43 Hz, 1H), 6.65 (s, 1H), 6.62 (dd, <i>J</i> = 8.43, 2.19 Hz, 1H), 6.51 (d, <i>J</i> = 2.19 Hz, 1H), 4.42–4.34 (m, 1H), 4.01 (t, <i>J</i> = 5.31, NH), 3.83 (s, 3H), 3.78 (s, 3H), 3.75 (t, <i>J</i> = 7.14 Hz, 2H), 3.36 (s, 2H), 3.11 (q, <i>J</i> = 6.03 Hz, 2H), 2.82–2.79 (br, 2H), 2.06 (d, <i>J</i> = 0.90 Hz, 3H), 2.05–2.01 (m, 2H), 1.81 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.74–1.68 (br, 2H), 1.38–1.34 (m, 2H); HRMS (ESI) calcd for C<sub>28</sub>H<sub>37</sub>FN<sub>5</sub>O<sub>3</sub> 510.2875, found: 510.2871.</div></div><div id="sec4_11_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(1-(pyridin-3-yl-methyl)piperidin-4-yl)urea (<b>96</b>)</h4><div class="NLM_p last">From compound <b>20</b>, procedure <b>G</b>, yield 74%, white solid, mp 116–117 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.40 (d, <i>J</i> = 1.65 Hz, 1H), 8.39 (dd, <i>J</i> = 4.74, 1.65 Hz, 1H), 7.51 (dt, <i>J</i> = 7.68, 1.83 Hz, 1H), 7.26 (s, 1H), 7.14 (dd, <i>J</i> = 7.86, 4.92 Hz, 1H), 6.80 (d, <i>J</i> = 8.43 Hz, 1H), 6.65 (s, 1H), 6.60 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.51 (d, <i>J</i> = 2.19 Hz, 1H), 4.38 (tt, <i>J</i> = 12.09, 3.87 Hz, 1H), 4.01 (t, <i>J</i> = 5.88 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 3.73 (t, <i>J</i> = 7.14 Hz, 2H), 3.37 (s, 2H), 3.08 (q, <i>J</i> = 6.21 Hz, 2H), 2.77 (d, <i>J</i> = 11.55 Hz, 2H), 2.16–2.02 (m, 2H), 2.06 (d, <i>J</i> = 0.72 Hz, 3H), 1.77 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.70 (d, <i>J</i> = 10.80 Hz, 2H), 1.32 (qd, <i>J</i> = 12.09, 3.66 Hz, 2H); HRMS (ESI) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 510.3187, found 510.3188.</div></div><div id="sec4_11_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(2-(piperazin-1-yl)ethyl)urea (<b>97</b>)</h4><div class="NLM_p last">From compound <b>37</b>, procedure <b>G</b> then <b>F</b>, yield 91%, white solid, mp 108–109 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.53 (s, 1H), 7.01 (d, <i>J</i> = 8.40 Hz, 1H), 6.89 (d, <i>J</i> = 2.37 Hz, 1H), 6.85 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.64 (s, 1H), 3.91 (t, <i>J</i> = 7.32 Hz, 2H), 3.84 (s, 3H), 3.82 (s, 3H), 3.78 (t, <i>J</i> = 6.75 Hz, 2H), 3.13 (t, <i>J</i> = 6.78 Hz, 2H), 2.80 (t, <i>J</i> = 4.95 Hz, 4H), 2.49–2.44 (m, 6H), 2.18 (d, <i>J</i> = 1.11 Hz, 3H), 1.88 (quintet, <i>J</i> = 6.78 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>35</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 431.27645, found 431.2773.</div></div><div id="sec4_11_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1-(3,4-Dimethoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-1-(2-morpholi-noethyl)urea (<b>98</b>)</h4><div class="NLM_p last">From compound <b>38</b>, procedure <b>G</b>, yield 54%, white solid, mp 59–60 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 1H), 6.82 (d, <i>J</i> = 8.43 Hz, 1H), 6.75–6.70 (m, 2H), 6.65 (s, 1H), 4.26 (t, <i>J</i> = 6.06 Hz, NH), 3.84 (s, 3H), 3.80 (s, 3H), 3.77–3.68 (m, 4H), 3.61 (t, <i>J</i> = 4.56 Hz, 4H), 3.13 (q, <i>J</i> = 6.57 Hz, 2H), 2.42–2.37 (m, 6H), 2.08 (d, <i>J</i> = 1.11 Hz, 3H), 1.83 (quintet, <i>J</i> = 7.14 Hz, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>34</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 432.2605, found 432.2601.</div></div><div id="sec4_11_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)acetamide (<b>100</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 67%, white solid, mp 85–86 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) 7.32 (s, 1H), 6.82 (d, <i>J</i> = 8.61 Hz, 1H), 6.75–6.70 (m, 3H), 5.75 (br, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.79 (t, <i>J</i> = 7.14 Hz, 2H), 3.46 (s, 2H), 3.22 (q, <i>J</i> = 6.57 Hz, 2H), 2.10 (s, 3H), 1.89 (quintet, <i>J</i> = 6.96 Hz, 2H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 318.1789, found 318.1801.</div></div><div id="sec4_11_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)propanamide (<b>101</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 16%, white solid, mp 88–89 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.33 (s, 1H), 6.86–6.79 (m, 3H), 6.75 (s, 1H), 5.39 (br, 1H), 3.88 (s, 6H), 3.77 (t, <i>J</i> = 7.14 Hz, 2H), 3.47 (q, <i>J</i> = 7.14 Hz, 1H), 3.22 (q, <i>J</i> = 8.06 Hz, 2H), 2.11 (s, 3H), 1.86 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.50 (d, <i>J</i> = 7.14 Hz, 3H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 332.1969, found 332.1962.</div></div><div id="sec4_11_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 2-(3,4-Dimethoxyphenyl)-2-methyl-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-propanamide (<b>102</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 59%, white solid, mp 89–91 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.30 (s, 1H), 6.93–6.83 (m, 3H), 6.73 (s, 1H), 5.23 (br, NH), 3.89 (d, <i>J</i> = 6.78 Hz, 6H), 3.78 (t, <i>J</i> = 6.96 Hz, 2H), 3.21 (quintet, <i>J</i> = 6.60 Hz, 2H), 2.12 (s, 3H), 1.88 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.55 (s, 6H); HRMS (fast atom bombardment (FAB)): calcd for C<sub>19</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 346.2125, found 346.2131.</div></div><div id="sec4_11_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 1-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)cyclopropanecarboxamide (<b>103</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 47%, white solid, mp 71–73 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.51 (d, <i>J</i> = 0.90 Hz, 1H), 6.96–6.94 (m, 3H), 6.65 (m, 1H), 3.85 (t, <i>J</i> = 7.14 Hz, 2H), 3.82 (s, 6H), 3.14 (t, <i>J</i> = 6.78 Hz, 2H), 2.16 (d, <i>J</i> = 0.90 Hz, 3H), 1.82 (quintet, <i>J</i> = 6.75 Hz, 2H), 1.45 (dd, <i>J</i> = 6.75, 3.84 Hz, 2H), 1.04 (dd, <i>J</i> = 6.60, 3.66 Hz, 2H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 344.1969, found 344.1964.</div></div><div id="sec4_11_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 1-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)cyclobutanecarboxamide (<b>104</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 22%, white solid, mp 75–77 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.30 (s, 1H), 6.87–6.82 (m, 2H), 6.73 (br, 2H), 5.14 (br, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 3.71 (t, <i>J</i> = 7.32 Hz, 2H), 3.17 (q, <i>J</i> = 6.60 Hz, 2H), 2.76 (br, 2H), 2.45 (br, 2H), 2.19 (br, 1H), 2.10 (s, 3H), 1.83–1.79 (m, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 358.2125, found 358.2117.</div></div><div id="sec4_11_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 1-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)cyclopentanecarboxamide (<b>105</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 32%, white solid, mp 76–77 °C: <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.38 (d, <i>J</i> = 0.93 Hz, 1H), 6.97–6.94 (m, 2H), 6.91–6.88 (m, 1H), 6.61 (s, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 3.71 (t, <i>J</i> = 7.35 Hz, 2H), 3.17 (t, <i>J</i> = 6.60 Hz, 2H), 2.49–2.44 (m, 2H), 2.04 (d, <i>J</i> = 0.93 Hz, 3H), 2.01–1.91 (m, 2H), 1.83 (quintet, <i>J</i> = 6.57 Hz, 2H), 1.72–1.68 (m, 4H); HRMS (FAB) calcd for C<sub>21</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 372.2287, found: 372.2287.</div></div><div id="sec4_11_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 1-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)cyclohexane-1-carboxamide (<b>106</b>)</h4><div class="NLM_p last">Procedure <b>K</b>, yield 43%, white solid, mp 79–80 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.22 (s, 1H), 6.89–6.74 (m, 3H), 6.65 (s, 1H), 5.34 (t, <i>J</i> = 5.67 Hz, NH), 3.81 (s, 3H), 3.79 (s, 3H), 3.65 (t, <i>J</i> = 7.14 Hz, 2H), 3.12 (q, <i>J</i> = 6.60 Hz, 2H), 2.19–2.11 (m, 2H), 2.02 (s, 3H), 1.90–1.83 (m, 2H), 1.77 (p, <i>J</i> = 6.96 Hz, 2H), 1.54–1.45 (m, 4H), 1.36–1.29 (m, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 386.2441, found 386.2441.</div></div><div id="sec4_11_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-3-phenylpropanamide (<b>107</b>)</h4><div class="NLM_p">Procedure <b>K</b>, yield 57%, white solid, mp 85–86 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.18–7.12 (m, 3H), 7.10–7.06 (m, 3H), 6.81–6.69 (m, 3H), 6.63 (s, 1H), 5.90 (t, <i>J</i> = 5.67 Hz, NH), 3.78 (s, 3H), 3.77 (s, 3H), 3.60–3.52 (m, 2H), 3.49–3.36 (m, 2H), 3.21–3.10 (m, 1H), 3.03–2.94 (m, 1H), 2.91 (dd, <i>J</i> = 5.10, 12.03 Hz, 1H), 1.99 (s, 3H), 1.73 (quintet, <i>J</i> = 6.78 Hz, 2H); HRMS (ESI) calcd for C<sub>24</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 408.2282, found 408.2317.</div><div id="sec4_11_61_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> 2-(3,4-Dimethoxyphenyl)-<i>N</i>-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-3-(pyridin-3-yl)propanamide (<b>108</b>)</h5><div class="NLM_p last">Procedure <b>K</b>, yield 51%, white solid, mp 109–110 °C: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.36–8.35 (m, 2H), 7.42–7.38 (m, 2H), 7.12 (dd, <i>J</i> = 7.68, 4.77 Hz, 1H), 6.84 (d, <i>J</i> = 1.44 Hz, 1H), 6.76–6.74 (m, 2H), 6.68 (s, 1H), 6.49 (br, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.66 (t, <i>J</i> = 7.14 Hz, 2H), 3.57 (t, <i>J</i> = 7.89 Hz, 1H), 3.47 (dd, <i>J</i> = 13.38, 8.07 Hz, 1H), 3.19–3.02 (m, 2H), 2.97 (dd, <i>J</i> = 13.26, 6.78 Hz, 1H), 2.05 (s, 3H), 1.82 (quintet, <i>J</i> = 6.60 Hz, 2H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 408.2160, found 408.2178.</div></div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Biological Study</h3><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> In Vitro QC Activity Assay</h4><div class="NLM_p last">For testing the inhibition activities of test compounds, QC activity was fluorometrically evaluated. The used buffer consisted of 25 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES) (Sigma), with pH 7.0, adjusted with HCl. The substrate H-Gln-AMC hydrobromide (<span class="smallcaps smallerCapital">l</span>-glutamine 7-amido-4-methylcoumarin, BACHEM, Switzerland) was used at a concentration of 0.4 mM. The auxiliary enzyme pGAPase (50 units, Qiagen, Germany) was prediluted 1:250 in HEPES. The human QC (10 μg/mL, rhQPCT, R&D systems) was prediluted 1:250 in HEPES. A typical reaction mixture consisted of 25 μL of substrate, 50 μL of the test compounds, and 25 μL of pGAPase. After incubation in 96-well black plates (Greiner, Austria) for 10 min at 37°C, the reaction was started by adding 50 μL of the <i>h</i>QC solution.</div></div><div id="sec4_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Cytotoxicity Assays</h4><div class="NLM_p last">HT-22 (mouse hippocampal cells) cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) supplemented with 10% (v/v) fetal bovine serum and antibiotics (100 mg/mL penicillin/streptomycin mix) in a humidified atmosphere at 37 °C with 5% CO<sub>2</sub>. 5000 HT-22 cells per well were seeded into a clear 96-well plate 1 day prior to the assay. The medium was removed from the plate, and cells were treated with 25 μL solution of each compound at 10 μM and incubated at 37 °C for 18 h. 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide solution (15 μL, 5 mg/mL) was added to each well and incubated for 3 h. The formazan formed was dissolved in dimethyl sulfoxide (DMSO), and absorbance at 570 nm was measured using a microplate reader (Sunrise, Tecan). optical density (OD) values from each well were subtracted with vehicle control, and cell viability was calculated using the signals from vehicle control as 100%.</div></div><div id="sec4_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> hERG Assay</h4><div class="NLM_p last">The affinity of small molecules for the hERG channel was determined using a Predictor hERG fluorescence polarization assay kit (Invitrogen). The assay is based on the principle of fluorescence polarization where a red fluorescent tracer is displaced from the hERG channel by compounds that bind to the channel. Sample triplicates were then run on fluorescence polarization following the protocol of the manufacturer. Fluorescence at 530/25-excitation and 590/35-emission of each well was recorded on a plate reader, Infinite F200 pro (Tecan, Austria).</div></div><div id="sec4_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Animals and Treatment</h4><div class="NLM_p">For acute model study, ICR mice were utilized. ICR mice were obtained from Samtako (Korea). Five micrograms in five microliters of human Aβ<sub>3-40</sub> (62-0-99, American peptide) in PBS was injected into the deep cortex/hippocampus of 5 week old ICR mice (25 g, <i>n</i> = 4, male) using a stereotaxic frame (myNeuroLab). Test compounds were administrated via deep cortical/hippocampal or ip injection. After mice were anesthetized with Zoletil 50 and 2% Rumpun (1:2 ratio, 0.4 mL/kg) intramuscular, the animal was placed into a stereotaxic frame. A small incision (1 cm) was made over the midline of the skull, which exposed the landmarks of the cranium (bregma and lambda). A small hole was drilled through the skull. Human Aβ<sub>3-40</sub> was injected into the deep cortex/hippocampus using the following coordinates: AP −2.0 mm, ML 1.2 mm, DV 1.0 mm from the bregma. Using a Hamilton 25 μL syringe with a 27 G guide needle, a 5 μL volume containing human Aβ<sub>3-40</sub> was delivered.</div><div class="NLM_p last">For transgenic mice model study, a total of 12 (<i>n</i> = 6 for vehicle and <i>n</i> = 6 for compound treatment) 5XFAD mice (Jackson Lab, ME) were utilized. 5XFAD mice coexpress a total of five FAD mutations, including APP with three FAD mutations [K670N/M671L (Swedish), I716V (Florida), and V717I (London)] and PS1 with two mutations (M146L and L286V) under the control of a neuronal-specific Thy1 promoter. In this study, we followed the national guidelines in conducting animal experiments. All procedures for animal tests were approved by the Medifron Animal Care and Use Committee (approval number, Medifron 2017-1, IACUC). All surgical procedures were performed with care to minimize pain and discomfort. To evaluate the test compounds on AD model mice, the test compounds were administrated via intraperitoneal injection to 32 week old male 5XFAD mice for 4 weeks. Mice were housed individually with a 12:12 h light/dark cycle (07:00–19:00 h).</div></div><div id="sec4_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Aβ Sandwich ELISAs</h4><div class="NLM_p last">Sandwich ELISA was performed for the quantification of N3pE-40 (for acute model mouse brain), Aβ<sub>42</sub> (for TG mouse brain), and N3pE-42 (for TG mouse brain). The mouse brains were completely lysed with radioimmunoprecipitation assay buffer using a sonicator (SONICS) and ultracentrifuged at 100 000<i>g</i> and 4 °C for 1 h. Protein concentrations were determined using a bicinchoninic acid kit (Thermo scientific). Sample duplicates were then run on Aβ<sub>42</sub>- and N3pE-42 Aβ-specific sandwich ELISAs following the protocol of the manufacturer (#27418 for N3pE-40, #27711 for Aβ<sub>42</sub>, and #27716 for N3pE-42, IBL Japan). Optical densities at 450 nm of each well were read on a plate reader, Safire (Tecan, Switzerland). The concentrations of the samples Aβ<sub>42</sub> and N3pE-42 Aβ were determined by their standard curves. All readings were in the linear range of the assay. The concentration values were normalized to the total brain weight and expressed in pg or ng of Aβ per mg of total protein. After the average of the duplicates was determined, the mean and standard error of the mean (SEM) for each group were calculated.</div></div><div id="sec4_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Statistical Analyses</h4><div class="NLM_p last">Data was expressed as mean ± SEM. All experiments were repeated at least three times. Statistical analyses between groups were performed using SPSS software (SPSS, Chicago, IL). For group comparisons of variables, we analyzed data with either one-way ANOVA by the Bonferroni post-hoc test or independent sample <i>t</i>-test in SPSS (ns: <i>p</i> > 0.05, *: <i>p</i> < 0.05, **: <i>p</i> < 0.01, ***: <i>p</i> < 0.001).</div></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Computational Study</h3><div id="sec4_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Conformational Search</h4><div class="NLM_p last"><b>1</b>, <b>62</b>, and <b>90</b> were submitted for CSearch of the MacroModel v.11.9 in Maestro v.11.5 (Schrödinger, LLC, NY). Mixed torsional/low-mode sampling was utilized, and the maximum number of steps were set as 1000. Coordinate scan by dihedral angles for the two compounds was also performed using the scan method in the MacroModel module. During this process, the atoms involved in urea/thiourea dihedral angle calculation of both compounds were manually picked.</div></div><div id="sec4_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Ab Initio Quantum Mechanics Calculations</h4><div class="NLM_p last">Total energy calculation for <b>1</b> and <b>62</b> was performed using a single-point energy and optimization module of Jaguar v.9.9 in Maestro. Density functional theory was selected, and all of the options were chosen for energy calculation using 100 iterations. The whole process was operated in a solvated system. The setting was the same for both single-point energy and optimization calculations.</div></div><div id="sec4_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Protein Structure Preparation</h4><div class="NLM_p last">The X-ray crystal structure of the human glutaminyl cyclase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> was selected and prepared utilizing the Protein Preparation Wizard in Maestro. During the preparation process, bond orders were assigned, zero-order bonds to Zn<sup>2+</sup> were created, and hydrogen atoms were added. All of the hydrogen atoms were energy-minimized with the optimized potential for liquid simulation (OPLS) 2005 force field until the average root-mean-square deviation for hydrogen atoms reached 0.30 Å.</div></div><div id="sec4_13_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Ligand Preparation</h4><div class="NLM_p last">The protonation states of <b>90</b> were predicted by the p<i>K</i><sub>a</sub> prediction module in the ADMET Predictor (Simulations Plus, Lancaster, CA). The three-dimensional structures of the ligand molecules were produced by LigPrep v.3.4 in Maestro. The resulting structures were energy-minimized in implicit solvent with the OPLS 2005 force field in Maestro.</div></div><div id="sec4_13_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Glide Quantum Mechanics Polarized Ligand Docking (QPLD)</h4><div class="NLM_p">The prepared ligand molecules were docked to <i>h</i>QC by Glide QM-polarized ligand docking in Maestro. First, the grid for the active site was generated using the centroid of the cocrystallized ligand, PBD150, and the grid box size was set as a default value. Metal coordination constraint was set as tetrahedral geometry for the Zn<sup>2+</sup>. For the initial docking, Glide SP docking was performed with the maximum number of 30 poses per ligand. The partial charges of the docked ligands were calculated using Jaguar with the accurate QM level. Finally, the ligands accompanied with the updated charges were redocked using Glide extra precision with maximum number of 30 poses per ligand.</div><div class="NLM_p last">All of the molecular graphic figures were generated using PyMOL software (<a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>). All computational studies were undertaken on an Intel Xeon Octa-Core 2.67 GHz workstation with Linux CentOS release 6.7.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00751" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00751" class="ext-link">10.1021/acs.jmedchem.9b00751</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic procedure and characterization details of intermediates; the purities of all final compounds; docking study of compound <b>84</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_001.pdf">jm9b00751_si_001.pdf (315.08 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_002.csv">jm9b00751_si_002.csv (3.54 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00751" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sun Choi</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7669-7954" title="Orcid link">http://orcid.org/0000-0002-7669-7954</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#eb989e8588838482ab8e9c838ac58a88c58099"><span class="__cf_email__" data-cfemail="e291978c818a8d8ba287958a83cc8381cc8990">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeewoo Lee</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7832-6719" title="Orcid link">http://orcid.org/0000-0002-7832-6719</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#58323d3d2f3737182b362d76393b76332a"><span class="__cf_email__" data-cfemail="85efe0e0f2eaeac5f6ebf0abe4e6abeef7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Van-Hai Hoang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7462-9598" title="Orcid link">http://orcid.org/0000-0001-7462-9598</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Van T. H. Ngo</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Theoretical and Computational Biophysics & Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 75307, Vietnam</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minghua Cui</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nguyen Van Manh</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phuong-Thao Tran</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Hanoi University
of Pharmacy, Hanoi 10000, Vietnam</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4855-2544" title="Orcid link">http://orcid.org/0000-0003-4855-2544</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jihyae Ann</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee-Jin Ha</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwanghyun Choi</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young-Ho Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyerim Chang</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephani Joy Y. Macalino</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyoun Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Global Medical Science, Sungshin University, Seoul 01133, Republic of Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>V.-H.H., V.T.H.N., and M.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6980-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Midcareer Researcher Program (2017R1A2B4011094) and Medical Research Center (MRC) grant (2018R1A5A2025286) funded by the National Research Foundation of Korea (NRF).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">E</td><td class="NLM_def"><p class="first last">glutamate</p></td></tr><tr><td class="NLM_term">pE</td><td class="NLM_def"><p class="first last">pyroglutamate</p></td></tr><tr><td class="NLM_term">QC</td><td class="NLM_def"><p class="first last">glutamyl cyclase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Anti-amyloid failures stack up as Alzheimer antibody flops</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">327</span> <span class="refDoi"> DOI: 10.1038/d41573-019-00064-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fd41573-019-00064-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&author=A.+Mullard&title=Anti-amyloid+failures+stack+up+as+Alzheimer+antibody+flops&doi=10.1038%2Fd41573-019-00064-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fd41573-019-00064-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41573-019-00064-1%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DAnti-amyloid%2520failures%2520stack%2520up%2520as%2520Alzheimer%2520antibody%2520flops%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26doi%3D10.1038%2Fd41573-019-00064-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozupone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logroscino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbimbo, B. P.</span></span> <span> </span><span class="NLM_article-title">A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1038/s41582-018-0116-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fs41582-018-0116-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=30610216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A280%3ADC%252BB3cnotFagtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=73-88&author=F.+Panzaauthor=M.+Lozuponeauthor=G.+Logroscinoauthor=B.+P.+Imbimbo&title=A+critical+appraisal+of+amyloid-%CE%B2-targeting+therapies+for+Alzheimer+disease&doi=10.1038%2Fs41582-018-0116-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease</span></div><div class="casAuthors">Panza Francesco; Lozupone Madia; Logroscino Giancarlo; Panza Francesco; Logroscino Giancarlo; Panza Francesco; Imbimbo Bruno P</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Brain accumulation of the amyloid-β (Aβ) peptide is believed to be the initial event in the Alzheimer disease (AD) process.  Aβ accumulation begins 15-20 years before clinical symptoms occur, mainly owing to defective brain clearance of the peptide.  Over the past 20 years, we have seen intensive efforts to decrease the levels of Aβ monomers, oligomers, aggregates and plaques using compounds that decrease production, antagonize aggregation or increase brain clearance of Aβ.  Unfortunately, these approaches have failed to show clinical benefit in large clinical trials involving patients with mild to moderate AD.  Clinical trials in patients at earlier stages of the disease are ongoing, but the initial results have not been clinically impressive.  Efforts are now being directed against Aβ oligomers, the most neurotoxic molecular species, and monoclonal antibodies directed against these oligomers are producing encouraging results.  However, Aβ oligomers are in equilibrium with both monomeric and aggregated species; thus, previous drugs that efficiently removed monomeric Aβ or Aβ plaques should have produced clinical benefits.  In patients with sporadic AD, Aβ accumulation could be a reactive compensatory response to neuronal damage of unknown cause, and alternative strategies, including interference with modifiable risk factors, might be needed to defeat this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwevf7x6znXRjv2lLSLOxFfW6udTcc2eal3EYHr9lsCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnotFagtA%253D%253D&md5=fa63b5a3ca7e25169dfd6566f56b5152</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fs41582-018-0116-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41582-018-0116-6%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DLozupone%26aufirst%3DM.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DA%2520critical%2520appraisal%2520of%2520amyloid-%25CE%25B2-targeting%2520therapies%2520for%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2019%26volume%3D15%26spage%3D73%26epage%3D88%26doi%3D10.1038%2Fs41582-018-0116-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Large soluble oligomers of amyloid-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1698-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1523%2FJNEUROSCI.1698-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=28053038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVyhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=152-163&author=T.+Yangauthor=S.+Liauthor=X.+Xuauthor=D.+M.+Walshauthor=D.+J.+Selkoe&title=Large+soluble+oligomers+of+amyloid-protein+from+Alzheimer+brain+are+far+less+neuroactive+than+the+smaller+oligomers+to+which+they+dissociate&doi=10.1523%2FJNEUROSCI.1698-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Large soluble oligomers of amyloid β-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate</span></div><div class="casAuthors">Yang, Ting; Li, Shaomin; Xu, XHuixin; Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-163</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Sol. oligomers of amyloid β-protein (oAβ) isolated from the brains of Alzheimer's disease (AD) patients have been shown exptl. (in the absence of amyloid plaques) to impair hippocampal synaptic plasticity, decrease synapses, induce tau hyperphosphorylation and neuritic dystrophy, activate microglial inflammation, and impair memory in normal adult rodents.  Nevertheless, there has been controversy about what types of oligomers actually confer these AD-like phenotypes.  Here, we show that the vast majority of sol. Aβ species obtained from brains of humans who died with confirmed AD elute at high mol. wt. (HMW) on nondenaturing size-exclusion chromatog.  These species have little or no cytotoxic activity in several bioassays.  However, incubation of HMW oAβ in mildly alk. buffer led to their quant. dissocn. into low mol. wt. oligomers (∼8 - 70 kDa), and these were now far more bioactive: they impaired hippocampal LTP, decreased neuronal levels of β2-adrenergic receptors, and activated microglia in wt mice in vivo.  Thus, most sol. Aβ assemblies in AD cortex are large and inactive but under certain circumstances can dissoc. into smaller, highly bioactive species.  Insol. amyloid plaques likely sequester sol. HMW oligomers, limiting their potential to dissoc.  We conclude that conditions that destabilize HMW oligomers or retard the sequestration of their smaller, more bioactive components are important drivers of Aβ toxicity.  Selectively targeting these small, cytotoxic forms should be therapeutically beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt1mPoeQFyOrVg90H21EOLACvtfcHk0lhuJTfYJD0fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVyhsL0%253D&md5=89668ff0e7c46b499818c2f171ab4185</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1698-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1698-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DLarge%2520soluble%2520oligomers%2520of%2520amyloid-protein%2520from%2520Alzheimer%2520brain%2520are%2520far%2520less%2520neuroactive%2520than%2520the%2520smaller%2520oligomers%2520to%2520which%2520they%2520dissociate%26jtitle%3DJ.%2520Neurosci.%26date%3D2017%26volume%3D37%26spage%3D152%26epage%3D163%26doi%3D10.1523%2FJNEUROSCI.1698-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polanco, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodea, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Marmol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, J.</span></span> <span> </span><span class="NLM_article-title">Amyloid-β and tau complexity towards improved biomarkers and targeted therapies</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2017.162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnrneurol.2017.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=29242522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=22-39&author=J.+C.+Polancoauthor=C.+Liauthor=L.-G.+Bodeaauthor=R.+Martinez-Marmolauthor=F.+A.+Meunierauthor=J.+G%C3%B6tz&title=Amyloid-%CE%B2+and+tau+complexity+towards+improved+biomarkers+and+targeted+therapies&doi=10.1038%2Fnrneurol.2017.162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies</span></div><div class="casAuthors">Polanco, Juan Carlos; Li, Chuanzhou; Bodea, Liviu-Gabriel; Martinez-Marmol, Ramon; Meunier, Frederic A.; Gotz, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-39</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Most neurodegenerative diseases are proteinopathies, which are characterized by the aggregation of misfolded proteins.  Although many proteins have an intrinsic propensity to aggregate, particularly when cellular clearance systems start to fail in the context of ageing, only a few form fibrillar aggregates.  In Alzheimer disease, the peptide amyloid-β (Aβ) and the protein tau aggregate to form plaques and tangles, resp., which comprise the histopathol. hallmarks of this disease.  This Review discusses the complexity of Aβ biogenesis, trafficking, post-translational modifications and aggregation states.  Tau and its various isoforms, which are subject to a vast array of post-translational modifications, are also explored.  The methodol. advances that revealed this complexity are described.  Finally, the toxic effects of distinct species of tau and Aβ are discussed, as well as the concept of protein 'strains', and how this knowledge can facilitate the development of early disease biomarkers for stratifying patients and validating new therapies.  By targeting distinct species of Aβ and tau for therapeutic intervention, the way might be paved for personalized medicine and more-targeted treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBOKmOJXAhIrVg90H21EOLACvtfcHk0lhuJTfYJD0fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbE&md5=1d5d35e842cc678e413b09b67879ce74</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2017.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2017.162%26sid%3Dliteratum%253Aachs%26aulast%3DPolanco%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBodea%26aufirst%3DL.-G.%26aulast%3DMartinez-Marmol%26aufirst%3DR.%26aulast%3DMeunier%26aufirst%3DF.%2BA.%26aulast%3DG%25C3%25B6tz%26aufirst%3DJ.%26atitle%3DAmyloid-%25CE%25B2%2520and%2520tau%2520complexity%2520towards%2520improved%2520biomarkers%2520and%2520targeted%2520therapies%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2018%26volume%3D14%26spage%3D22%26epage%3D39%26doi%3D10.1038%2Fnrneurol.2017.162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulisano, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span> <span> </span><span class="NLM_article-title">The keystone of Alzheimer pathogenesis might be sought in Aβ physiology</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2015.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.neuroscience.2015.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26314631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVajsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2015&pages=26-36&author=D.+Puzzoauthor=W.+Gulisanoauthor=O.+Arancioauthor=A.+Palmeri&title=The+keystone+of+Alzheimer+pathogenesis+might+be+sought+in+A%CE%B2+physiology&doi=10.1016%2Fj.neuroscience.2015.08.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The keystone of Alzheimer pathogenesis might be sought in Aβ physiology</span></div><div class="casAuthors">Puzzo, D.; Gulisano, W.; Arancio, O.; Palmeri, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">For several years Amyloid-beta peptide (Aβ) has been considered the main pathogenetic factor of Alzheimer's disease (AD).  According to the so called Amyloid Cascade Hypothesis the increase of Aβ triggers a series of events leading to synaptic dysfunction and memory loss as well as to the structural brain damage in the later stage of the disease.  However, several evidences suggest that this hypothesis is not sufficient to explain AD pathogenesis, esp. considering that most of the clin. trials aimed to decrease Aβ levels have been unsuccessful.  Moreover, Aβ is physiol. produced in the healthy brain during neuronal activity and it is needed for synaptic plasticity and memory.  Here we propose a model interpreting AD pathogenesis as an alteration of the neg. feedback loop between Aβ and its physiol. receptors, focusing on alpha7 nicotinic acetylcholine receptors (α7-nAchRs).  According to this vision, when Aβ cannot exert its physiol. function a neg. feedback mechanism would induce a compensatory increase of its prodn. leading to an abnormal accumulation that reduces α7-nAchR function, leading to synaptic dysfunction and memory loss.  In this perspective, the indiscriminate Aβ removal might worsen neuronal homeostasis, causing a further impoverishment of learning and memory.  Even if further studies are needed to better understand and validate these mechanisms, we believe that to deepen the role of Aβ in physiol. conditions might represent the keystone to elucidate important aspects of AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhXpsOzEHjbVg90H21EOLACvtfcHk0lgqimG0h1WREw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVajsrrO&md5=de890b9cb601a3d5db9320ae2d159013</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2015.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2015.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DGulisano%26aufirst%3DW.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DPalmeri%26aufirst%3DA.%26atitle%3DThe%2520keystone%2520of%2520Alzheimer%2520pathogenesis%2520might%2520be%2520sought%2520in%2520A%25CE%25B2%2520physiology%26jtitle%3DNeuroscience%26date%3D2015%26volume%3D307%26spage%3D26%26epage%3D36%26doi%3D10.1016%2Fj.neuroscience.2015.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjernberg, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schedin-Weiss, S.</span></span> <span> </span><span class="NLM_article-title">Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e201800028</span> <span class="refDoi"> DOI: 10.26508/lsa.201800028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.26508%2Flsa.201800028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=30456353" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&author=Y.+Yuauthor=D.+C.+Jansauthor=B.+Winbladauthor=L.+O.+Tjernbergauthor=S.+Schedin-Weiss&title=Neuronal+A%CE%B242+is+enriched+in+small+vesicles+at+the+presynaptic+side+of+synapses&doi=10.26508%2Flsa.201800028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800028%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DJans%26aufirst%3DD.%2BC.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DTjernberg%26aufirst%3DL.%2BO.%26aulast%3DSchedin-Weiss%26aufirst%3DS.%26atitle%3DNeuronal%2520A%25CE%25B242%2520is%2520enriched%2520in%2520small%2520vesicles%2520at%2520the%2520presynaptic%2520side%2520of%2520synapses%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2018%26volume%3D1%26doi%3D10.26508%2Flsa.201800028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer amyloid hypothesis lives on</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnrd.2016.281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=3-5&author=A.+Mullard&title=Alzheimer+amyloid+hypothesis+lives+on&doi=10.1038%2Fnrd.2016.281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer amyloid hypothesis lives on</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-5</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the failure of Eli Lilly's anti-amyloid antibody solanezumab in its latest phase III trial for Alzheimer disease, a bulging pipeline of amyloid-modulating candidates and novel clin. trial strategies still hold promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcI_woBsrqLVg90H21EOLACvtfcHk0lgqimG0h1WREw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVWq&md5=6a001e532429624f0d4a8d906650e3c0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.281%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DAlzheimer%2520amyloid%2520hypothesis%2520lives%2520on%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D3%26epage%3D5%26doi%3D10.1038%2Fnrd.2016.281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larner, A. J.</span></span> <span> </span><span class="NLM_article-title">Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/S0197-4580(99)00014-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2FS0197-4580%2899%2900014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10466895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=65-69&author=A.+J.+Larner&title=Hypothesis%3A+amyloid+beta-peptides+truncated+at+the+N-terminus+contribute+to+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2899%2900014-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Larner, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Fragments of amyloid β-peptide truncated at the N-terminus are present in AD brain early in the course of Alzheimer's disease.  It is proposed that these species contribute to the pathogenesis of AD, possibly through destabilization of elements of the neuronal cytoskeleton by small fibrillar deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBDWqVDUChLVg90H21EOLACvtfcHk0lhHokfmycaWmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D&md5=c6fc637848837e8d6b797073966df531</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2899%2900014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252899%252900014-7%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DA.%2BJ.%26atitle%3DHypothesis%253A%2520amyloid%2520beta-peptides%2520truncated%2520at%2520the%2520N-terminus%2520contribute%2520to%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1999%26volume%3D20%26spage%3D65%26epage%3D69%26doi%3D10.1016%2FS0197-4580%2899%2900014-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar-Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderstichele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderhoeven, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backhovens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanmechelen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroisel, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeckhoven, C.</span></span> <span> </span><span class="NLM_article-title">Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer’s disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2598</span>, <span class="refDoi"> DOI: 10.1093/hmg/9.18.2589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1093%2Fhmg%2F9.18.2589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=11063718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2589-2598&author=S.+Kumar-Singhauthor=C.+De+Jongheauthor=M.+Crutsauthor=R.+Kleinertauthor=R.+Wangauthor=M.+Merckenauthor=B.+De+Strooperauthor=H.+Vandersticheleauthor=A.+Lofgrenauthor=I.+Vanderhoevenauthor=H.+Backhovensauthor=E.+Vanmechelenauthor=P.+M.+Kroiselauthor=C.+Van+Broeckhoven&title=Nonfibrillar+diffuse+amyloid+deposition+due+to+a+gamma%2842%29-secretase+site+mutation+points+to+an+essential+role+for+N-truncated+A+beta%2842%29+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fhmg%2F9.18.2589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nonfibrillar diffuse amyloid deposition due to a γ42-secretase site mutation points to an essential role for N-truncated Aβ42 in Alzheimer's disease</span></div><div class="casAuthors">Kumar-Singh, Samir; De Jonghe, Chris; Cruts, Marc; Kleinert, Reinhold; Wang, Rong; Mercken, Marc; De Strooper, Bart; Vanderstichele, Hugo; Lofgren, Ann; Vanderhoeven, Inge; Backhovens, Hubert; Vanmechelen, Eugeen; Kroisel, Peter M.; Van Broeckhoven, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2589-2598</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Amyloidogenic processing of the amyloid precursor protein (APP) with deposition in brain of the 42-amino acid long amyloid β-peptide (Aβ42) is considered central to Alzheimer's disease (AD) pathol.  However, it is generally believed that nonfibrillar pre-amyloid Aβ42 deposits have to mature in the presence of Aβ40 into fibrillar amyloid plaques to cause neurodegeneration.  Here, an aggressive form of AD is shown to be caused by a novel missense mutation in APP (T714I) directly involving γ-secretase cleavages of APP.  The mutation had the most drastic effect on Aβ42/Aβ40 ratio in vitro of ∼11-fold, simultaneously increasing Aβ42 and decreasing Aβ40 secretion, as measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.  This coincided in brain with deposition of abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated Aβ42 in complete absence of Aβ40.  These data indicate that N-truncated Aβ42 as diffuse nonfibrillar plaques has an essential but undermined role in AD pathol.  Importantly, inhibiting secretion of full-length Aβ42 by therapeutic targeting of APP processing should not result in secretion of an equally toxic N-truncated Aβ42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZLr8Yf4DdbVg90H21EOLACvtfcHk0lhHokfmycaWmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D&md5=49e857dfb99cefd1e71df74cfd407fd1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F9.18.2589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F9.18.2589%26sid%3Dliteratum%253Aachs%26aulast%3DKumar-Singh%26aufirst%3DS.%26aulast%3DDe%2BJonghe%26aufirst%3DC.%26aulast%3DCruts%26aufirst%3DM.%26aulast%3DKleinert%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DLofgren%26aufirst%3DA.%26aulast%3DVanderhoeven%26aufirst%3DI.%26aulast%3DBackhovens%26aufirst%3DH.%26aulast%3DVanmechelen%26aufirst%3DE.%26aulast%3DKroisel%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBroeckhoven%26aufirst%3DC.%26atitle%3DNonfibrillar%2520diffuse%2520amyloid%2520deposition%2520due%2520to%2520a%2520gamma%252842%2529-secretase%2520site%2520mutation%2520points%2520to%2520an%2520essential%2520role%2520for%2520N-truncated%2520A%2520beta%252842%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2000%26volume%3D9%26spage%3D2589%26epage%3D2598%26doi%3D10.1093%2Fhmg%2F9.18.2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miravalle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, R.</span></span> <span> </span><span class="NLM_article-title">Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">10810</span>– <span class="NLM_lpage">10821</span>, <span class="refDoi"> DOI: 10.1021/bi0508237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0508237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10810-10821&author=L.+Miravalleauthor=M.+Caleroauthor=M.+Takaoauthor=A.+E.+Roherauthor=B.+Ghettiauthor=R.+Vidal&title=Amino-terminally+truncated+Abeta+peptide+species+are+the+main+component+of+cotton+wool+plaques&doi=10.1021%2Fbi0508237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-Terminally Truncated Aβ Peptide Species Are the Main Component of Cotton Wool Plaques</span></div><div class="casAuthors">Miravalle, Leticia; Calero, Miguel; Takao, Masaki; Roher, Alex E.; Ghetti, Bernardino; Vidal, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">10810-10821</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cotton wool plaques (CWPs) are round lesions that lack a central amyloid core.  CWPs have been obsd. in individuals affected by early-onset familial Alzheimer disease (FAD) assocd. with mutations in the presenilin 1 (PSEN1) gene.  Here we present the characterization of the amyloid-β (Aβ) peptides deposited in the brain of an individual affected by FAD carrying the novel missense (V261I) mutation in the PSEN1 gene.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was used to det. the Aβ peptide species present in the cerebral and cerebellar cortexes, in leptomeningeal vessels, and in CWPs isolated by laser microdissection (LMD).  Our results indicate that amino-terminally truncated Aβ peptide species ending at residues 42 and 43 are the main Aβ peptides deposited in brain parenchyma and LMD-CWPs in assocn. with the PSEN1 V261I mutation.  Full-length Aβ1-42 and Aβ1-43 peptide species were underrepresented.  CWPs were not found to be assocd. with vessels and did not contain Aβ1-40 peptides, the main component of the vascular deposits.  Although Aβ deposits were present mostly in the form of CWPs in the cerebral cortex and as diffuse deposits in the cerebellar cortex, a similar array of amino-terminally truncated Aβ peptide species was seen in both cases.  The biochem. data support the concept that parenchymal and vascular amyloid deposits are assocd. with a different array of Aβ peptide species.  The generation and parenchymal deposition of highly insol. amino-terminally truncated Aβ peptides may play an important role in the pathogenesis of AD and must be taken into consideration in developing new diagnostic and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAq_XS9LmMPrVg90H21EOLACvtfcHk0lhHokfmycaWmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D&md5=15b5a7a7cc10e2f4013b40f344988c81</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi0508237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0508237%26sid%3Dliteratum%253Aachs%26aulast%3DMiravalle%26aufirst%3DL.%26aulast%3DCalero%26aufirst%3DM.%26aulast%3DTakao%26aufirst%3DM.%26aulast%3DRoher%26aufirst%3DA.%2BE.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DVidal%26aufirst%3DR.%26atitle%3DAmino-terminally%2520truncated%2520Abeta%2520peptide%2520species%2520are%2520the%2520main%2520component%2520of%2520cotton%2520wool%2520plaques%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10810%26epage%3D10821%26doi%3D10.1021%2Fbi0508237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">38825</span>– <span class="NLM_lpage">38832</span>, <span class="refDoi"> DOI: 10.1074/jbc.R111.288308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.R111.288308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21965666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38825-38832&author=S.+Jawharauthor=O.+Wirthsauthor=T.+A.+Bayer&title=Pyroglutamate+amyloid-beta+%28Abeta%29%3A+a+hatchet+man+in+Alzheimer+disease&doi=10.1074%2Fjbc.R111.288308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">38825-38832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Pyroglutamate-modified amyloid-β (AβpE3) peptides are gaining considerable attention as potential key participants in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Transgenic mice that produce high levels of AβpE3-42 show severe neuron loss.  Recent in vitro and in vivo expts. have proven that the enzyme glutaminyl cyclase catalyzes the formation of AβpE3.  In this minireview, we summarize the current knowledge on AβpE3, discussing its discovery, biochem. properties, mol. events detg. formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9SRHPGwO6ErVg90H21EOLACvtfcHk0lhSek00KQyz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE&md5=e7b0363724dd2e7cbbfc2071abdc8241</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.288308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.288308%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520amyloid-beta%2520%2528Abeta%2529%253A%2520a%2520hatchet%2520man%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38825%26epage%3D38832%26doi%3D10.1074%2Fjbc.R111.288308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span> <span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-466&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0lhSek00KQyz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D466%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hause, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willbold, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7072</span>– <span class="NLM_lpage">7078</span>, <span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-7078&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0lhSek00KQyz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D7078%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venezia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolcini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benatti, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schettini, G.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-modified amyloid β-peptides – AβN3(pE) – strongly affect cultured neuron and astrocyte survival</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01107.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1046%2Fj.1471-4159.2002.01107.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=12354296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1480-1489&author=C.+Russoauthor=E.+Violaniauthor=S.+Salisauthor=V.+Veneziaauthor=V.+Dolciniauthor=G.+Damonteauthor=U.+Benattiauthor=C.+D%E2%80%99Arrigoauthor=E.+Patroneauthor=P.+Carloauthor=G.+Schettini&title=Pyroglutamate-modified+amyloid+%CE%B2-peptides+%E2%80%93+A%CE%B2N3%28pE%29+%E2%80%93+strongly+affect+cultured+neuron+and+astrocyte+survival&doi=10.1046%2Fj.1471-4159.2002.01107.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-modified amyloid β-peptides - AβN3(pE) -strongly affect cultured neuron and astrocyte survival</span></div><div class="casAuthors">Russo, Claudio; Violani, Elisabetta; Salis, Serena; Venezia, Valentina; Dolcini, Virginia; Damonte, Gianluca; Benatti, Umberto; D'Arrigo, Cristina; Patrone, Eligio; Carlo, Pia; Schettini, Gennaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1480-1489</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">N-terminally truncated amyloid-β (Aβ) peptides are present in early and diffuse plaques of individuals with Alzheimer's disease (AD), are overproduced in early onset familial AD and their amt. seems to be directly correlated to the severity and the progression of the disease in AD and Down's syndrome (DS).  The pyroglutamate-contg. isoforms at position 3 [AβN3(pE)-40/42] represent the prominent form among the N-truncated species, and may account for more than 50% of Aβ accumulated in plaques.  In this study, the authors compared the toxic properties, fibrillogenic capabilities, and in vitro degrdn. profile of Aβ1-40, Aβ1-42, AβN3(pE)-40 and AβN3(pE)-42.  The authors' data show that fiber morphol. of Aβ peptides is greatly influenced by the C-terminus while toxicity, interaction with cell membranes and degrdn. are influenced by the N-terminus.  AβN3(pE)-40 induced significantly more cell loss than the other species both in neuronal and glial cell cultures.  Aggregated AβN3(pE) peptides were heavily distributed on plasma membrane and within the cytoplasm of treated cells.  AβN3(pE)-40/42 peptides showed a significant resistance to degrdn. by cultured astrocytes, while full-length peptides resulted partially degraded.  These findings suggest that formation of N-terminally modified peptides may enhance β-amyloid aggregation and toxicity, likely worsening the onset and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR0uvn5GQRVLVg90H21EOLACvtfcHk0lg1ThXB8R6t0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D&md5=41ad79cbdbb8f5debcec7c93035a709d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01107.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01107.x%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DViolani%26aufirst%3DE.%26aulast%3DSalis%26aufirst%3DS.%26aulast%3DVenezia%26aufirst%3DV.%26aulast%3DDolcini%26aufirst%3DV.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DBenatti%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DE.%26aulast%3DCarlo%26aufirst%3DP.%26aulast%3DSchettini%26aufirst%3DG.%26atitle%3DPyroglutamate-modified%2520amyloid%2520%25CE%25B2-peptides%2520%25E2%2580%2593%2520A%25CE%25B2N3%2528pE%2529%2520%25E2%2580%2593%2520strongly%2520affect%2520cultured%2520neuron%2520and%2520astrocyte%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1480%26epage%3D1489%26doi%3D10.1046%2Fj.1471-4159.2002.01107.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, C. J.</span></span> <span> </span><span class="NLM_article-title">The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">10871</span>– <span class="NLM_lpage">10877</span>, <span class="refDoi"> DOI: 10.1021/bi990563r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi990563r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=10871-10877&author=W.+Heauthor=C.+J.+Barrow&title=The+A+beta+3-pyroglutamyl+and+11-pyroglutamyl+peptides+found+in+senile+plaque+have+greater+beta-sheet+forming+and+aggregation+propensities+in+vitro+than+full-length+A+beta&doi=10.1021%2Fbi990563r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ</span></div><div class="casAuthors">He, Weilan; Barrow, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10871-10877</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ isolated from neuritic plaque and vascular walls of the brains of patients with Alzheimer's disease has been shown to contain significant quantities of Aβ peptides which begin at residue 3Glu or 11Glu in the form of pyroglutamyl residues (Aβ3pE and Aβ11pE).  To investigate the effects of these N-terminal modifications on the biophys. properties of Aβ, peptides Aβ1-40, Aβ3pE-40, Aβ11pE-40, Aβ1-28, Aβ3pE-28, and Aβ11pE-28 were synthesized.  Using CD spectroscopy, we detd. that the pyroglutamyl-contg. peptides form β-sheet structure more readily than the corresponding full-length Aβ peptides, both in aq. solns. and in 10% SDS micelles.  Trifluoroethanol spectra indicated that the relative β-sheet to α-helical stability is higher for the pyroglutamyl-contg. peptides.  Sedimentation expts. show that the pyroglutamyl-contg. peptides have greater aggregation propensities than the corresponding full-length peptides.  Comparison between the Aβ40 and the Aβ28 series indicated that the greater β-sheet forming and aggregation propensities of the pyroglutamyl peptides are not simply due to an increase in hydrophobicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5xcOsA5djELVg90H21EOLACvtfcHk0lg1ThXB8R6t0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D&md5=edb7b92c11ef110e8d87d397b7531a8d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi990563r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990563r%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DW.%26aulast%3DBarrow%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520A%2520beta%25203-pyroglutamyl%2520and%252011-pyroglutamyl%2520peptides%2520found%2520in%2520senile%2520plaque%2520have%2520greater%2520beta-sheet%2520forming%2520and%2520aggregation%2520propensities%2520in%2520vitro%2520than%2520full-length%2520A%2520beta%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D10871%26epage%3D10877%26doi%3D10.1021%2Fbi990563r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsanut, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronicke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-655&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0lg1ThXB8R6t0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D655%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span> <span> </span><span class="NLM_article-title">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1007/s00401-014-1287-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1007%2Fs00401-014-1287-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=24803226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=787-801&author=T.+A.+Bayerauthor=O.+Wirths&title=Focusing+the+amyloid+cascade+hypothesis+on+N-truncated+Abeta+peptides+as+drug+targets+against+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1287-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease</span></div><div class="casAuthors">Bayer, Thomas A.; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-801</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although N-truncated Aβ variants are known to be the main constituent of amyloid plaques in the brains of patients with Alzheimer's disease, their potential as targets for pharmacol. intervention has only recently been investigated.  In the last few years, the Alzheimer field has experienced a paradigm shift with the ever increasing understanding that targeting amyloid plaques has not led to a successful immunotherapy.  On the other hand, there can be no doubt that the amyloid cascade hypothesis is central to the etiol. of Alzheimer's disease, raising the question as to why it is apparently failing to translate into the clinic.  In this review, we aim to refocus the amyloid hypothesis integrating N-truncated Aβ peptides based on mounting evidence that they may represent better targets than full-length Aβ.  In addn. to Aβ peptides starting with an Asp at position 1, a variety of different N-truncated Aβ peptides have been identified starting with amino residue Ala-2, pyroglutamylated Glu-3, Phe-4, Arg-5, His-6, Asp-7, Ser-8, Gly-9, Tyr-10 and pyroglutamylated Glu-11.  Certain forms of N-truncated species are better correlates for early pathol. changes found pre-symptomatically more often than others.  There is also evidence that, together with full-length Aβ, they might be physiol. detectable and are naturally secreted by neurons.  Others are known to form sol. aggregates, which have neurotoxic properties in transgenic mouse models.  It has been clearly demonstrated by several groups that some N-truncated Aβs dominate full-length Aβ in the brains of Alzheimer's patients.  We try to address which of the N-truncated variants may be promising therapeutic targets and which enzymes might be involved in the generation of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONpP9jWQ-X7Vg90H21EOLACvtfcHk0lilJor5e1eh3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D&md5=5374727ba0b50e40ed87a122da1c65bd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1287-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1287-x%26sid%3Dliteratum%253Aachs%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DFocusing%2520the%2520amyloid%2520cascade%2520hypothesis%2520on%2520N-truncated%2520Abeta%2520peptides%2520as%2520drug%2520targets%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D127%26spage%3D787%26epage%3D801%26doi%3D10.1007%2Fs00401-014-1287-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busby, W. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. S.</span></span> <span> </span><span class="NLM_article-title">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">8532</span>– <span class="NLM_lpage">8536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=3597387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8532-8536&author=W.+H.+Busbyauthor=G.+E.+Quackenbushauthor=J.+Hummauthor=W.+W.+Youngbloodauthor=J.+S.+Kizer&title=An+enzyme%28s%29+that+converts+glutaminyl-peptides+into+pyroglutamyl-peptides.+Presence+in+pituitary%2C+brain%2C+adrenal+medulla%2C+and+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides.  Presence in pituitary, brain, adrenal medulla, and lymphocytes</span></div><div class="casAuthors">Busby, Walker H., Jr.; Quackenbush, Gail E.; Humm, Jane; Youngblood, William W.; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8532-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The mechanism for the post-translational conversion of glutamine to pyroglutamic acid on the N-terminus of newly synthesized peptides and proteins is unknown.  An assay is reported here that permits measurement of the rate of conversion of Gln-His-Pro-NH2 to <Glu-His-Pro-NH2 (TRH), where <Glu is pyroglutamate.  Using this assay, it was demonstrated that the spontaneous cyclization of the N-terminal glutamine of this peptide occurs only slowly under physiol. conditions.  Furthermore, the presence in rat brain, porcine pituitary, and human B lymphocytes of a glutaminyl-peptide cyclase which converts Gln-His-Pro-NH2 into <Glu-His-Pro-NH2, is described.  The enzyme(s) appears to be a glycoprotein, is maximally active at neutral pH, has a mol. wt. of 55,000, and contains catalytically significant SH groups.  The product of the enzymic reaction was confirmed by high-resoln. fast atom bombardment-mass spectrometry.  In preliminary studies, it was found that >90% of the enzyme in bovine adrenal medulla is contained in the sol. chromaffin vesicle fraction.  These findings indicate that in vivo the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is neither spontaneous nor abiotic as has been previously proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgXDyJEuhjrVg90H21EOLACvtfcHk0lilJor5e1eh3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D&md5=8a8b35c61b2c94f4437fd06fc400656e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBusby%26aufirst%3DW.%2BH.%26aulast%3DQuackenbush%26aufirst%3DG.%2BE.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DW.%2BW.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520enzyme%2528s%2529%2520that%2520converts%2520glutaminyl-peptides%2520into%2520pyroglutamyl-peptides.%2520Presence%2520in%2520pituitary%252C%2520brain%252C%2520adrenal%2520medulla%252C%2520and%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8532%26epage%3D8536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Böckers, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.1995.tb00780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1111%2Fj.1365-2826.1995.tb00780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=7550291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=445-453&author=T.+M.+B%C3%B6ckersauthor=M.+R.+Kreutzauthor=T.+Pohl&title=Glutaminyl-cyclase+expression+in+the+bovine%2Fporcine+hypothalamus+and+pituitary&doi=10.1111%2Fj.1365-2826.1995.tb00780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span></div><div class="casAuthors">Bockers T M; Kreutz M R; Pohl T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroendocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-53</span>
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    </div><div class="casAbstract">The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization.  In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs.  In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled.  The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings.  Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity.  Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis.  Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable.  Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis).  These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe.  Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvTdinpe-TVvEeosoOnpOLfW6udTcc2eYxAxY0e3oO9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D&md5=623044c0c3d4e838cf9b833b04722f41</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.1995.tb00780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.1995.tb00780.x%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6ckers%26aufirst%3DT.%2BM.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DPohl%26aufirst%3DT.%26atitle%3DGlutaminyl-cyclase%2520expression%2520in%2520the%2520bovine%252Fporcine%2520hypothalamus%2520and%2520pituitary%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D1995%26volume%3D7%26spage%3D445%26epage%3D453%26doi%3D10.1111%2Fj.1365-2826.1995.tb00780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugele, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiess, J.</span></span> <span> </span><span class="NLM_article-title">Primary structure and functional expression of a glutaminyl cyclase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">10059</span>– <span class="NLM_lpage">10063</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.22.10059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1073%2Fpnas.88.22.10059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1946423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10059-10063&author=T.+Pohlauthor=M.+Zimmerauthor=K.+Mugeleauthor=J.+Spiess&title=Primary+structure+and+functional+expression+of+a+glutaminyl+cyclase&doi=10.1073%2Fpnas.88.22.10059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional expression of a glutaminyl cyclase</span></div><div class="casAuthors">Pohl, Thomas; Zimmer, Michael; Mugele, Katrin; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10059-63</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A glutaminyl cyclase (QC) that is probably involved in the biosynthesis of pyroglutamyl peptides such as gonadotropin-releasing hormone and TSH-releasing hormone has been purified to homogeneity from bovine anterior pituitary.  On the basis of N-terminal sequence anal., a 2088-base-pair cDNA clone was isolated from a bovine anterior pituitary library.  From the nucleotide sequence of this clone, the primary structure of a 330-residue protein and a preceding 31-residue prepropeptide sequence was deduced.  By transfection of COS-7 monkey cells with a QC cDNA/pCDM8 vector construct, QC activity was expressed.  Hybridization with mRNAs of various bovine tissues revealed expression of QC mainly in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdQGThtNPlPLVg90H21EOLACvtfcHk0liO1kFuUz7U5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D&md5=3d0e422d9b00b1184d8646c5a12bf353</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.22.10059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.22.10059%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DMugele%26aufirst%3DK.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DPrimary%2520structure%2520and%2520functional%2520expression%2520of%2520a%2520glutaminyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D10059%26epage%3D10063%26doi%3D10.1073%2Fpnas.88.22.10059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuzberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.3233/JAD-131535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.3233%2FJAD-131535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=24164736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=385-400&author=M.+Morawskiauthor=S.+Schillingauthor=M.+Kreuzbergerauthor=A.+Waniekauthor=C.+Jagerauthor=B.+Kochauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=M.+Hartlage-Rubsamenauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+in+human+cortex%3A+correlation+with+%28pGlu%29-amyloid-beta+load+and+cognitive+decline+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-131535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease</span></div><div class="casAuthors">Morawski, Markus; Schilling, Stephan; Kreuzberger, Moritz; Waniek, Alexander; Jaeger, Carsten; Koch, Birgit; Cynis, Holger; Kehlen, Astrid; Arendt, Thomas; Hartlage-Ruebsamen, Maike; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Brains of Alzheimer's disease (AD) patients are characterized in part by the formation of high mol. wt. aggregates of amyloid-β (Aβ) peptides, which interfere with neuronal function and provoke neuronal cell death.  The pyroglutamate (pGlu) modification of Aβ was demonstrated to be catalyzed by the enzyme glutaminyl cyclase (QC) and to enhance pathogenicity and neurotoxicity.  Here, we addressed the role of QC in AD pathogenesis in human cortex.  Two sets of human postmortem brain tissue from a total of 13 non-demented controls and 11 AD cases were analyzed by immunohistochem. and unbiased stereol., quant. RT-PCR, and enzymic activity assays for the expression level of QC in temporal and entorhinal cortex.  Addnl., cortical Aβ and pGlu-Aβ concns. were quantified by ELISA.  Data on QC expression and Aβ peptide concns. were correlated with each other and with the Mini-Mental State Examn. (MMSE) of individual cases.  In control cases, QC expression was higher in the more vulnerable entorhinal cortex than in temporal cortex.  In AD brains, QC mRNA expression and the immunoreactivity of QC were increased in both cortical regions and frequently assocd. with pGlu-Aβ deposits.  The analyses of individual cases revealed significant correlations between QC mRNA levels and the concn. of insol. pGlu-Aβ aggregates, but not of unmodified Aβ peptides.  Elevated pGlu-Aβ load showed a better correlation with the decline in MMSE than elevated concn. of unmodified Aβ.  Our observations provide evidence for an involvement of QC in AD pathogenesis and cognitive decline by QC-catalyzed pGlu-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS8tVHNEV2BbVg90H21EOLACvtfcHk0liO1kFuUz7U5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D&md5=6500fe542f7ccbc6b61c9a4c862cde6d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3233%2FJAD-131535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131535%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKreuzberger%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520in%2520human%2520cortex%253A%2520correlation%2520with%2520%2528pGlu%2529-amyloid-beta%2520load%2520and%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D385%26epage%3D400%26doi%3D10.3233%2FJAD-131535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitschel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokesch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-1111&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0ljyB_tsYXB7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D1111%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">4460</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-4460&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%7Bbeta%7D+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0ljyB_tsYXB7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%257Bbeta%257D%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D4460%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-1236&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Horstenauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0lgz-rQKX9v9hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D1236%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennekens, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensadon, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zivin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaziano, J. M.</span></span> <span> </span><span class="NLM_article-title">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer’s disease and related dementias</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1586/14737175.2015.1088784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1586%2F14737175.2015.1088784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26450764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=1245-1248&author=C.+H.+Hennekensauthor=B.+A.+Bensadonauthor=R.+Zivinauthor=J.+M.+Gaziano&title=Hypothesis%3A+glutaminyl+cyclase+inhibitors+decrease+risks+of+Alzheimer%E2%80%99s+disease+and+related+dementias&doi=10.1586%2F14737175.2015.1088784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias</span></div><div class="casAuthors">Hennekens, Charles H.; Bensadon, Benjamin A.; Zivin, Robert; Gaziano, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-1248</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease and related dementias (ADRD) comprise several progressive and incurable neurodegenerative disorders that some have classified as amyloidosis.  With increased aging of the world's population, the prevalence of the sporadic form of ADRD, which comprises over 99% of cases, continues to rise at an alarming rate.  The enormous societal burdens of ADRD already rival those of the many other major chronic diseases causing premature morbidity and mortality in the USA and worldwide such as cardiovascular disease and cancer.  At present, there is an insufficient totality of evidence concerning the efficacy and safety of any pharmacol. agents to delay slow progression or reduce complications of ADRD.  In this context, glutaminyl cyclase (QC) inhibitors have shown some early possible evidence of efficacy with a reassuring safety profile.  To reliably test the glutaminyl cyclase (QC) and any other promising hypotheses will require cogent data from large-scale randomized trials of sufficient size and duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh2s8nTowdx7Vg90H21EOLACvtfcHk0lgz-rQKX9v9hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI&md5=f098733e6e4f05dce39581b04d5df230</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.1088784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.1088784%26sid%3Dliteratum%253Aachs%26aulast%3DHennekens%26aufirst%3DC.%2BH.%26aulast%3DBensadon%26aufirst%3DB.%2BA.%26aulast%3DZivin%26aufirst%3DR.%26aulast%3DGaziano%26aufirst%3DJ.%2BM.%26atitle%3DHypothesis%253A%2520glutaminyl%2520cyclase%2520inhibitors%2520decrease%2520risks%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520dementias%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D1245%26epage%3D1248%26doi%3D10.1586%2F14737175.2015.1088784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer’s disease ?</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.4155%2Ffmc-2017-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=29076753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1979-1981&author=H.+Wu&title=Can+small+molecule+inhibitors+of+glutaminyl+cyclase+be+used+as+a+therapeutic+for+Alzheimer%E2%80%99s+disease+%3F&doi=10.4155%2Ffmc-2017-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer's disease?</span></div><div class="casAuthors">Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1979-1981</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial and socioeconomically burdensome disease.  In view of the failures of anti-AD candidates, we should try to rethink what we did before and what we should do next, in part at least.  Research shows that the more neurotoxic factor, pyroglutamate-Aβs, and the more important inflammatory mediators, pyroglutamate-CCL2, both contribute to the initiation of AD specifically and the generation of N-terminal intramol. cyclization catalyzed by glutaminyl cyclase quality control, the over-expression of which correlates pos. with the severity of AD.  Subsequently, lowering pyroglutamate-Aβs and pyroglutamate-CCL2 levels by quality control inhibition using small mol. inhibitors could be expected as an amazing strategy for the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7otPkBSO4HLVg90H21EOLACvtfcHk0lgz-rQKX9v9hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOit7bP&md5=9ecc009d79671aad9641627a23945db7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0190%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26atitle%3DCan%2520small%2520molecule%2520inhibitors%2520of%2520glutaminyl%2520cyclase%2520be%2520used%2520as%2520a%2520therapeutic%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1979%26epage%3D1981%26doi%3D10.4155%2Ffmc-2017-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7069</span>– <span class="NLM_lpage">7080</span>, <span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-7080&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0lhmo79i4f6Yng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D7080%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6613</span>– <span class="NLM_lpage">6625</span>, <span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-6625&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0lhmo79i4f6Yng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D6625%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bühring, K.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farcher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of Alzheimer’s disease-Studies on relation to effective target occupancy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.240614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1124%2Fjpet.117.240614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=28446518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2017&pages=119-130&author=T.+Hoffmannauthor=A.+Meyerauthor=U.+Heiserauthor=S.+Kuratauthor=L.+B%C3%B6hmeauthor=M.+Kleinschmidtauthor=K.-U.+B%C3%BChringauthor=B.+Hutter-Paierauthor=M.+Farcherauthor=H.-U.+Demuthauthor=I.+Luesauthor=S.+Schilling&title=Glutaminyl+cyclase+inhibitor+PQ912+improves+cognition+in+mouse+models+of+Alzheimer%E2%80%99s+disease-Studies+on+relation+to+effective+target+occupancy&doi=10.1124%2Fjpet.117.240614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of alzheimer's disease-studies on relation to effective target occupancy</span></div><div class="casAuthors">Hoffmann, Torsten; Meyer, Antje; Heiser, Ulrich; Kurat, Stephan; Boehme, Livia; Kleinschmidt, Martin; Buehring, Karl-Ulrich; Hutter-Paier, Birgit; Farcher, Martina; Demuth, Hans-Ulrich; Lues, Inge; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-130</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Numerous studies suggest that the majority of amyloid-β (Aβ) peptides deposited in Alzheimer's disease (AD) are truncated and post-translationally modified at the N terminus.  Among these modified species, pyroglutamyl-Aβ(pE-Aβ, including N3pE-Aβ40/42 and N11pE-Aβ40/42) has been identified as particularly neurotoxic.  The N-terminal modification renders the peptide hydrophobic, accelerates formation of oligomers, and reduces degrdn. by peptidases, leading ultimately to the accumulation of the peptide and progression of AD.  It has been shown that the formation of pyroglutamyl residues is catalyzed by glutaminyl cyclase (QC).  Here, we present data about the pharmacol. in vitro and in vivo efficacy of the QC inhibitor (S)-1-(1H-benzo[d]imidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one (PQ912), the first-in-class compd. that is in clin. development.  PQ912 inhibits human, rat, and mouse QC activity, with Ki values ranging between 20 and 65 nM.  Chronic oral treatment of hAPPSLxhQC double-transgenic mice with approx. 200 mg/kg/day via chow shows a significant redn. of pE-Aβ levels and concomitant improvement of spatial learning in a Morris water maze test paradigm.  This dose results in a brain and cerebrospinal fluid concn. of PQ912 which relates to a QC target occupancy of about 60%.  Thus, we conclude that >50% inhibition of QC activity in the brain leads to robust treatment effects.  Secondary pharmacol. expts. in mice indicate a fairly large potency difference for Aβ cyclization compared with cyclization of physiol. substrates, suggesting a robust therapeutic window in humans.  This information constitutes an important translational guidance for predicting the therapeutic dose range in clin. studies with PQ912.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9VVUSISdmtrVg90H21EOLACvtfcHk0lhmo79i4f6Yng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J&md5=080e83d1ac24b892e74a556f04db9232</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.240614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.240614%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DKurat%26aufirst%3DS.%26aulast%3DB%25C3%25B6hme%26aufirst%3DL.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DB%25C3%25BChring%26aufirst%3DK.-U.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DFarcher%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.-U.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibitor%2520PQ912%2520improves%2520cognition%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease-Studies%2520on%2520relation%2520to%2520effective%2520target%2520occupancy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D362%26spage%3D119%26epage%3D130%26doi%3D10.1124%2Fjpet.117.240614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhring, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn-Wache, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokorny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiesa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glund, K.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.trci.2015.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=182-195&author=I.+Luesauthor=F.+Weberauthor=A.+Meyerauthor=U.+Buhringauthor=T.+Hoffmannauthor=K.+Kuhn-Wacheauthor=S.+Manhartauthor=U.+Heiserauthor=R.+Pokornyauthor=J.+Chiesaauthor=K.+Glund&title=A+phase+1+study+to+evaluate+the+safety+and+pharmacokinetics+of+PQ912%2C+a+glutaminyl+cyclase+inhibitor%2C+in+healthy+subjects&doi=10.1016%2Fj.trci.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span></div><div class="casAuthors">Lues Inge; Weber Frank; Meyer Antje; Buhring Uli; Hoffmann Torsten; Kuhn-Wache Kerstin; Manhart Susanne; Heiser Ulrich; Glund Konrad; Pokorny Rolf; Chiesa Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-195</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Pyroglutamate-amyloid-β (pE-Aβ) peptides are major components of Aβ-oligomers and Aβ-plaques, which are regarded as key culprits of Alzheimer's disease (AD) pathology.  PQ912 is a competitive inhibitor of the enzyme glutaminyl cyclase (QC), essential for the formation of pE-Aβ peptides.  Methods:  A randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study investigated the safety, pharmacokinetics, and pharmacodynamics of PQ912 in healthy nonelderly and elderly subjects.  Results:  PQ912 was considered safe and well tolerated with dose-proportional pharmacokinetics up to doses of 200 mg.  At higher doses up to 1800 mg, exposure was supraproportional and exposure in elderly subjects was approximately 1.5- to 2.1-fold higher.  Exposure in cerebrospinal fluid (CSF) was approximately 20% of the unbound drug in plasma, and both serum and CSF QC activity was inhibited in a dose-related manner.  Discussion:  This first-in-man study of a compound-targeting QC inhibition justifies further development of PQ912 for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_8LDrMzHWYDjk2McQZ6XmfW6udTcc2eaG1nKshH1Db7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D&md5=49cc7018331e760dfef1b844f93cc31c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DLues%26aufirst%3DI.%26aulast%3DWeber%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DBuhring%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKuhn-Wache%26aufirst%3DK.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DPokorny%26aufirst%3DR.%26aulast%3DChiesa%26aufirst%3DJ.%26aulast%3DGlund%26aufirst%3DK.%26atitle%3DA%2520phase%25201%2520study%2520to%2520evaluate%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520PQ912%252C%2520a%2520glutaminyl%2520cyclase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2015%26volume%3D1%26spage%3D182%26epage%3D195%26doi%3D10.1016%2Fj.trci.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>New Alzheimer’s
drug shows safety, hints of efficacy in phase 2. <a href="https://www.alzforum.org/news/research-news/new-alzheimers-drug-shows-safety-hints-efficacy-phase-2" class="extLink">https://www.alzforum.org/news/research-news/new-alzheimers-drug-shows-safety-hints-efficacy-phase-2</a> (accessed May 01, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Alzheimer%E2%80%99s%0Adrug+shows+safety%2C+hints+of+efficacy+in+phase+2.+https%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fnew-alzheimers-drug-shows-safety-hints-efficacy-phase-2+%28accessed+May+01%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sönnichsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imarisio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarditi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dami, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Couto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamanti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satagopam, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caramelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardone, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradonna, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcari, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Kane, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caricasole, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span> <span> </span><span class="NLM_article-title">siRNAscreen identifies QPCT as a druggable target for Huntington’s disease</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnchembio.1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=25848931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=347-357&author=M.+Jimenez-Sanchezauthor=W.+Lamauthor=M.+Hannusauthor=B.+S%C3%B6nnichsenauthor=S.+Imarisioauthor=A.+Flemingauthor=A.+Tarditiauthor=F.+Menziesauthor=T.+E.+Damiauthor=C.+Xuauthor=E.+Gonzalez-Coutoauthor=G.+Lazzeroniauthor=F.+Heitzauthor=D.+Diamantiauthor=L.+Massaiauthor=V.+P.+Satagopamauthor=G.+Marconiauthor=C.+Caramelliauthor=A.+Nenciniauthor=M.+Andreiniauthor=G.+L.+Sardoneauthor=N.+P.+Caradonnaauthor=V.+Porcariauthor=C.+Scaliauthor=R.+Schneiderauthor=G.+Pollioauthor=C.+J.+O%E2%80%99Kaneauthor=A.+Caricasoleauthor=D.+C.+Rubinsztein&title=siRNAscreen+identifies+QPCT+as+a+druggable+target+for+Huntington%E2%80%99s+disease&doi=10.1038%2Fnchembio.1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">siRNA screen identifies QPCT as a druggable target for Huntington's disease</span></div><div class="casAuthors">Jimenez-Sanchez, Maria; Lam, Wun; Hannus, Michael; Sonnichsen, Birte; Imarisio, Sara; Fleming, Angeleen; Tarditi, Alessia; Menzies, Fiona; Ed Dami, Teresa; Xu, Catherine; Gonzalez-Couto, Eduardo; Lazzeroni, Giulia; Heitz, Freddy; Diamanti, Daniela; Massai, Luisa; Satagopam, Venkata P.; Marconi, Guido; Caramelli, Chiara; Nencini, Arianna; Andreini, Matteo; Sardone, Gian Luca; Caradonna, Nicola P.; Porcari, Valentina; Scali, Carla; Schneider, Reinhard; Pollio, Giuseppe; O'Kane, Cahir J.; Caricasole, Andrea; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a currently incurable neurodegenerative condition caused by an abnormally expanded polyglutamine tract in huntingtin (HTT).  We identified new modifiers of mutant HTT toxicity by performing a large-scale 'druggable genome' siRNA screen in human cultured cells, followed by hit validation in Drosophila.  We focused on glutaminyl cyclase (QPCT), which had one of the strongest effects on mutant HTT-induced toxicity and aggregation in the cell-based siRNA screen and also rescued these phenotypes in Drosophila.  We found that QPCT inhibition induced the levels of the mol. chaperone αB-crystallin and reduced the aggregation of diverse proteins.  We generated new QPCT inhibitors using in silico methods followed by in vitro screening, which rescued the HD-related phenotypes in cell, Drosophila and zebrafish HD models.  Our data reveal a new HD druggable target affecting mutant HTT aggregation and provide proof of principle for a discovery pipeline from druggable genome screen to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz5Pncahjf0LVg90H21EOLACvtfcHk0lihgC2WE-Wj6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D&md5=1566a7af4210e871931ed7bbae6ba42a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1790%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Sanchez%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DW.%26aulast%3DHannus%26aufirst%3DM.%26aulast%3DS%25C3%25B6nnichsen%26aufirst%3DB.%26aulast%3DImarisio%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DA.%26aulast%3DTarditi%26aufirst%3DA.%26aulast%3DMenzies%26aufirst%3DF.%26aulast%3DDami%26aufirst%3DT.%2BE.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGonzalez-Couto%26aufirst%3DE.%26aulast%3DLazzeroni%26aufirst%3DG.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DDiamanti%26aufirst%3DD.%26aulast%3DMassai%26aufirst%3DL.%26aulast%3DSatagopam%26aufirst%3DV.%2BP.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DCaramelli%26aufirst%3DC.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DSardone%26aufirst%3DG.%2BL.%26aulast%3DCaradonna%26aufirst%3DN.%2BP.%26aulast%3DPorcari%26aufirst%3DV.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DPollio%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DC.%2BJ.%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DsiRNAscreen%2520identifies%2520QPCT%2520as%2520a%2520druggable%2520target%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D347%26epage%3D357%26doi%3D10.1038%2Fnchembio.1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6664</span>– <span class="NLM_lpage">6677</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6664-6677&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Liauthor=Y.+Zouauthor=Y.+Zhengauthor=Z.+Heauthor=Z.+Liuauthor=J.+Quanauthor=X.+Buauthor=H.+Wu&title=Synthesis+and+evaluation+of+diphenyl+conjugated+imidazole+derivatives+as+potential+glutaminyl+cyclase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Li, Yue; Zou, Yongdong; Zheng, Yizhi; He, Zhendan; Liu, Zhigang; Quan, Junmin; Bu, Xianzhang; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6664-6677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer's disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides.  Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD.  In this work, a series of di-Ph conjugated imidazole derivs. (DPCIs) was rationally designed and synthesized.  Analogs with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good in vitro blood-brain barrier (BBB) permeability.  Further assessments corroborated that the selected hQC inhibitor I inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and in vivo, and improves the behavior of AD mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMrmUpYJCVhrVg90H21EOLACvtfcHk0lh22DFU5EWz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE&md5=8ffec76fc13fbe8520675ee884c12772</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00648%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520diphenyl%2520conjugated%2520imidazole%2520derivatives%2520as%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6664%26epage%3D6677%26doi%3D10.1021%2Facs.jmedchem.7b00648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hielscher-Michael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griehl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L. A.</span></span> <span> </span><span class="NLM_article-title">Natural products from microalgae with potential against Alzheimer’s disease: Sulfolipids are potent glutaminyl cyclase inhibitors</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.3390/md14110203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.3390%2Fmd14110203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=203-218&author=S.+Hielscher-Michaelauthor=C.+Griehlauthor=M.+Buchholzauthor=H.-U.+Demuthauthor=N.+Arnoldauthor=L.+A.+Wessjohann&title=Natural+products+from+microalgae+with+potential+against+Alzheimer%E2%80%99s+disease%3A+Sulfolipids+are+potent+glutaminyl+cyclase+inhibitors&doi=10.3390%2Fmd14110203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products from microalgae with potential against Alzheimer's disease: sulfolipids are potent glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Hielscher-Michael, Stephanie; Griehl, Carola; Buchholz, Mirko; Demuth, Hans-Ulrich; Arnold, Norbert; Wessjohann, Ludger A.</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">203/1-203/16</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In recent years, many new enzymes, like glutaminyl cyclase (QC), could be assocd. with pathophysiol. processes and represent targets for many diseases, so that enzyme-inhibiting properties of natural substances are becoming increasingly important.  In different studies, the pathophysiol. connection of QC to various diseases including Alzheimer's disease (AD) was described.  Algae are known for the ability to synthesize complex and highly-diverse compds. with specific enzyme inhibition properties.  Therefore, we screened different algae species for the presence of QC inhibiting metabolites using a new "Reverse Metabolomics" technique including an Activity-correlation Anal. (AcorA), which is based on the correlation of bioactivities to mass spectral data with the aid of mathematic informatics deconvolution.  Thus, three QC inhibiting compds. from microalgae belonging to the family of sulfolipids were identified.  The compds. showed a QC inhibition of 81% and 76% at concns. of 0.25 mg/mL and 0.025 mg/mL, resp.  Thus, for the first time, sulfolipids are identified as QC inhibiting compds. and possess substructures with the required pharmacophore qualities.  They represent a new lead structure for QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruC1d9bEVkyrVg90H21EOLACvtfcHk0lhxszd3hs2iuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM&md5=3097fbf425c5ff891dd01e9186d8c817</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fmd14110203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd14110203%26sid%3Dliteratum%253Aachs%26aulast%3DHielscher-Michael%26aufirst%3DS.%26aulast%3DGriehl%26aufirst%3DC.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.-U.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26atitle%3DNatural%2520products%2520from%2520microalgae%2520with%2520potential%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Sulfolipids%2520are%2520potent%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DMar.%2520Drugs%26date%3D2016%26volume%3D14%26spage%3D203%26epage%3D218%26doi%3D10.3390%2Fmd14110203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of flavonoids on human glutaminyl cyclase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2280</span>– <span class="NLM_lpage">2286</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.bmc.2016.03.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=27061673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2280-2286&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Zouauthor=Y.+Zhengauthor=X.+Buauthor=J.+Quanauthor=Z.+Heauthor=H.+Wu&title=Inhibitory+effect+of+flavonoids+on+human+glutaminyl+cyclase&doi=10.1016%2Fj.bmc.2016.03.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of flavonoids on human glutaminyl cyclase</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Zou, Yongdong; Zheng, Yizhi; Bu, Xianzhang; Quan, Junmin; He, Zhendan; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2280-2286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents.  However, the study of QC inhibitors are still less.  Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivs. were synthesized as a new class of human QC (hQC) inhibitors.  The efficacy investigation of these compds. was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated.  Mol. docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo3dENiH0N7Vg90H21EOLACvtfcHk0lhxszd3hs2iuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D&md5=86df2e8e2c427d483dea92e747ddf116</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.064%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DInhibitory%2520effect%2520of%2520flavonoids%2520on%2520human%2520glutaminyl%2520cyclase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2280%26epage%3D2286%26doi%3D10.1016%2Fj.bmc.2016.03.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szaszkó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdú, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flachner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lörincz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pázmány, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cseh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dormán, G.</span></span> <span> </span><span class="NLM_article-title">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/s11030-016-9717-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1007%2Fs11030-016-9717-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=28070724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=175-186&author=M.+Szaszk%C3%B3author=I.+Hajd%C3%BAauthor=B.+Flachnerauthor=K.+Dobiauthor=C.+Magyarauthor=I.+Simonauthor=Z.+L%C3%B6rinczauthor=Z.+Kapuiauthor=T.+P%C3%A1zm%C3%A1nyauthor=S.+Csehauthor=G.+Dorm%C3%A1n&title=Identification+of+potential+glutaminyl+cyclase+inhibitors+from+lead-like+libraries+by+in+silico+and+in+vitro+fragment-based+screening&doi=10.1007%2Fs11030-016-9717-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span></div><div class="casAuthors">Szaszko, Maria; Hajdu, Istvan; Flachner, Beata; Dobi, Krisztina; Magyar, Csaba; Simon, Istvan; Lorincz, Zsolt; Kapui, Zoltan; Pazmany, Tamas; Cseh, Sandor; Dorman, Gyorgy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-186</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A glutaminyl cyclase (QC) fragment library was in silico selected by disconnection of the structure of known QC inhibitors and by lead-like 2D virtual screening of the same set.  The resulting fragment library (204 compds.) was acquired from com. suppliers and pre-screened by differential scanning fluorimetry followed by functional in vitro assays.  In this way, 10 fragment hits were identified ( ∼ 5 % hit rate, best inhibitory activity: 16 μM).  The in vitro hits were then docked to the active site of QC, and the best scoring compds. were analyzed for binding interactions.  Two fragments bound to different regions in a complementary manner, and thus, linking those fragments offered a rational strategy to generate novel QC inhibitors.  Based on the structure of the virtual linked fragment, a 77-membered QC target focused library was selected from vendor databases and docked to the active site of QC.  A PubChem search confirmed that the best scoring analogs are novel, potential QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VdqwKUctWrVg90H21EOLACvtfcHk0lhxszd3hs2iuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D&md5=1eb4a1423d7e0bc0cf4ea621848d4580</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs11030-016-9717-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-016-9717-4%26sid%3Dliteratum%253Aachs%26aulast%3DSzaszk%25C3%25B3%26aufirst%3DM.%26aulast%3DHajd%25C3%25BA%26aufirst%3DI.%26aulast%3DFlachner%26aufirst%3DB.%26aulast%3DDobi%26aufirst%3DK.%26aulast%3DMagyar%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DI.%26aulast%3DL%25C3%25B6rincz%26aufirst%3DZ.%26aulast%3DKapui%26aufirst%3DZ.%26aulast%3DP%25C3%25A1zm%25C3%25A1ny%26aufirst%3DT.%26aulast%3DCseh%26aufirst%3DS.%26aulast%3DDorm%25C3%25A1n%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520from%2520lead-like%2520libraries%2520by%2520in%2520silico%2520and%2520in%2520vitro%2520fragment-based%2520screening%26jtitle%3DMol.%2520Diversity%26date%3D2017%26volume%3D21%26spage%3D175%26epage%3D186%26doi%3D10.1007%2Fs11030-016-9717-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropog, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesada, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of [<sup>11</sup>C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer’s disease prior to amyloid β aggregation</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1039/C5MD00148J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1039%2FC5MD00148J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26101580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1065-1068&author=A.+F.+Brooksauthor=I.+M.+Jacksonauthor=X.+Shaoauthor=G.+W.+Kropogauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=P.+J.+H.+Scott&title=Synthesis+and+evaluation+of+%5B11C%5DPBD150%2C+a+radiolabeled+glutaminyl+cyclase+inhibitor+for+the+potential+detection+of+Alzheimer%E2%80%99s+disease+prior+to+amyloid+%CE%B2+aggregation&doi=10.1039%2FC5MD00148J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation</span></div><div class="casAuthors">Brooks, Allen F.; Jackson, Isaac M.; Shao, Xia; Kropog, George W.; Sherman, Phillip; Quesada, Carole A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-1068</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The hydroxy moiety of 1-[3-(1H-imidazol-1-yl)propyl]-3-(4-hydroxy-3-methoxyphenyl)thiourea was selectively carbon-11 labeled to generate [11C]PBD150 in 7.3% yield from [11C]methyl triflate (non-decay cor.; radiochem. purity ≥95%, specific activity = 5.7 Ci μmol-1, n = 5).  Evaluation of [11C]PBD150 by small animal PET imaging (mouse and rat) detd. that it did not permeate the blood brain barrier, indicating that a previously described therapeutic effect in transgenic mice was likely not the result of inhibiting central nervous system glutaminyl cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmg-DpdoFU-7Vg90H21EOLACvtfcHk0lhjARYbow2Vaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D&md5=eaea24571848b33c06b92756ff873161</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC5MD00148J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00148J%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DJackson%26aufirst%3DI.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DKropog%26aufirst%3DG.%2BW.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B11C%255DPBD150%252C%2520a%2520radiolabeled%2520glutaminyl%2520cyclase%2520inhibitor%2520for%2520the%2520potential%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prior%2520to%2520amyloid%2520%25CE%25B2%2520aggregation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1065%26epage%3D1068%26doi%3D10.1039%2FC5MD00148J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent human glutaminyl cyclase inhibitors as anti-Alzheimer’s agents based on rational design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2573</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2573-2590&author=V.+H.+Hoangauthor=P.+T.+Tranauthor=M.+Cuiauthor=V.+T.+Ngoauthor=J.+Annauthor=J.+Parkauthor=J.+Leeauthor=K.+Choiauthor=H.+Choauthor=H.+Kimauthor=H.+J.+Haauthor=H.+S.+Hongauthor=S.+Choiauthor=Y.-H.+Kimauthor=J.+Lee&title=Discovery+of+potent+human+glutaminyl+cyclase+inhibitors+as+anti-Alzheimer%E2%80%99s+agents+based+on+rational+design&doi=10.1021%2Facs.jmedchem.7b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design</span></div><div class="casAuthors">Hoang, Van-Hai; Tran, Phuong-Thao; Cui, Minghua; Ngo, Van T. H.; Ann, Jihyae; Park, Jongmi; Lee, Jiyoun; Choi, Kwanghyun; Cho, Hanyang; Kim, Hee; Ha, Hee-Jin; Hong, Hyun-Seok; Choi, Sun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2573-2590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer's disease (AD).  The authors designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E-42.  An in vitro structure-activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor.  When tested in mouse models of AD, compd. 212 (I) significantly reduced the brain concns. of pyroform Aβ and total Aβ and restored cognitive functions.  This potent Aβ-lowering effect was achieved by incorporating an addnl. binding region into the authors' previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu 327 in the QC binding site.  The authors' study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqaMS-1r-2bVg90H21EOLACvtfcHk0lhjARYbow2Vaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D&md5=856a0159f8249b82f8b79d25ab162973</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00098%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DNgo%26aufirst%3DV.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.-H.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520based%2520on%2520rational%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2573%26epage%3D2590%26doi%3D10.1021%2Facs.jmedchem.7b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">12439</span>– <span class="NLM_lpage">12449</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-12449&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0lhjARYbow2Vaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D12449%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillaspy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, D. J.</span></span> <span> </span><span class="NLM_article-title">A simple method for the formation of cyclopropylamines: The first synthesis of tricyclopropylamine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7399</span>– <span class="NLM_lpage">7402</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(95)01560-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2F0040-4039%2895%2901560-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK2MXoslOqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=7399-7402&author=M.+L.+Gillaspyauthor=B.+A.+Lefkerauthor=W.+A.+Hadaauthor=D.+J.+Hoover&title=A+simple+method+for+the+formation+of+cyclopropylamines%3A+The+first+synthesis+of+tricyclopropylamine&doi=10.1016%2F0040-4039%2895%2901560-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for the formation of cyclopropylamines: the first synthesis of tricyclopropylamine.</span></div><div class="casAuthors">Gillaspy, Melissa; Lefker, Bruce A.; Hada, William A.; Hoover, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7399-402</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Treatment of a variety of secondary and primary amines with [(1-ethoxycyclopropyl)oxy]trimethylsilane and NaBH3CN in MeOH gave mono- and dicyclopropylamines in 41-91% yield.  Sterically hindered di- and tricyclopropylamines, including tricyclopropylamine, were prepd.  The pKas of some mono-, di- and tricyclopropylamines were measured showing a redn. of ∼1-2 pKa unit per added cyclopropyl group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBHlBQO9wq2LVg90H21EOLACvtfcHk0lgNtH486qkBVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslOqu70%253D&md5=03d4a4010d1b5b4a9bf075b24fdc3b1d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2901560-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252901560-4%26sid%3Dliteratum%253Aachs%26aulast%3DGillaspy%26aufirst%3DM.%2BL.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26atitle%3DA%2520simple%2520method%2520for%2520the%2520formation%2520of%2520cyclopropylamines%253A%2520The%2520first%2520synthesis%2520of%2520tricyclopropylamine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D7399%26epage%3D7402%26doi%3D10.1016%2F0040-4039%2895%2901560-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinick, F.</span></span> <span> </span><span class="NLM_article-title">The mechanism of the Robinson-Gabriel synthesis of oxazoles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2407</span>– <span class="NLM_lpage">2408</span>, <span class="refDoi"> DOI: 10.1021/jo00953a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00953a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaE3sXksVWmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=2407-2408&author=H.+H.+Wassermanauthor=F.+Vinick&title=The+mechanism+of+the+Robinson-Gabriel+synthesis+of+oxazoles&doi=10.1021%2Fjo00953a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the Robinson-Gabriel synthesis of oxazoles</span></div><div class="casAuthors">Wasserman, Harry H.; Vinick, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2407-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The mechanism of the Robinson-Gabriel synthesis of oxazoles from α-acylamino ketones was elucidated.  The reaction takes  place by incorporation of the oxygen of the amide group and elimination of the ketone oxygen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkDjrXlwu56bVg90H21EOLACvtfcHk0lgNtH486qkBVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXksVWmu70%253D&md5=c22a1b17ba838f26ea937892232f6d3f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo00953a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00953a028%26sid%3Dliteratum%253Aachs%26aulast%3DWasserman%26aufirst%3DH.%2BH.%26aulast%3DVinick%26aufirst%3DF.%26atitle%3DThe%2520mechanism%2520of%2520the%2520Robinson-Gabriel%2520synthesis%2520of%2520oxazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D2407%26epage%3D2408%26doi%3D10.1021%2Fjo00953a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukuyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jow, C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span> <span> </span><span class="NLM_article-title">2- and 4-Nitrobenzenesulfonamides: Exceptionally versatile means for preparation of secondary amines and protection of amines</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">6373</span>– <span class="NLM_lpage">6374</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(95)01316-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2F0040-4039%2895%2901316-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFCmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=6373-6374&author=T.+Fukuyamaauthor=C.-K.+Jowauthor=M.+Cheung&title=2-+and+4-Nitrobenzenesulfonamides%3A+Exceptionally+versatile+means+for+preparation+of+secondary+amines+and+protection+of+amines&doi=10.1016%2F0040-4039%2895%2901316-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">2- and 4-nitrobenzenesulfonamides: exceptionally versatile means for preparation of secondary amines and protection of amines</span></div><div class="casAuthors">Fukuyama, Tohru; Jow, Chung-Kuang; Cheung, Mui</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">6373-4</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">2- And 4-nitrobenzenesulfonamides I (R = Y = H, X = NO2; R = X = H, Y = NO2) , readily prepd. from primary amines, undergo smooth alkylation by Mitsunobu reaction or by conventional methods to give N-alkylated sulfonamides I (R = PhCH2, Pr, PhCH2CH2, CHMeCO2Et) in near quant. yields.  These sulfonamides could be deprotected readily via Meisenheimer complexes upon treatment with thiolates in DMF at room temp., giving secondary amines RNHCH2C6H4OMe-4 in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70dPXo4L1urVg90H21EOLACvtfcHk0lgNtH486qkBVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFCmu7k%253D&md5=eb9ffe1b2070a87db41962623495139c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2901316-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252901316-A%26sid%3Dliteratum%253Aachs%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DJow%26aufirst%3DC.-K.%26aulast%3DCheung%26aufirst%3DM.%26atitle%3D2-%2520and%25204-Nitrobenzenesulfonamides%253A%2520Exceptionally%2520versatile%2520means%2520for%2520preparation%2520of%2520secondary%2520amines%2520and%2520protection%2520of%2520amines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D6373%26epage%3D6374%26doi%3D10.1016%2F0040-4039%2895%2901316-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goddard-Borger, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stick, R. V.</span></span> <span> </span><span class="NLM_article-title">An efficient, inexpensive, and shelf-stable diazotransfer reagent: Imidazole-1-sulfonyl azide hydrochloride</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3797</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.1021/ol701581g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol701581g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3797-3800&author=E.+D.+Goddard-Borgerauthor=R.+V.+Stick&title=An+efficient%2C+inexpensive%2C+and+shelf-stable+diazotransfer+reagent%3A+Imidazole-1-sulfonyl+azide+hydrochloride&doi=10.1021%2Fol701581g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient, Inexpensive, and Shelf-Stable Diazotransfer Reagent: Imidazole-1-sulfonyl Azide Hydrochloride</span></div><div class="casAuthors">Goddard-Borger, Ethan D.; Stick, Robert V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3797-3800</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of a new diazotransfer reagent, imidazole-1-sulfonyl azide hydrochloride, are reported.  This reagent has proven to equal triflyl azide in its ability to act as a "diazo donor" in the conversion of both primary amines into azides and activated methylene substrates into diazo compds.  Crucially, this reagent can be prepd. in a one-pot reaction on a large scale from inexpensive materials, is shelf-stable, and is conveniently cryst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp47A7S4vCoO7Vg90H21EOLACvtfcHk0lgYmtt6i7nAlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D&md5=f664d543b21303c0101ddedd9cc37744</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fol701581g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol701581g%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard-Borger%26aufirst%3DE.%2BD.%26aulast%3DStick%26aufirst%3DR.%2BV.%26atitle%3DAn%2520efficient%252C%2520inexpensive%252C%2520and%2520shelf-stable%2520diazotransfer%2520reagent%253A%2520Imidazole-1-sulfonyl%2520azide%2520hydrochloride%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3797%26epage%3D3800%26doi%3D10.1021%2Fol701581g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubiales, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Santos, J. M.</span></span> <span> </span><span class="NLM_article-title">The aza-Wittig reaction: an efficient tool for the construction of carbon-nitrogen double bonds</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.tet.2006.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlagtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=523-575&author=F.+Palaciosauthor=C.+Alonsoauthor=D.+Aparicioauthor=G.+Rubialesauthor=J.+M.+de+los+Santos&title=The+aza-Wittig+reaction%3A+an+efficient+tool+for+the+construction+of+carbon-nitrogen+double+bonds&doi=10.1016%2Fj.tet.2006.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The aza-Wittig reaction. An efficient tool for the construction of carbon-nitrogen double bonds</span></div><div class="casAuthors">Palacios, Francisco; Alonso, Concepcion; Aparicio, Domitila; Rubiales, Gloria; de los Santos, Jesus M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">523-575</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the aza-Wittig reaction of phosphazene derivs. with several carbonyl compds. are reviewed.  Phosphazenes afford inter- and intramol. aza-Wittig reactions with different compds. such as aldehydes, ketones, esters, thioesters, amides, anhydrides, and sulfimides.  One of the most important applications of this reaction is the synthesis of a wide range of acyclic and heterocyclic compds., ranging from simple monocyclic compds. to complex polycyclic and macrocyclic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Jq_OhMZNQLVg90H21EOLACvtfcHk0lgYmtt6i7nAlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlagtr3P&md5=9da0a948b7d1275dbcb9d15edb76a404</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DF.%26aulast%3DAlonso%26aufirst%3DC.%26aulast%3DAparicio%26aufirst%3DD.%26aulast%3DRubiales%26aufirst%3DG.%26aulast%3Dde%2Blos%2BSantos%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520aza-Wittig%2520reaction%253A%2520an%2520efficient%2520tool%2520for%2520the%2520construction%2520of%2520carbon-nitrogen%2520double%2520bonds%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D523%26epage%3D575%26doi%3D10.1016%2Fj.tet.2006.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Continuous spectrometric assays for glutaminyl cyclase activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1006/abio.2001.5560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1006%2Fabio.2001.5560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=11906150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=49-56&author=S.+Schillingauthor=T.+Hoffmannauthor=M.+Wermannauthor=U.+Heiserauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Continuous+spectrometric+assays+for+glutaminyl+cyclase+activity&doi=10.1006%2Fabio.2001.5560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Spectrometric Assays for Glutaminyl Cyclase Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Wermann, Michael; Heiser, Ulrich; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The enzymic conversion of one chromogenic substrate, L-glutamine-p-nitroanilide, and two fluorogenic substrates, L-glutaminyl-2-naphthylamide and L-glutaminyl-4-methylcoumarinylamide, into their resp. pyroglutamic acid derivs. by glutaminyl cyclase (QC) was estd. by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme.  For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-Bu ester.  The assay can be performed in the presence of ammonia up to a concn. of 50 mM.  Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymic activity of about 20%.  This is the first report of a fast, continuous, and reliable detn. of QC activity, even in the presence of ammonium ions, during the course of protein purifn. and enzymic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQW4L1wwLqbVg90H21EOLACvtfcHk0lgYmtt6i7nAlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D&md5=18509903cf5017f855c3c3ea68dc9915</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5560%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DContinuous%2520spectrometric%2520assays%2520for%2520glutaminyl%2520cyclase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2002%26volume%3D303%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.2001.5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plank, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>397</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1515%2Fhsz-2015-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26351917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=45-55&author=A.+Beckerauthor=R.+Eichentopfauthor=R.+Sedlmeierauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=A.+Stephanauthor=C.+Bauscherauthor=S.+Kohlmannauthor=T.+Hoffmannauthor=A.+Kehlenauthor=S.+Bergauthor=E.+J.+Freyseauthor=A.+Osmandauthor=A.+C.+Plankauthor=S.+Rossnerauthor=S.+von+Horstenauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=S.+Schilling&title=IsoQC+%28QPCTL%29+knock-out+mice+suggest+differential+substrate+conversion+by+glutaminyl+cyclase+isoenzymes&doi=10.1515%2Fhsz-2015-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span></div><div class="casAuthors">Becker, Andreas; Eichentopf, Rico; Sedlmeier, Reinhard; Waniek, Alexander; Cynis, Holger; Koch, Birgit; Stephan, Anett; Baeuscher, Christoph; Kohlmann, Stephanie; Hoffmann, Torsten; Kehlen, Astrid; Berg, Sabine; Freyse, Ernst-Joachim; Osmand, Alexander; Plank, Anne-Christine; Rossner, Steffen; von Hoersten, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Secretory peptides and proteins are frequently modified by pyroglutamic acid (pE, pGlu) at their N-terminus.  This modification is catalyzed by the glutaminyl cyclases QC and isoQC.  Here, we decipher the roles of the isoenzymes by characterization of IsoQC-/- mice.  These mice show a significant redn. of glutaminyl cyclase activity in brain and peripheral tissue, suggesting ubiquitous expression of the isoQC enzyme.  An assay of substrate conversion in vivo reveals impaired generation of the pGlu-modified C-C chemokine ligand 2 (CCL2, MCP-1) in isoQC-/- mice.  The pGlu-formation was also impaired in primary neurons, which express significant levels of QC.  Interestingly, however, the formation of the neuropeptide hormone TSH-releasing hormone (TRH), assessed by immunohistochem. and hormonal anal. of hypothalamic-pituitary-thyroid axis, was not affected in isoQC-/-, which contrasts to QC-/-.  Thus, the results reveal differential functions of isoQC and QC in the formation of the pGlu-peptides CCL2 and TRH.  Substrates requiring extensive prohormone processing in secretory granules, such as TRH, are primarily converted by QC.  In contrast, protein substrates such as CCL2 appear to be primarily converted by isoQC.  The results provide a new example, how subtle differences in subcellular localization of enzymes and substrate precursor maturation might influence pGlu-product formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6FvRmQrpJjbVg90H21EOLACvtfcHk0liZRNWSjhUBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN&md5=d49367e240255a8fa1546bae79865508</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0192%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DOsmand%26aufirst%3DA.%26aulast%3DPlank%26aufirst%3DA.%2BC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsoQC%2520%2528QPCTL%2529%2520knock-out%2520mice%2520suggest%2520differential%2520substrate%2520conversion%2520by%2520glutaminyl%2520cyclase%2520isoenzymes%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26spage%3D45%26epage%3D55%26doi%3D10.1515%2Fhsz-2015-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate Aβ formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">4460</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-4460&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%CE%B2+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0liZRNWSjhUBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%25CE%25B2%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D4460%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaupp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">On the seeding and oligomerization of pGlu-amyloid peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12393</span>– <span class="NLM_lpage">12399</span>, <span class="refDoi"> DOI: 10.1021/bi0612667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0612667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=12393-12399&author=S.+Schillingauthor=T.+Lauberauthor=M.+Schauppauthor=S.+Manhartauthor=E.+Scheelauthor=G.+B%C3%B6hmauthor=H.-U.+Demuth&title=On+the+seeding+and+oligomerization+of+pGlu-amyloid+peptides&doi=10.1021%2Fbi0612667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">On the Seeding and Oligomerization of pGlu-Amyloid Peptides (in vitro)</span></div><div class="casAuthors">Schilling, Stephan; Lauber, Thomas; Schaupp, Michael; Manhart, Susanne; Scheel, Eike; Boehm, Gerald; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12393-12399</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligomerization of amyloid β (Aβ) peptides is the decisive event in the development of Alzheimer's disease (AD), the most common neuro-generative disorder in developed countries.  Recent evidence links this conformation-driven process to primary- and secondary-structure modifications of Aβ.  The N and C terminus of deposited Aβ has been shown to possess conspicuous heterogeneity.  While the C-terminally longer form of Aβ, i.e., Aβ (42), is considered more amyloidogenic, the role of the N-terminal modifications, e.g., truncation and glutamate cyclization accounting for the majority of the deposited peptides, is less understood.  In the present study, we characterized the oligomerization and seeding capacity of pGlu-amyloid peptides using two unrelated techniques based on flow cytometry or fluorescence dye binding.  Under different conditions and irresp. of the C terminus of Aβ, i.e., Aβ40 or 42, pGlu-modified peptides displayed an up to 250-fold accelerated initial formation of aggregates compared to unmodified Aβ.  The accelerated seed formation is accompanied by a change in the oligomerization kinetics because of N-terminal pGlu formation.  Furthermore, the formation of mixed aggregates consisting of either pGlu-Aβ (3-42) or ADan or ABri and Aβ (1-42) was investigated by Aβ fluorescence labeling in flow cytometry.  The results suggest that pGlu-modified peptides are potential seeding species of aggregate formation in vivo.  The data presented here and the abundance of pGlu peptides in amyloidoses, such as FBD and AD, suggest pGlu-amyloid peptides as a species with biophys. characteristics that might be in particular crucial for the initiation of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6CurUnBcAULVg90H21EOLACvtfcHk0liZRNWSjhUBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D&md5=3c41f4ad0b1cbe27a9dbc55bab2be8f4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbi0612667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0612667%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DLauber%26aufirst%3DT.%26aulast%3DSchaupp%26aufirst%3DM.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DScheel%26aufirst%3DE.%26aulast%3DB%25C3%25B6hm%26aufirst%3DG.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DOn%2520the%2520seeding%2520and%2520oligomerization%2520of%2520pGlu-amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D12393%26epage%3D12399%26doi%3D10.1021%2Fbi0612667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase ameliorates amyloid pathology in an animal model of Alzheimer’s disease via the modulation of γ-secretase activity</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.3233/JAD-141356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.3233%2FJAD-141356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=797-807&author=H.+Songauthor=Y.+J.+Changauthor=M.+Moonauthor=S.+K.+Parkauthor=P.-T.+Tranauthor=V.-H.+Hoangauthor=J.+Leeauthor=I.+Mook-Jung&title=Inhibition+of+glutaminyl+cyclase+ameliorates+amyloid+pathology+in+an+animal+model+of+Alzheimer%E2%80%99s+disease+via+the+modulation+of+%CE%B3-secretase+activity&doi=10.3233%2FJAD-141356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3233%2FJAD-141356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141356%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DTran%26aufirst%3DP.-T.%26aulast%3DHoang%26aufirst%3DV.-H.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520ameliorates%2520amyloid%2520pathology%2520in%2520an%2520animal%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520via%2520the%2520modulation%2520of%2520%25CE%25B3-secretase%2520activity%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2014%26volume%3D43%26spage%3D797%26epage%3D807%26doi%3D10.3233%2FJAD-141356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chenshu Xu, Yi-nan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haiqiang Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6549-6565. <a href="https://doi.org/10.1021/acs.jmedchem.1c00325" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlutaminyl%252BCyclase%25252C%252BDiseases%25252C%252Band%252BDevelopment%252Bof%252BGlutaminyl%252BCyclase%252BInhibitors%26aulast%3DXu%26aufirst%3DChenshu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21022021%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6549%26epage%3D6565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Arun K. Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Margherita Brindisi</span>. </span><span class="cited-content_cbyCitation_article-title">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2751-2788. <a href="https://doi.org/10.1021/acs.jmedchem.9b01541" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01541%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUrea%252BDerivatives%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BMedicinal%252BChemistry%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D16092019%26date%3D02122019%26volume%3D63%26issue%3D6%26spage%3D2751%26epage%3D2788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R.M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Jorge A.R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of glutaminyl cyclase inhibitors (2004–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>276 </em>, 1-28. <a href="https://doi.org/10.1080/13543776.2021.1917549" title="DOI URL">https://doi.org/10.1080/13543776.2021.1917549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1917549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1917549%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bglutaminyl%252Bcyclase%252Binhibitors%252B%2525282004%2525E2%252580%252593present%252529%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.M.%26date%3D2021%26date%3D2021%26volume%3D276%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Fa  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-Siou  Huang</span>, <span class="hlFld-ContribAuthor ">Mao-Lun  Wu</span>, <span class="hlFld-ContribAuthor ">Wan-Ling  Hsieh</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Hsu</span>, <span class="hlFld-ContribAuthor ">Tzu-Ping  Ko</span>, <span class="hlFld-ContribAuthor ">Andrew H.-J.  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A Unique Carboxylic-Acid Hydrogen-Bond Network (CAHBN) Confers Glutaminyl Cyclase Activity on M28 Family Enzymes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2021,</strong> <em>433 </em>
                                    (13)
                                     , 166960. <a href="https://doi.org/10.1016/j.jmb.2021.166960" title="DOI URL">https://doi.org/10.1016/j.jmb.2021.166960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2021.166960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2021.166960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DA%252BUnique%252BCarboxylic-Acid%252BHydrogen-Bond%252BNetwork%252B%252528CAHBN%252529%252BConfers%252BGlutaminyl%252BCyclase%252BActivity%252Bon%252BM28%252BFamily%252BEnzymes%26aulast%3DHuang%26aufirst%3DKai-Fa%26date%3D2021%26volume%3D433%26issue%3D13%26spage%3D166960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srishti  Sharma</span>, <span class="hlFld-ContribAuthor ">Manoj Kumar  Banjare</span>, <span class="hlFld-ContribAuthor ">Namrata  Singh</span>, <span class="hlFld-ContribAuthor ">Jan  Korábečný</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Fišar</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuča</span>, <span class="hlFld-ContribAuthor ">Kallol K.  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring spectroscopic insights into molecular recognition of potential anti-Alzheimer's drugs within the hydrophobic pockets of β-cycloamylose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Liquids</span><span> <strong>2020,</strong> <em>311 </em>, 113269. <a href="https://doi.org/10.1016/j.molliq.2020.113269" title="DOI URL">https://doi.org/10.1016/j.molliq.2020.113269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molliq.2020.113269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molliq.2020.113269%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Liquids%26atitle%3DExploring%252Bspectroscopic%252Binsights%252Binto%252Bmolecular%252Brecognition%252Bof%252Bpotential%252Banti-Alzheimer%252527s%252Bdrugs%252Bwithin%252Bthe%252Bhydrophobic%252Bpockets%252Bof%252B%2525CE%2525B2-cycloamylose%26aulast%3DSharma%26aufirst%3DSrishti%26date%3D2020%26volume%3D311%26spage%3D113269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported QC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked pose of <b>1</b> in the Z–E conformation in <i>h</i>QC. <b>1</b> is displayed as sticks with purple carbon atoms, and Zn<sup>2+</sup> is shown as the magenta ball. The interacting residues are shown as thin sticks with their carbon atoms shown in light blue. Hydrogen bonds are depicted as black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy to facilitate Z–E conformation by N-substitution on thiourea/urea analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of N-Substituted 3,4-Dimethoxyaniline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (method <b>A</b>) aldehyde or ketone, NaBH<sub>3</sub>CN, AcOH, MeOH, 40 °C, 4 h; 1-ethoxy-1-(trimethylsilyloxy)cyclopropane, AcOH/MeOH (1:1), NaBH<sub>3</sub>CN, reflux, overnight; (method <b>B</b>) iodobenzene, Pd(OAc)<sub>2</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, reflux, overnight for <b>30</b>; (method <b>C</b>) 2-chlorothiazole, TsOH, EtOH, reflux, overnight for <b>31</b>; (method <b>D</b>) (i) PhOCOCl, NEt<sub>3</sub> then (CH<sub>3</sub>O)<sub>2</sub>CHCH<sub>2</sub>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, room temperature (r.t.), overnight and (ii) c-HCl, MeOH, r.t., 2 h for <b>32</b>; (b) 2-nitrobenzenesulfonyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 4 h; (c) alkyl halide, Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), r.t., 2 h; (d) hydroxyalkyl derivatives, Ph<sub>3</sub>P, diethyl azodicarboxylate, CH<sub>2</sub>Cl<sub>2</sub>, r.t., overnight; (e) thiophenol, K<sub>2</sub>CO<sub>3</sub>, MeCN, r.t., overnight.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of N-substituted Thiourea and Urea Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1<i>H</i>-imidazole-1-sulfonyl azide hydrogen chloride, CuSO<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, MeOH, r.t., overnight; (b) CS<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight; (c) (method <b>E</b>) CO<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight; (method <b>F</b>) (i) CO<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight and (ii) CF<sub>3</sub>CO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, r.t., overnight; (method <b>G</b>) triphosgene, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, r.t. then <b>44</b>, reflux; (method <b>H</b>) (i) CO<sub>2</sub>, Ph<sub>3</sub>P, toluene, heat, 4 h to overnight and (ii) Pd/C, c-HCl, H<sub>2</sub>, MeOH, r.t.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of α-Substituted Amide Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, alkyl halide, tetrahydrofuran (THF) or DMF, r.t. to 60 °C; (b) NaOH, H<sub>2</sub>O, EtOH, reflux, 24 h; (c) <b>44</b>, EDC·HCl, 1-hydroxybenzotriazole (HOBt), NEt<sub>3</sub>, r.t., overnight.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of the formation of human Aβ<sub>N3pE-40/42</sub> and Aβ<sub>1-40/42</sub> in 5XFAD mice. Brain concentrations of (a) Aβ<sub>N3pE-40</sub>, (b) Aβ<sub>N3pE-42</sub>, (c) Aβ<sub>40</sub>, and (c) Aβ<sub>42</sub>. Data were analyzed by unpaired <i>t</i>-test or one-way analysis of variance (ANOVA) (*: <i>p</i> < 0.05, **: <i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plots of energy vs incremental conformational changes from calculated dihedral angles: (A) thiourea in <b>1</b>, (B) urea in <b>62</b>, and (C) <i>N</i>-piperidinyl urea in <b>90</b>. The <i>X</i> axis represents the dihedral angle (C–C–N–C) found near the 5-methyl imidazole ring, while the <i>Y</i> axis represents the dihedral angle (N–C–N–C) near the dimethoxy phenyl group. Dihedral angle (in degrees) close to 0 denotes the E-form and close to 180/–180 denotes the Z-form. The plots show that low-energy conformations occupied mostly the Z–E form in thiourea <b>1</b> and N-substituted urea <b>90</b>. In contrast, diversity (both Z–Z and Z–E) of low-energy conformations exist for the urea compound, <b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/medium/jm9b00751_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docked result of <b>90</b> in <i>h</i>QC. (A) Binding interactions of <b>90</b> at the active site of <i>h</i>QC. <b>90</b> is displayed as sticks with cyan carbon atoms, and Zn<sup>2+</sup> is shown as a purple ball. The interacting residues are shown as thin sticks with their carbon atoms shown in light blue. Hydrogen bonds are depicted as black dashed lines. (B) Two-dimensional representation of the interactions of <b>90</b> with the active site residues of the <i>h</i>QC. Hydrophobic interactions are marked in light brown. Hydrogen bonds are shown as red-dotted arrows with directionality. The π–π stacking interaction is marked by a blue disc and arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00751/20190905/images/large/jm9b00751_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00751&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i115">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Anti-amyloid failures stack up as Alzheimer antibody flops</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">327</span> <span class="refDoi"> DOI: 10.1038/d41573-019-00064-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fd41573-019-00064-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&author=A.+Mullard&title=Anti-amyloid+failures+stack+up+as+Alzheimer+antibody+flops&doi=10.1038%2Fd41573-019-00064-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fd41573-019-00064-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41573-019-00064-1%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DAnti-amyloid%2520failures%2520stack%2520up%2520as%2520Alzheimer%2520antibody%2520flops%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26doi%3D10.1038%2Fd41573-019-00064-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozupone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logroscino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbimbo, B. P.</span></span> <span> </span><span class="NLM_article-title">A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1038/s41582-018-0116-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fs41582-018-0116-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=30610216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A280%3ADC%252BB3cnotFagtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=73-88&author=F.+Panzaauthor=M.+Lozuponeauthor=G.+Logroscinoauthor=B.+P.+Imbimbo&title=A+critical+appraisal+of+amyloid-%CE%B2-targeting+therapies+for+Alzheimer+disease&doi=10.1038%2Fs41582-018-0116-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease</span></div><div class="casAuthors">Panza Francesco; Lozupone Madia; Logroscino Giancarlo; Panza Francesco; Logroscino Giancarlo; Panza Francesco; Imbimbo Bruno P</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Brain accumulation of the amyloid-β (Aβ) peptide is believed to be the initial event in the Alzheimer disease (AD) process.  Aβ accumulation begins 15-20 years before clinical symptoms occur, mainly owing to defective brain clearance of the peptide.  Over the past 20 years, we have seen intensive efforts to decrease the levels of Aβ monomers, oligomers, aggregates and plaques using compounds that decrease production, antagonize aggregation or increase brain clearance of Aβ.  Unfortunately, these approaches have failed to show clinical benefit in large clinical trials involving patients with mild to moderate AD.  Clinical trials in patients at earlier stages of the disease are ongoing, but the initial results have not been clinically impressive.  Efforts are now being directed against Aβ oligomers, the most neurotoxic molecular species, and monoclonal antibodies directed against these oligomers are producing encouraging results.  However, Aβ oligomers are in equilibrium with both monomeric and aggregated species; thus, previous drugs that efficiently removed monomeric Aβ or Aβ plaques should have produced clinical benefits.  In patients with sporadic AD, Aβ accumulation could be a reactive compensatory response to neuronal damage of unknown cause, and alternative strategies, including interference with modifiable risk factors, might be needed to defeat this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwevf7x6znXRjv2lLSLOxFfW6udTcc2eann37ADs2nlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnotFagtA%253D%253D&md5=fa63b5a3ca7e25169dfd6566f56b5152</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fs41582-018-0116-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41582-018-0116-6%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DLozupone%26aufirst%3DM.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DA%2520critical%2520appraisal%2520of%2520amyloid-%25CE%25B2-targeting%2520therapies%2520for%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2019%26volume%3D15%26spage%3D73%26epage%3D88%26doi%3D10.1038%2Fs41582-018-0116-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Large soluble oligomers of amyloid-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1698-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1523%2FJNEUROSCI.1698-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=28053038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovVyhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=152-163&author=T.+Yangauthor=S.+Liauthor=X.+Xuauthor=D.+M.+Walshauthor=D.+J.+Selkoe&title=Large+soluble+oligomers+of+amyloid-protein+from+Alzheimer+brain+are+far+less+neuroactive+than+the+smaller+oligomers+to+which+they+dissociate&doi=10.1523%2FJNEUROSCI.1698-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Large soluble oligomers of amyloid β-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate</span></div><div class="casAuthors">Yang, Ting; Li, Shaomin; Xu, XHuixin; Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-163</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Sol. oligomers of amyloid β-protein (oAβ) isolated from the brains of Alzheimer's disease (AD) patients have been shown exptl. (in the absence of amyloid plaques) to impair hippocampal synaptic plasticity, decrease synapses, induce tau hyperphosphorylation and neuritic dystrophy, activate microglial inflammation, and impair memory in normal adult rodents.  Nevertheless, there has been controversy about what types of oligomers actually confer these AD-like phenotypes.  Here, we show that the vast majority of sol. Aβ species obtained from brains of humans who died with confirmed AD elute at high mol. wt. (HMW) on nondenaturing size-exclusion chromatog.  These species have little or no cytotoxic activity in several bioassays.  However, incubation of HMW oAβ in mildly alk. buffer led to their quant. dissocn. into low mol. wt. oligomers (∼8 - 70 kDa), and these were now far more bioactive: they impaired hippocampal LTP, decreased neuronal levels of β2-adrenergic receptors, and activated microglia in wt mice in vivo.  Thus, most sol. Aβ assemblies in AD cortex are large and inactive but under certain circumstances can dissoc. into smaller, highly bioactive species.  Insol. amyloid plaques likely sequester sol. HMW oligomers, limiting their potential to dissoc.  We conclude that conditions that destabilize HMW oligomers or retard the sequestration of their smaller, more bioactive components are important drivers of Aβ toxicity.  Selectively targeting these small, cytotoxic forms should be therapeutically beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt1mPoeQFyOrVg90H21EOLACvtfcHk0lgZ_RSVuqnTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovVyhsL0%253D&md5=89668ff0e7c46b499818c2f171ab4185</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1698-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1698-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DLarge%2520soluble%2520oligomers%2520of%2520amyloid-protein%2520from%2520Alzheimer%2520brain%2520are%2520far%2520less%2520neuroactive%2520than%2520the%2520smaller%2520oligomers%2520to%2520which%2520they%2520dissociate%26jtitle%3DJ.%2520Neurosci.%26date%3D2017%26volume%3D37%26spage%3D152%26epage%3D163%26doi%3D10.1523%2FJNEUROSCI.1698-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polanco, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodea, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Marmol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, J.</span></span> <span> </span><span class="NLM_article-title">Amyloid-β and tau complexity towards improved biomarkers and targeted therapies</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2017.162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnrneurol.2017.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=29242522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=22-39&author=J.+C.+Polancoauthor=C.+Liauthor=L.-G.+Bodeaauthor=R.+Martinez-Marmolauthor=F.+A.+Meunierauthor=J.+G%C3%B6tz&title=Amyloid-%CE%B2+and+tau+complexity+towards+improved+biomarkers+and+targeted+therapies&doi=10.1038%2Fnrneurol.2017.162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies</span></div><div class="casAuthors">Polanco, Juan Carlos; Li, Chuanzhou; Bodea, Liviu-Gabriel; Martinez-Marmol, Ramon; Meunier, Frederic A.; Gotz, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-39</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Most neurodegenerative diseases are proteinopathies, which are characterized by the aggregation of misfolded proteins.  Although many proteins have an intrinsic propensity to aggregate, particularly when cellular clearance systems start to fail in the context of ageing, only a few form fibrillar aggregates.  In Alzheimer disease, the peptide amyloid-β (Aβ) and the protein tau aggregate to form plaques and tangles, resp., which comprise the histopathol. hallmarks of this disease.  This Review discusses the complexity of Aβ biogenesis, trafficking, post-translational modifications and aggregation states.  Tau and its various isoforms, which are subject to a vast array of post-translational modifications, are also explored.  The methodol. advances that revealed this complexity are described.  Finally, the toxic effects of distinct species of tau and Aβ are discussed, as well as the concept of protein 'strains', and how this knowledge can facilitate the development of early disease biomarkers for stratifying patients and validating new therapies.  By targeting distinct species of Aβ and tau for therapeutic intervention, the way might be paved for personalized medicine and more-targeted treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBOKmOJXAhIrVg90H21EOLACvtfcHk0lgZ_RSVuqnTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOntbbE&md5=1d5d35e842cc678e413b09b67879ce74</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2017.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2017.162%26sid%3Dliteratum%253Aachs%26aulast%3DPolanco%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBodea%26aufirst%3DL.-G.%26aulast%3DMartinez-Marmol%26aufirst%3DR.%26aulast%3DMeunier%26aufirst%3DF.%2BA.%26aulast%3DG%25C3%25B6tz%26aufirst%3DJ.%26atitle%3DAmyloid-%25CE%25B2%2520and%2520tau%2520complexity%2520towards%2520improved%2520biomarkers%2520and%2520targeted%2520therapies%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2018%26volume%3D14%26spage%3D22%26epage%3D39%26doi%3D10.1038%2Fnrneurol.2017.162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulisano, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span> <span> </span><span class="NLM_article-title">The keystone of Alzheimer pathogenesis might be sought in Aβ physiology</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2015.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.neuroscience.2015.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26314631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVajsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2015&pages=26-36&author=D.+Puzzoauthor=W.+Gulisanoauthor=O.+Arancioauthor=A.+Palmeri&title=The+keystone+of+Alzheimer+pathogenesis+might+be+sought+in+A%CE%B2+physiology&doi=10.1016%2Fj.neuroscience.2015.08.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The keystone of Alzheimer pathogenesis might be sought in Aβ physiology</span></div><div class="casAuthors">Puzzo, D.; Gulisano, W.; Arancio, O.; Palmeri, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">For several years Amyloid-beta peptide (Aβ) has been considered the main pathogenetic factor of Alzheimer's disease (AD).  According to the so called Amyloid Cascade Hypothesis the increase of Aβ triggers a series of events leading to synaptic dysfunction and memory loss as well as to the structural brain damage in the later stage of the disease.  However, several evidences suggest that this hypothesis is not sufficient to explain AD pathogenesis, esp. considering that most of the clin. trials aimed to decrease Aβ levels have been unsuccessful.  Moreover, Aβ is physiol. produced in the healthy brain during neuronal activity and it is needed for synaptic plasticity and memory.  Here we propose a model interpreting AD pathogenesis as an alteration of the neg. feedback loop between Aβ and its physiol. receptors, focusing on alpha7 nicotinic acetylcholine receptors (α7-nAchRs).  According to this vision, when Aβ cannot exert its physiol. function a neg. feedback mechanism would induce a compensatory increase of its prodn. leading to an abnormal accumulation that reduces α7-nAchR function, leading to synaptic dysfunction and memory loss.  In this perspective, the indiscriminate Aβ removal might worsen neuronal homeostasis, causing a further impoverishment of learning and memory.  Even if further studies are needed to better understand and validate these mechanisms, we believe that to deepen the role of Aβ in physiol. conditions might represent the keystone to elucidate important aspects of AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhXpsOzEHjbVg90H21EOLACvtfcHk0lgZ_RSVuqnTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVajsrrO&md5=de890b9cb601a3d5db9320ae2d159013</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2015.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2015.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DGulisano%26aufirst%3DW.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DPalmeri%26aufirst%3DA.%26atitle%3DThe%2520keystone%2520of%2520Alzheimer%2520pathogenesis%2520might%2520be%2520sought%2520in%2520A%25CE%25B2%2520physiology%26jtitle%3DNeuroscience%26date%3D2015%26volume%3D307%26spage%3D26%26epage%3D36%26doi%3D10.1016%2Fj.neuroscience.2015.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjernberg, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schedin-Weiss, S.</span></span> <span> </span><span class="NLM_article-title">Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses</span>. <i>Life Sci. Alliance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e201800028</span> <span class="refDoi"> DOI: 10.26508/lsa.201800028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.26508%2Flsa.201800028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=30456353" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&author=Y.+Yuauthor=D.+C.+Jansauthor=B.+Winbladauthor=L.+O.+Tjernbergauthor=S.+Schedin-Weiss&title=Neuronal+A%CE%B242+is+enriched+in+small+vesicles+at+the+presynaptic+side+of+synapses&doi=10.26508%2Flsa.201800028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.26508%2Flsa.201800028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26508%252Flsa.201800028%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DJans%26aufirst%3DD.%2BC.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DTjernberg%26aufirst%3DL.%2BO.%26aulast%3DSchedin-Weiss%26aufirst%3DS.%26atitle%3DNeuronal%2520A%25CE%25B242%2520is%2520enriched%2520in%2520small%2520vesicles%2520at%2520the%2520presynaptic%2520side%2520of%2520synapses%26jtitle%3DLife%2520Sci.%2520Alliance%26date%3D2018%26volume%3D1%26doi%3D10.26508%2Flsa.201800028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer amyloid hypothesis lives on</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnrd.2016.281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=3-5&author=A.+Mullard&title=Alzheimer+amyloid+hypothesis+lives+on&doi=10.1038%2Fnrd.2016.281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer amyloid hypothesis lives on</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-5</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the failure of Eli Lilly's anti-amyloid antibody solanezumab in its latest phase III trial for Alzheimer disease, a bulging pipeline of amyloid-modulating candidates and novel clin. trial strategies still hold promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcI_woBsrqLVg90H21EOLACvtfcHk0lhSdSXuuM4srA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVWq&md5=6a001e532429624f0d4a8d906650e3c0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.281%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DAlzheimer%2520amyloid%2520hypothesis%2520lives%2520on%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D3%26epage%3D5%26doi%3D10.1038%2Fnrd.2016.281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larner, A. J.</span></span> <span> </span><span class="NLM_article-title">Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/S0197-4580(99)00014-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2FS0197-4580%2899%2900014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10466895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=65-69&author=A.+J.+Larner&title=Hypothesis%3A+amyloid+beta-peptides+truncated+at+the+N-terminus+contribute+to+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2899%2900014-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Larner, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Fragments of amyloid β-peptide truncated at the N-terminus are present in AD brain early in the course of Alzheimer's disease.  It is proposed that these species contribute to the pathogenesis of AD, possibly through destabilization of elements of the neuronal cytoskeleton by small fibrillar deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBDWqVDUChLVg90H21EOLACvtfcHk0lhSdSXuuM4srA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D&md5=c6fc637848837e8d6b797073966df531</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2899%2900014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252899%252900014-7%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DA.%2BJ.%26atitle%3DHypothesis%253A%2520amyloid%2520beta-peptides%2520truncated%2520at%2520the%2520N-terminus%2520contribute%2520to%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1999%26volume%3D20%26spage%3D65%26epage%3D69%26doi%3D10.1016%2FS0197-4580%2899%2900014-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar-Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderstichele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderhoeven, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backhovens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanmechelen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroisel, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeckhoven, C.</span></span> <span> </span><span class="NLM_article-title">Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer’s disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2598</span>, <span class="refDoi"> DOI: 10.1093/hmg/9.18.2589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1093%2Fhmg%2F9.18.2589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=11063718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2589-2598&author=S.+Kumar-Singhauthor=C.+De+Jongheauthor=M.+Crutsauthor=R.+Kleinertauthor=R.+Wangauthor=M.+Merckenauthor=B.+De+Strooperauthor=H.+Vandersticheleauthor=A.+Lofgrenauthor=I.+Vanderhoevenauthor=H.+Backhovensauthor=E.+Vanmechelenauthor=P.+M.+Kroiselauthor=C.+Van+Broeckhoven&title=Nonfibrillar+diffuse+amyloid+deposition+due+to+a+gamma%2842%29-secretase+site+mutation+points+to+an+essential+role+for+N-truncated+A+beta%2842%29+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fhmg%2F9.18.2589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nonfibrillar diffuse amyloid deposition due to a γ42-secretase site mutation points to an essential role for N-truncated Aβ42 in Alzheimer's disease</span></div><div class="casAuthors">Kumar-Singh, Samir; De Jonghe, Chris; Cruts, Marc; Kleinert, Reinhold; Wang, Rong; Mercken, Marc; De Strooper, Bart; Vanderstichele, Hugo; Lofgren, Ann; Vanderhoeven, Inge; Backhovens, Hubert; Vanmechelen, Eugeen; Kroisel, Peter M.; Van Broeckhoven, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2589-2598</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Amyloidogenic processing of the amyloid precursor protein (APP) with deposition in brain of the 42-amino acid long amyloid β-peptide (Aβ42) is considered central to Alzheimer's disease (AD) pathol.  However, it is generally believed that nonfibrillar pre-amyloid Aβ42 deposits have to mature in the presence of Aβ40 into fibrillar amyloid plaques to cause neurodegeneration.  Here, an aggressive form of AD is shown to be caused by a novel missense mutation in APP (T714I) directly involving γ-secretase cleavages of APP.  The mutation had the most drastic effect on Aβ42/Aβ40 ratio in vitro of ∼11-fold, simultaneously increasing Aβ42 and decreasing Aβ40 secretion, as measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.  This coincided in brain with deposition of abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated Aβ42 in complete absence of Aβ40.  These data indicate that N-truncated Aβ42 as diffuse nonfibrillar plaques has an essential but undermined role in AD pathol.  Importantly, inhibiting secretion of full-length Aβ42 by therapeutic targeting of APP processing should not result in secretion of an equally toxic N-truncated Aβ42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZLr8Yf4DdbVg90H21EOLACvtfcHk0lhSdSXuuM4srA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D&md5=49e857dfb99cefd1e71df74cfd407fd1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F9.18.2589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F9.18.2589%26sid%3Dliteratum%253Aachs%26aulast%3DKumar-Singh%26aufirst%3DS.%26aulast%3DDe%2BJonghe%26aufirst%3DC.%26aulast%3DCruts%26aufirst%3DM.%26aulast%3DKleinert%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DLofgren%26aufirst%3DA.%26aulast%3DVanderhoeven%26aufirst%3DI.%26aulast%3DBackhovens%26aufirst%3DH.%26aulast%3DVanmechelen%26aufirst%3DE.%26aulast%3DKroisel%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBroeckhoven%26aufirst%3DC.%26atitle%3DNonfibrillar%2520diffuse%2520amyloid%2520deposition%2520due%2520to%2520a%2520gamma%252842%2529-secretase%2520site%2520mutation%2520points%2520to%2520an%2520essential%2520role%2520for%2520N-truncated%2520A%2520beta%252842%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2000%26volume%3D9%26spage%3D2589%26epage%3D2598%26doi%3D10.1093%2Fhmg%2F9.18.2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miravalle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, R.</span></span> <span> </span><span class="NLM_article-title">Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">10810</span>– <span class="NLM_lpage">10821</span>, <span class="refDoi"> DOI: 10.1021/bi0508237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0508237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10810-10821&author=L.+Miravalleauthor=M.+Caleroauthor=M.+Takaoauthor=A.+E.+Roherauthor=B.+Ghettiauthor=R.+Vidal&title=Amino-terminally+truncated+Abeta+peptide+species+are+the+main+component+of+cotton+wool+plaques&doi=10.1021%2Fbi0508237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-Terminally Truncated Aβ Peptide Species Are the Main Component of Cotton Wool Plaques</span></div><div class="casAuthors">Miravalle, Leticia; Calero, Miguel; Takao, Masaki; Roher, Alex E.; Ghetti, Bernardino; Vidal, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">10810-10821</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cotton wool plaques (CWPs) are round lesions that lack a central amyloid core.  CWPs have been obsd. in individuals affected by early-onset familial Alzheimer disease (FAD) assocd. with mutations in the presenilin 1 (PSEN1) gene.  Here we present the characterization of the amyloid-β (Aβ) peptides deposited in the brain of an individual affected by FAD carrying the novel missense (V261I) mutation in the PSEN1 gene.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was used to det. the Aβ peptide species present in the cerebral and cerebellar cortexes, in leptomeningeal vessels, and in CWPs isolated by laser microdissection (LMD).  Our results indicate that amino-terminally truncated Aβ peptide species ending at residues 42 and 43 are the main Aβ peptides deposited in brain parenchyma and LMD-CWPs in assocn. with the PSEN1 V261I mutation.  Full-length Aβ1-42 and Aβ1-43 peptide species were underrepresented.  CWPs were not found to be assocd. with vessels and did not contain Aβ1-40 peptides, the main component of the vascular deposits.  Although Aβ deposits were present mostly in the form of CWPs in the cerebral cortex and as diffuse deposits in the cerebellar cortex, a similar array of amino-terminally truncated Aβ peptide species was seen in both cases.  The biochem. data support the concept that parenchymal and vascular amyloid deposits are assocd. with a different array of Aβ peptide species.  The generation and parenchymal deposition of highly insol. amino-terminally truncated Aβ peptides may play an important role in the pathogenesis of AD and must be taken into consideration in developing new diagnostic and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAq_XS9LmMPrVg90H21EOLACvtfcHk0ljCA1ctjgnlVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D&md5=15b5a7a7cc10e2f4013b40f344988c81</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi0508237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0508237%26sid%3Dliteratum%253Aachs%26aulast%3DMiravalle%26aufirst%3DL.%26aulast%3DCalero%26aufirst%3DM.%26aulast%3DTakao%26aufirst%3DM.%26aulast%3DRoher%26aufirst%3DA.%2BE.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DVidal%26aufirst%3DR.%26atitle%3DAmino-terminally%2520truncated%2520Abeta%2520peptide%2520species%2520are%2520the%2520main%2520component%2520of%2520cotton%2520wool%2520plaques%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10810%26epage%3D10821%26doi%3D10.1021%2Fbi0508237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">38825</span>– <span class="NLM_lpage">38832</span>, <span class="refDoi"> DOI: 10.1074/jbc.R111.288308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.R111.288308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21965666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38825-38832&author=S.+Jawharauthor=O.+Wirthsauthor=T.+A.+Bayer&title=Pyroglutamate+amyloid-beta+%28Abeta%29%3A+a+hatchet+man+in+Alzheimer+disease&doi=10.1074%2Fjbc.R111.288308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">38825-38832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Pyroglutamate-modified amyloid-β (AβpE3) peptides are gaining considerable attention as potential key participants in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Transgenic mice that produce high levels of AβpE3-42 show severe neuron loss.  Recent in vitro and in vivo expts. have proven that the enzyme glutaminyl cyclase catalyzes the formation of AβpE3.  In this minireview, we summarize the current knowledge on AβpE3, discussing its discovery, biochem. properties, mol. events detg. formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9SRHPGwO6ErVg90H21EOLACvtfcHk0ljCA1ctjgnlVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE&md5=e7b0363724dd2e7cbbfc2071abdc8241</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.288308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.288308%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520amyloid-beta%2520%2528Abeta%2529%253A%2520a%2520hatchet%2520man%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38825%26epage%3D38832%26doi%3D10.1074%2Fjbc.R111.288308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span> <span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-466&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0ljCA1ctjgnlVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D466%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hause, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willbold, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7072</span>– <span class="NLM_lpage">7078</span>, <span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-7078&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0lhg_B_-C_0DJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D7078%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venezia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolcini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benatti, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schettini, G.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-modified amyloid β-peptides – AβN3(pE) – strongly affect cultured neuron and astrocyte survival</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01107.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1046%2Fj.1471-4159.2002.01107.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=12354296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1480-1489&author=C.+Russoauthor=E.+Violaniauthor=S.+Salisauthor=V.+Veneziaauthor=V.+Dolciniauthor=G.+Damonteauthor=U.+Benattiauthor=C.+D%E2%80%99Arrigoauthor=E.+Patroneauthor=P.+Carloauthor=G.+Schettini&title=Pyroglutamate-modified+amyloid+%CE%B2-peptides+%E2%80%93+A%CE%B2N3%28pE%29+%E2%80%93+strongly+affect+cultured+neuron+and+astrocyte+survival&doi=10.1046%2Fj.1471-4159.2002.01107.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-modified amyloid β-peptides - AβN3(pE) -strongly affect cultured neuron and astrocyte survival</span></div><div class="casAuthors">Russo, Claudio; Violani, Elisabetta; Salis, Serena; Venezia, Valentina; Dolcini, Virginia; Damonte, Gianluca; Benatti, Umberto; D'Arrigo, Cristina; Patrone, Eligio; Carlo, Pia; Schettini, Gennaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1480-1489</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">N-terminally truncated amyloid-β (Aβ) peptides are present in early and diffuse plaques of individuals with Alzheimer's disease (AD), are overproduced in early onset familial AD and their amt. seems to be directly correlated to the severity and the progression of the disease in AD and Down's syndrome (DS).  The pyroglutamate-contg. isoforms at position 3 [AβN3(pE)-40/42] represent the prominent form among the N-truncated species, and may account for more than 50% of Aβ accumulated in plaques.  In this study, the authors compared the toxic properties, fibrillogenic capabilities, and in vitro degrdn. profile of Aβ1-40, Aβ1-42, AβN3(pE)-40 and AβN3(pE)-42.  The authors' data show that fiber morphol. of Aβ peptides is greatly influenced by the C-terminus while toxicity, interaction with cell membranes and degrdn. are influenced by the N-terminus.  AβN3(pE)-40 induced significantly more cell loss than the other species both in neuronal and glial cell cultures.  Aggregated AβN3(pE) peptides were heavily distributed on plasma membrane and within the cytoplasm of treated cells.  AβN3(pE)-40/42 peptides showed a significant resistance to degrdn. by cultured astrocytes, while full-length peptides resulted partially degraded.  These findings suggest that formation of N-terminally modified peptides may enhance β-amyloid aggregation and toxicity, likely worsening the onset and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR0uvn5GQRVLVg90H21EOLACvtfcHk0lhg_B_-C_0DJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D&md5=41ad79cbdbb8f5debcec7c93035a709d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01107.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01107.x%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DViolani%26aufirst%3DE.%26aulast%3DSalis%26aufirst%3DS.%26aulast%3DVenezia%26aufirst%3DV.%26aulast%3DDolcini%26aufirst%3DV.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DBenatti%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DE.%26aulast%3DCarlo%26aufirst%3DP.%26aulast%3DSchettini%26aufirst%3DG.%26atitle%3DPyroglutamate-modified%2520amyloid%2520%25CE%25B2-peptides%2520%25E2%2580%2593%2520A%25CE%25B2N3%2528pE%2529%2520%25E2%2580%2593%2520strongly%2520affect%2520cultured%2520neuron%2520and%2520astrocyte%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1480%26epage%3D1489%26doi%3D10.1046%2Fj.1471-4159.2002.01107.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, C. J.</span></span> <span> </span><span class="NLM_article-title">The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">10871</span>– <span class="NLM_lpage">10877</span>, <span class="refDoi"> DOI: 10.1021/bi990563r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi990563r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=10871-10877&author=W.+Heauthor=C.+J.+Barrow&title=The+A+beta+3-pyroglutamyl+and+11-pyroglutamyl+peptides+found+in+senile+plaque+have+greater+beta-sheet+forming+and+aggregation+propensities+in+vitro+than+full-length+A+beta&doi=10.1021%2Fbi990563r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ</span></div><div class="casAuthors">He, Weilan; Barrow, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10871-10877</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ isolated from neuritic plaque and vascular walls of the brains of patients with Alzheimer's disease has been shown to contain significant quantities of Aβ peptides which begin at residue 3Glu or 11Glu in the form of pyroglutamyl residues (Aβ3pE and Aβ11pE).  To investigate the effects of these N-terminal modifications on the biophys. properties of Aβ, peptides Aβ1-40, Aβ3pE-40, Aβ11pE-40, Aβ1-28, Aβ3pE-28, and Aβ11pE-28 were synthesized.  Using CD spectroscopy, we detd. that the pyroglutamyl-contg. peptides form β-sheet structure more readily than the corresponding full-length Aβ peptides, both in aq. solns. and in 10% SDS micelles.  Trifluoroethanol spectra indicated that the relative β-sheet to α-helical stability is higher for the pyroglutamyl-contg. peptides.  Sedimentation expts. show that the pyroglutamyl-contg. peptides have greater aggregation propensities than the corresponding full-length peptides.  Comparison between the Aβ40 and the Aβ28 series indicated that the greater β-sheet forming and aggregation propensities of the pyroglutamyl peptides are not simply due to an increase in hydrophobicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5xcOsA5djELVg90H21EOLACvtfcHk0ljd3QywOnvqGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D&md5=edb7b92c11ef110e8d87d397b7531a8d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi990563r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990563r%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DW.%26aulast%3DBarrow%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520A%2520beta%25203-pyroglutamyl%2520and%252011-pyroglutamyl%2520peptides%2520found%2520in%2520senile%2520plaque%2520have%2520greater%2520beta-sheet%2520forming%2520and%2520aggregation%2520propensities%2520in%2520vitro%2520than%2520full-length%2520A%2520beta%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D10871%26epage%3D10877%26doi%3D10.1021%2Fbi990563r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsanut, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronicke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-655&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0ljd3QywOnvqGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D655%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span> <span> </span><span class="NLM_article-title">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1007/s00401-014-1287-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1007%2Fs00401-014-1287-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=24803226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=787-801&author=T.+A.+Bayerauthor=O.+Wirths&title=Focusing+the+amyloid+cascade+hypothesis+on+N-truncated+Abeta+peptides+as+drug+targets+against+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1287-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease</span></div><div class="casAuthors">Bayer, Thomas A.; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-801</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although N-truncated Aβ variants are known to be the main constituent of amyloid plaques in the brains of patients with Alzheimer's disease, their potential as targets for pharmacol. intervention has only recently been investigated.  In the last few years, the Alzheimer field has experienced a paradigm shift with the ever increasing understanding that targeting amyloid plaques has not led to a successful immunotherapy.  On the other hand, there can be no doubt that the amyloid cascade hypothesis is central to the etiol. of Alzheimer's disease, raising the question as to why it is apparently failing to translate into the clinic.  In this review, we aim to refocus the amyloid hypothesis integrating N-truncated Aβ peptides based on mounting evidence that they may represent better targets than full-length Aβ.  In addn. to Aβ peptides starting with an Asp at position 1, a variety of different N-truncated Aβ peptides have been identified starting with amino residue Ala-2, pyroglutamylated Glu-3, Phe-4, Arg-5, His-6, Asp-7, Ser-8, Gly-9, Tyr-10 and pyroglutamylated Glu-11.  Certain forms of N-truncated species are better correlates for early pathol. changes found pre-symptomatically more often than others.  There is also evidence that, together with full-length Aβ, they might be physiol. detectable and are naturally secreted by neurons.  Others are known to form sol. aggregates, which have neurotoxic properties in transgenic mouse models.  It has been clearly demonstrated by several groups that some N-truncated Aβs dominate full-length Aβ in the brains of Alzheimer's patients.  We try to address which of the N-truncated variants may be promising therapeutic targets and which enzymes might be involved in the generation of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONpP9jWQ-X7Vg90H21EOLACvtfcHk0lhDHFAeaMatxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D&md5=5374727ba0b50e40ed87a122da1c65bd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1287-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1287-x%26sid%3Dliteratum%253Aachs%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DFocusing%2520the%2520amyloid%2520cascade%2520hypothesis%2520on%2520N-truncated%2520Abeta%2520peptides%2520as%2520drug%2520targets%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D127%26spage%3D787%26epage%3D801%26doi%3D10.1007%2Fs00401-014-1287-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busby, W. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. S.</span></span> <span> </span><span class="NLM_article-title">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">8532</span>– <span class="NLM_lpage">8536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=3597387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8532-8536&author=W.+H.+Busbyauthor=G.+E.+Quackenbushauthor=J.+Hummauthor=W.+W.+Youngbloodauthor=J.+S.+Kizer&title=An+enzyme%28s%29+that+converts+glutaminyl-peptides+into+pyroglutamyl-peptides.+Presence+in+pituitary%2C+brain%2C+adrenal+medulla%2C+and+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides.  Presence in pituitary, brain, adrenal medulla, and lymphocytes</span></div><div class="casAuthors">Busby, Walker H., Jr.; Quackenbush, Gail E.; Humm, Jane; Youngblood, William W.; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8532-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The mechanism for the post-translational conversion of glutamine to pyroglutamic acid on the N-terminus of newly synthesized peptides and proteins is unknown.  An assay is reported here that permits measurement of the rate of conversion of Gln-His-Pro-NH2 to <Glu-His-Pro-NH2 (TRH), where <Glu is pyroglutamate.  Using this assay, it was demonstrated that the spontaneous cyclization of the N-terminal glutamine of this peptide occurs only slowly under physiol. conditions.  Furthermore, the presence in rat brain, porcine pituitary, and human B lymphocytes of a glutaminyl-peptide cyclase which converts Gln-His-Pro-NH2 into <Glu-His-Pro-NH2, is described.  The enzyme(s) appears to be a glycoprotein, is maximally active at neutral pH, has a mol. wt. of 55,000, and contains catalytically significant SH groups.  The product of the enzymic reaction was confirmed by high-resoln. fast atom bombardment-mass spectrometry.  In preliminary studies, it was found that >90% of the enzyme in bovine adrenal medulla is contained in the sol. chromaffin vesicle fraction.  These findings indicate that in vivo the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is neither spontaneous nor abiotic as has been previously proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgXDyJEuhjrVg90H21EOLACvtfcHk0lhDHFAeaMatxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D&md5=8a8b35c61b2c94f4437fd06fc400656e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBusby%26aufirst%3DW.%2BH.%26aulast%3DQuackenbush%26aufirst%3DG.%2BE.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DW.%2BW.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520enzyme%2528s%2529%2520that%2520converts%2520glutaminyl-peptides%2520into%2520pyroglutamyl-peptides.%2520Presence%2520in%2520pituitary%252C%2520brain%252C%2520adrenal%2520medulla%252C%2520and%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8532%26epage%3D8536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Böckers, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.1995.tb00780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1111%2Fj.1365-2826.1995.tb00780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=7550291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=445-453&author=T.+M.+B%C3%B6ckersauthor=M.+R.+Kreutzauthor=T.+Pohl&title=Glutaminyl-cyclase+expression+in+the+bovine%2Fporcine+hypothalamus+and+pituitary&doi=10.1111%2Fj.1365-2826.1995.tb00780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span></div><div class="casAuthors">Bockers T M; Kreutz M R; Pohl T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroendocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-53</span>
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    </div><div class="casAbstract">The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization.  In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs.  In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled.  The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings.  Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity.  Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis.  Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable.  Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis).  These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe.  Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvTdinpe-TVvEeosoOnpOLfW6udTcc2eZT2HZ8jFB7zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D&md5=623044c0c3d4e838cf9b833b04722f41</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.1995.tb00780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.1995.tb00780.x%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6ckers%26aufirst%3DT.%2BM.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DPohl%26aufirst%3DT.%26atitle%3DGlutaminyl-cyclase%2520expression%2520in%2520the%2520bovine%252Fporcine%2520hypothalamus%2520and%2520pituitary%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D1995%26volume%3D7%26spage%3D445%26epage%3D453%26doi%3D10.1111%2Fj.1365-2826.1995.tb00780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugele, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiess, J.</span></span> <span> </span><span class="NLM_article-title">Primary structure and functional expression of a glutaminyl cyclase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">10059</span>– <span class="NLM_lpage">10063</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.22.10059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1073%2Fpnas.88.22.10059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1946423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10059-10063&author=T.+Pohlauthor=M.+Zimmerauthor=K.+Mugeleauthor=J.+Spiess&title=Primary+structure+and+functional+expression+of+a+glutaminyl+cyclase&doi=10.1073%2Fpnas.88.22.10059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional expression of a glutaminyl cyclase</span></div><div class="casAuthors">Pohl, Thomas; Zimmer, Michael; Mugele, Katrin; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10059-63</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A glutaminyl cyclase (QC) that is probably involved in the biosynthesis of pyroglutamyl peptides such as gonadotropin-releasing hormone and TSH-releasing hormone has been purified to homogeneity from bovine anterior pituitary.  On the basis of N-terminal sequence anal., a 2088-base-pair cDNA clone was isolated from a bovine anterior pituitary library.  From the nucleotide sequence of this clone, the primary structure of a 330-residue protein and a preceding 31-residue prepropeptide sequence was deduced.  By transfection of COS-7 monkey cells with a QC cDNA/pCDM8 vector construct, QC activity was expressed.  Hybridization with mRNAs of various bovine tissues revealed expression of QC mainly in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdQGThtNPlPLVg90H21EOLACvtfcHk0lhDHFAeaMatxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D&md5=3d0e422d9b00b1184d8646c5a12bf353</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.22.10059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.22.10059%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DMugele%26aufirst%3DK.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DPrimary%2520structure%2520and%2520functional%2520expression%2520of%2520a%2520glutaminyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D10059%26epage%3D10063%26doi%3D10.1073%2Fpnas.88.22.10059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuzberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer’s disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.3233/JAD-131535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.3233%2FJAD-131535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=24164736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=385-400&author=M.+Morawskiauthor=S.+Schillingauthor=M.+Kreuzbergerauthor=A.+Waniekauthor=C.+Jagerauthor=B.+Kochauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=M.+Hartlage-Rubsamenauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+in+human+cortex%3A+correlation+with+%28pGlu%29-amyloid-beta+load+and+cognitive+decline+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-131535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease</span></div><div class="casAuthors">Morawski, Markus; Schilling, Stephan; Kreuzberger, Moritz; Waniek, Alexander; Jaeger, Carsten; Koch, Birgit; Cynis, Holger; Kehlen, Astrid; Arendt, Thomas; Hartlage-Ruebsamen, Maike; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Brains of Alzheimer's disease (AD) patients are characterized in part by the formation of high mol. wt. aggregates of amyloid-β (Aβ) peptides, which interfere with neuronal function and provoke neuronal cell death.  The pyroglutamate (pGlu) modification of Aβ was demonstrated to be catalyzed by the enzyme glutaminyl cyclase (QC) and to enhance pathogenicity and neurotoxicity.  Here, we addressed the role of QC in AD pathogenesis in human cortex.  Two sets of human postmortem brain tissue from a total of 13 non-demented controls and 11 AD cases were analyzed by immunohistochem. and unbiased stereol., quant. RT-PCR, and enzymic activity assays for the expression level of QC in temporal and entorhinal cortex.  Addnl., cortical Aβ and pGlu-Aβ concns. were quantified by ELISA.  Data on QC expression and Aβ peptide concns. were correlated with each other and with the Mini-Mental State Examn. (MMSE) of individual cases.  In control cases, QC expression was higher in the more vulnerable entorhinal cortex than in temporal cortex.  In AD brains, QC mRNA expression and the immunoreactivity of QC were increased in both cortical regions and frequently assocd. with pGlu-Aβ deposits.  The analyses of individual cases revealed significant correlations between QC mRNA levels and the concn. of insol. pGlu-Aβ aggregates, but not of unmodified Aβ peptides.  Elevated pGlu-Aβ load showed a better correlation with the decline in MMSE than elevated concn. of unmodified Aβ.  Our observations provide evidence for an involvement of QC in AD pathogenesis and cognitive decline by QC-catalyzed pGlu-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS8tVHNEV2BbVg90H21EOLACvtfcHk0ljNb0f8UY9Vwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D&md5=6500fe542f7ccbc6b61c9a4c862cde6d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3233%2FJAD-131535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131535%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKreuzberger%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520in%2520human%2520cortex%253A%2520correlation%2520with%2520%2528pGlu%2529-amyloid-beta%2520load%2520and%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D385%26epage%3D400%26doi%3D10.3233%2FJAD-131535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitschel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokesch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-1111&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0ljNb0f8UY9Vwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D1111%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">4460</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-4460&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%7Bbeta%7D+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0ljNb0f8UY9Vwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%257Bbeta%257D%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D4460%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-1236&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Horstenauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0lh0gQ7MDOJkqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D1236%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennekens, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensadon, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zivin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaziano, J. M.</span></span> <span> </span><span class="NLM_article-title">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer’s disease and related dementias</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1245</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1586/14737175.2015.1088784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1586%2F14737175.2015.1088784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26450764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=1245-1248&author=C.+H.+Hennekensauthor=B.+A.+Bensadonauthor=R.+Zivinauthor=J.+M.+Gaziano&title=Hypothesis%3A+glutaminyl+cyclase+inhibitors+decrease+risks+of+Alzheimer%E2%80%99s+disease+and+related+dementias&doi=10.1586%2F14737175.2015.1088784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias</span></div><div class="casAuthors">Hennekens, Charles H.; Bensadon, Benjamin A.; Zivin, Robert; Gaziano, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-1248</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease and related dementias (ADRD) comprise several progressive and incurable neurodegenerative disorders that some have classified as amyloidosis.  With increased aging of the world's population, the prevalence of the sporadic form of ADRD, which comprises over 99% of cases, continues to rise at an alarming rate.  The enormous societal burdens of ADRD already rival those of the many other major chronic diseases causing premature morbidity and mortality in the USA and worldwide such as cardiovascular disease and cancer.  At present, there is an insufficient totality of evidence concerning the efficacy and safety of any pharmacol. agents to delay slow progression or reduce complications of ADRD.  In this context, glutaminyl cyclase (QC) inhibitors have shown some early possible evidence of efficacy with a reassuring safety profile.  To reliably test the glutaminyl cyclase (QC) and any other promising hypotheses will require cogent data from large-scale randomized trials of sufficient size and duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh2s8nTowdx7Vg90H21EOLACvtfcHk0lh0gQ7MDOJkqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGmsrnI&md5=f098733e6e4f05dce39581b04d5df230</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.1088784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.1088784%26sid%3Dliteratum%253Aachs%26aulast%3DHennekens%26aufirst%3DC.%2BH.%26aulast%3DBensadon%26aufirst%3DB.%2BA.%26aulast%3DZivin%26aufirst%3DR.%26aulast%3DGaziano%26aufirst%3DJ.%2BM.%26atitle%3DHypothesis%253A%2520glutaminyl%2520cyclase%2520inhibitors%2520decrease%2520risks%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520dementias%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D1245%26epage%3D1248%26doi%3D10.1586%2F14737175.2015.1088784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer’s disease ?</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.4155%2Ffmc-2017-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=29076753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1979-1981&author=H.+Wu&title=Can+small+molecule+inhibitors+of+glutaminyl+cyclase+be+used+as+a+therapeutic+for+Alzheimer%E2%80%99s+disease+%3F&doi=10.4155%2Ffmc-2017-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer's disease?</span></div><div class="casAuthors">Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1979-1981</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial and socioeconomically burdensome disease.  In view of the failures of anti-AD candidates, we should try to rethink what we did before and what we should do next, in part at least.  Research shows that the more neurotoxic factor, pyroglutamate-Aβs, and the more important inflammatory mediators, pyroglutamate-CCL2, both contribute to the initiation of AD specifically and the generation of N-terminal intramol. cyclization catalyzed by glutaminyl cyclase quality control, the over-expression of which correlates pos. with the severity of AD.  Subsequently, lowering pyroglutamate-Aβs and pyroglutamate-CCL2 levels by quality control inhibition using small mol. inhibitors could be expected as an amazing strategy for the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7otPkBSO4HLVg90H21EOLACvtfcHk0lijA7TFZKUp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOit7bP&md5=9ecc009d79671aad9641627a23945db7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0190%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26atitle%3DCan%2520small%2520molecule%2520inhibitors%2520of%2520glutaminyl%2520cyclase%2520be%2520used%2520as%2520a%2520therapeutic%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1979%26epage%3D1981%26doi%3D10.4155%2Ffmc-2017-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7069</span>– <span class="NLM_lpage">7080</span>, <span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-7080&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0lijA7TFZKUp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D7080%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6613</span>– <span class="NLM_lpage">6625</span>, <span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-6625&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0lijA7TFZKUp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D6625%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bühring, K.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farcher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of Alzheimer’s disease-Studies on relation to effective target occupancy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.240614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1124%2Fjpet.117.240614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=28446518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2017&pages=119-130&author=T.+Hoffmannauthor=A.+Meyerauthor=U.+Heiserauthor=S.+Kuratauthor=L.+B%C3%B6hmeauthor=M.+Kleinschmidtauthor=K.-U.+B%C3%BChringauthor=B.+Hutter-Paierauthor=M.+Farcherauthor=H.-U.+Demuthauthor=I.+Luesauthor=S.+Schilling&title=Glutaminyl+cyclase+inhibitor+PQ912+improves+cognition+in+mouse+models+of+Alzheimer%E2%80%99s+disease-Studies+on+relation+to+effective+target+occupancy&doi=10.1124%2Fjpet.117.240614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of alzheimer's disease-studies on relation to effective target occupancy</span></div><div class="casAuthors">Hoffmann, Torsten; Meyer, Antje; Heiser, Ulrich; Kurat, Stephan; Boehme, Livia; Kleinschmidt, Martin; Buehring, Karl-Ulrich; Hutter-Paier, Birgit; Farcher, Martina; Demuth, Hans-Ulrich; Lues, Inge; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-130</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Numerous studies suggest that the majority of amyloid-β (Aβ) peptides deposited in Alzheimer's disease (AD) are truncated and post-translationally modified at the N terminus.  Among these modified species, pyroglutamyl-Aβ(pE-Aβ, including N3pE-Aβ40/42 and N11pE-Aβ40/42) has been identified as particularly neurotoxic.  The N-terminal modification renders the peptide hydrophobic, accelerates formation of oligomers, and reduces degrdn. by peptidases, leading ultimately to the accumulation of the peptide and progression of AD.  It has been shown that the formation of pyroglutamyl residues is catalyzed by glutaminyl cyclase (QC).  Here, we present data about the pharmacol. in vitro and in vivo efficacy of the QC inhibitor (S)-1-(1H-benzo[d]imidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one (PQ912), the first-in-class compd. that is in clin. development.  PQ912 inhibits human, rat, and mouse QC activity, with Ki values ranging between 20 and 65 nM.  Chronic oral treatment of hAPPSLxhQC double-transgenic mice with approx. 200 mg/kg/day via chow shows a significant redn. of pE-Aβ levels and concomitant improvement of spatial learning in a Morris water maze test paradigm.  This dose results in a brain and cerebrospinal fluid concn. of PQ912 which relates to a QC target occupancy of about 60%.  Thus, we conclude that >50% inhibition of QC activity in the brain leads to robust treatment effects.  Secondary pharmacol. expts. in mice indicate a fairly large potency difference for Aβ cyclization compared with cyclization of physiol. substrates, suggesting a robust therapeutic window in humans.  This information constitutes an important translational guidance for predicting the therapeutic dose range in clin. studies with PQ912.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9VVUSISdmtrVg90H21EOLACvtfcHk0lj352M12xcG7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J&md5=080e83d1ac24b892e74a556f04db9232</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.240614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.240614%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DKurat%26aufirst%3DS.%26aulast%3DB%25C3%25B6hme%26aufirst%3DL.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DB%25C3%25BChring%26aufirst%3DK.-U.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DFarcher%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.-U.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibitor%2520PQ912%2520improves%2520cognition%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease-Studies%2520on%2520relation%2520to%2520effective%2520target%2520occupancy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D362%26spage%3D119%26epage%3D130%26doi%3D10.1124%2Fjpet.117.240614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhring, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn-Wache, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokorny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiesa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glund, K.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.trci.2015.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=182-195&author=I.+Luesauthor=F.+Weberauthor=A.+Meyerauthor=U.+Buhringauthor=T.+Hoffmannauthor=K.+Kuhn-Wacheauthor=S.+Manhartauthor=U.+Heiserauthor=R.+Pokornyauthor=J.+Chiesaauthor=K.+Glund&title=A+phase+1+study+to+evaluate+the+safety+and+pharmacokinetics+of+PQ912%2C+a+glutaminyl+cyclase+inhibitor%2C+in+healthy+subjects&doi=10.1016%2Fj.trci.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span></div><div class="casAuthors">Lues Inge; Weber Frank; Meyer Antje; Buhring Uli; Hoffmann Torsten; Kuhn-Wache Kerstin; Manhart Susanne; Heiser Ulrich; Glund Konrad; Pokorny Rolf; Chiesa Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-195</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Pyroglutamate-amyloid-β (pE-Aβ) peptides are major components of Aβ-oligomers and Aβ-plaques, which are regarded as key culprits of Alzheimer's disease (AD) pathology.  PQ912 is a competitive inhibitor of the enzyme glutaminyl cyclase (QC), essential for the formation of pE-Aβ peptides.  Methods:  A randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study investigated the safety, pharmacokinetics, and pharmacodynamics of PQ912 in healthy nonelderly and elderly subjects.  Results:  PQ912 was considered safe and well tolerated with dose-proportional pharmacokinetics up to doses of 200 mg.  At higher doses up to 1800 mg, exposure was supraproportional and exposure in elderly subjects was approximately 1.5- to 2.1-fold higher.  Exposure in cerebrospinal fluid (CSF) was approximately 20% of the unbound drug in plasma, and both serum and CSF QC activity was inhibited in a dose-related manner.  Discussion:  This first-in-man study of a compound-targeting QC inhibition justifies further development of PQ912 for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_8LDrMzHWYDjk2McQZ6XmfW6udTcc2eb3XONINXeMAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D&md5=49cc7018331e760dfef1b844f93cc31c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DLues%26aufirst%3DI.%26aulast%3DWeber%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DBuhring%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKuhn-Wache%26aufirst%3DK.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DPokorny%26aufirst%3DR.%26aulast%3DChiesa%26aufirst%3DJ.%26aulast%3DGlund%26aufirst%3DK.%26atitle%3DA%2520phase%25201%2520study%2520to%2520evaluate%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520PQ912%252C%2520a%2520glutaminyl%2520cyclase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2015%26volume%3D1%26spage%3D182%26epage%3D195%26doi%3D10.1016%2Fj.trci.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>New Alzheimer’s
drug shows safety, hints of efficacy in phase 2. <a href="https://www.alzforum.org/news/research-news/new-alzheimers-drug-shows-safety-hints-efficacy-phase-2" class="extLink">https://www.alzforum.org/news/research-news/new-alzheimers-drug-shows-safety-hints-efficacy-phase-2</a> (accessed May 01, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Alzheimer%E2%80%99s%0Adrug+shows+safety%2C+hints+of+efficacy+in+phase+2.+https%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fnew-alzheimers-drug-shows-safety-hints-efficacy-phase-2+%28accessed+May+01%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sönnichsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imarisio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarditi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dami, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Couto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamanti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satagopam, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caramelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardone, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradonna, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcari, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Kane, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caricasole, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span> <span> </span><span class="NLM_article-title">siRNAscreen identifies QPCT as a druggable target for Huntington’s disease</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1038%2Fnchembio.1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=25848931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=347-357&author=M.+Jimenez-Sanchezauthor=W.+Lamauthor=M.+Hannusauthor=B.+S%C3%B6nnichsenauthor=S.+Imarisioauthor=A.+Flemingauthor=A.+Tarditiauthor=F.+Menziesauthor=T.+E.+Damiauthor=C.+Xuauthor=E.+Gonzalez-Coutoauthor=G.+Lazzeroniauthor=F.+Heitzauthor=D.+Diamantiauthor=L.+Massaiauthor=V.+P.+Satagopamauthor=G.+Marconiauthor=C.+Caramelliauthor=A.+Nenciniauthor=M.+Andreiniauthor=G.+L.+Sardoneauthor=N.+P.+Caradonnaauthor=V.+Porcariauthor=C.+Scaliauthor=R.+Schneiderauthor=G.+Pollioauthor=C.+J.+O%E2%80%99Kaneauthor=A.+Caricasoleauthor=D.+C.+Rubinsztein&title=siRNAscreen+identifies+QPCT+as+a+druggable+target+for+Huntington%E2%80%99s+disease&doi=10.1038%2Fnchembio.1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">siRNA screen identifies QPCT as a druggable target for Huntington's disease</span></div><div class="casAuthors">Jimenez-Sanchez, Maria; Lam, Wun; Hannus, Michael; Sonnichsen, Birte; Imarisio, Sara; Fleming, Angeleen; Tarditi, Alessia; Menzies, Fiona; Ed Dami, Teresa; Xu, Catherine; Gonzalez-Couto, Eduardo; Lazzeroni, Giulia; Heitz, Freddy; Diamanti, Daniela; Massai, Luisa; Satagopam, Venkata P.; Marconi, Guido; Caramelli, Chiara; Nencini, Arianna; Andreini, Matteo; Sardone, Gian Luca; Caradonna, Nicola P.; Porcari, Valentina; Scali, Carla; Schneider, Reinhard; Pollio, Giuseppe; O'Kane, Cahir J.; Caricasole, Andrea; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a currently incurable neurodegenerative condition caused by an abnormally expanded polyglutamine tract in huntingtin (HTT).  We identified new modifiers of mutant HTT toxicity by performing a large-scale 'druggable genome' siRNA screen in human cultured cells, followed by hit validation in Drosophila.  We focused on glutaminyl cyclase (QPCT), which had one of the strongest effects on mutant HTT-induced toxicity and aggregation in the cell-based siRNA screen and also rescued these phenotypes in Drosophila.  We found that QPCT inhibition induced the levels of the mol. chaperone αB-crystallin and reduced the aggregation of diverse proteins.  We generated new QPCT inhibitors using in silico methods followed by in vitro screening, which rescued the HD-related phenotypes in cell, Drosophila and zebrafish HD models.  Our data reveal a new HD druggable target affecting mutant HTT aggregation and provide proof of principle for a discovery pipeline from druggable genome screen to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz5Pncahjf0LVg90H21EOLACvtfcHk0lj352M12xcG7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D&md5=1566a7af4210e871931ed7bbae6ba42a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1790%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Sanchez%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DW.%26aulast%3DHannus%26aufirst%3DM.%26aulast%3DS%25C3%25B6nnichsen%26aufirst%3DB.%26aulast%3DImarisio%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DA.%26aulast%3DTarditi%26aufirst%3DA.%26aulast%3DMenzies%26aufirst%3DF.%26aulast%3DDami%26aufirst%3DT.%2BE.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGonzalez-Couto%26aufirst%3DE.%26aulast%3DLazzeroni%26aufirst%3DG.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DDiamanti%26aufirst%3DD.%26aulast%3DMassai%26aufirst%3DL.%26aulast%3DSatagopam%26aufirst%3DV.%2BP.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DCaramelli%26aufirst%3DC.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DSardone%26aufirst%3DG.%2BL.%26aulast%3DCaradonna%26aufirst%3DN.%2BP.%26aulast%3DPorcari%26aufirst%3DV.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DPollio%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DC.%2BJ.%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DsiRNAscreen%2520identifies%2520QPCT%2520as%2520a%2520druggable%2520target%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D347%26epage%3D357%26doi%3D10.1038%2Fnchembio.1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6664</span>– <span class="NLM_lpage">6677</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6664-6677&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Liauthor=Y.+Zouauthor=Y.+Zhengauthor=Z.+Heauthor=Z.+Liuauthor=J.+Quanauthor=X.+Buauthor=H.+Wu&title=Synthesis+and+evaluation+of+diphenyl+conjugated+imidazole+derivatives+as+potential+glutaminyl+cyclase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Li, Yue; Zou, Yongdong; Zheng, Yizhi; He, Zhendan; Liu, Zhigang; Quan, Junmin; Bu, Xianzhang; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6664-6677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer's disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides.  Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD.  In this work, a series of di-Ph conjugated imidazole derivs. (DPCIs) was rationally designed and synthesized.  Analogs with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good in vitro blood-brain barrier (BBB) permeability.  Further assessments corroborated that the selected hQC inhibitor I inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and in vivo, and improves the behavior of AD mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMrmUpYJCVhrVg90H21EOLACvtfcHk0liBdEf5swg53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE&md5=8ffec76fc13fbe8520675ee884c12772</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00648%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520diphenyl%2520conjugated%2520imidazole%2520derivatives%2520as%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6664%26epage%3D6677%26doi%3D10.1021%2Facs.jmedchem.7b00648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hielscher-Michael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griehl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L. A.</span></span> <span> </span><span class="NLM_article-title">Natural products from microalgae with potential against Alzheimer’s disease: Sulfolipids are potent glutaminyl cyclase inhibitors</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.3390/md14110203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.3390%2Fmd14110203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=203-218&author=S.+Hielscher-Michaelauthor=C.+Griehlauthor=M.+Buchholzauthor=H.-U.+Demuthauthor=N.+Arnoldauthor=L.+A.+Wessjohann&title=Natural+products+from+microalgae+with+potential+against+Alzheimer%E2%80%99s+disease%3A+Sulfolipids+are+potent+glutaminyl+cyclase+inhibitors&doi=10.3390%2Fmd14110203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products from microalgae with potential against Alzheimer's disease: sulfolipids are potent glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Hielscher-Michael, Stephanie; Griehl, Carola; Buchholz, Mirko; Demuth, Hans-Ulrich; Arnold, Norbert; Wessjohann, Ludger A.</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">203/1-203/16</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In recent years, many new enzymes, like glutaminyl cyclase (QC), could be assocd. with pathophysiol. processes and represent targets for many diseases, so that enzyme-inhibiting properties of natural substances are becoming increasingly important.  In different studies, the pathophysiol. connection of QC to various diseases including Alzheimer's disease (AD) was described.  Algae are known for the ability to synthesize complex and highly-diverse compds. with specific enzyme inhibition properties.  Therefore, we screened different algae species for the presence of QC inhibiting metabolites using a new "Reverse Metabolomics" technique including an Activity-correlation Anal. (AcorA), which is based on the correlation of bioactivities to mass spectral data with the aid of mathematic informatics deconvolution.  Thus, three QC inhibiting compds. from microalgae belonging to the family of sulfolipids were identified.  The compds. showed a QC inhibition of 81% and 76% at concns. of 0.25 mg/mL and 0.025 mg/mL, resp.  Thus, for the first time, sulfolipids are identified as QC inhibiting compds. and possess substructures with the required pharmacophore qualities.  They represent a new lead structure for QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruC1d9bEVkyrVg90H21EOLACvtfcHk0liBdEf5swg53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM&md5=3097fbf425c5ff891dd01e9186d8c817</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fmd14110203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd14110203%26sid%3Dliteratum%253Aachs%26aulast%3DHielscher-Michael%26aufirst%3DS.%26aulast%3DGriehl%26aufirst%3DC.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.-U.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26atitle%3DNatural%2520products%2520from%2520microalgae%2520with%2520potential%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Sulfolipids%2520are%2520potent%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DMar.%2520Drugs%26date%3D2016%26volume%3D14%26spage%3D203%26epage%3D218%26doi%3D10.3390%2Fmd14110203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of flavonoids on human glutaminyl cyclase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2280</span>– <span class="NLM_lpage">2286</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.bmc.2016.03.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=27061673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2280-2286&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Zouauthor=Y.+Zhengauthor=X.+Buauthor=J.+Quanauthor=Z.+Heauthor=H.+Wu&title=Inhibitory+effect+of+flavonoids+on+human+glutaminyl+cyclase&doi=10.1016%2Fj.bmc.2016.03.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of flavonoids on human glutaminyl cyclase</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Zou, Yongdong; Zheng, Yizhi; Bu, Xianzhang; Quan, Junmin; He, Zhendan; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2280-2286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents.  However, the study of QC inhibitors are still less.  Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivs. were synthesized as a new class of human QC (hQC) inhibitors.  The efficacy investigation of these compds. was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated.  Mol. docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo3dENiH0N7Vg90H21EOLACvtfcHk0ljZ54q4j6TL7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D&md5=86df2e8e2c427d483dea92e747ddf116</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.064%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DInhibitory%2520effect%2520of%2520flavonoids%2520on%2520human%2520glutaminyl%2520cyclase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2280%26epage%3D2286%26doi%3D10.1016%2Fj.bmc.2016.03.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szaszkó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdú, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flachner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lörincz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pázmány, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cseh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dormán, G.</span></span> <span> </span><span class="NLM_article-title">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/s11030-016-9717-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1007%2Fs11030-016-9717-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=28070724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=175-186&author=M.+Szaszk%C3%B3author=I.+Hajd%C3%BAauthor=B.+Flachnerauthor=K.+Dobiauthor=C.+Magyarauthor=I.+Simonauthor=Z.+L%C3%B6rinczauthor=Z.+Kapuiauthor=T.+P%C3%A1zm%C3%A1nyauthor=S.+Csehauthor=G.+Dorm%C3%A1n&title=Identification+of+potential+glutaminyl+cyclase+inhibitors+from+lead-like+libraries+by+in+silico+and+in+vitro+fragment-based+screening&doi=10.1007%2Fs11030-016-9717-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span></div><div class="casAuthors">Szaszko, Maria; Hajdu, Istvan; Flachner, Beata; Dobi, Krisztina; Magyar, Csaba; Simon, Istvan; Lorincz, Zsolt; Kapui, Zoltan; Pazmany, Tamas; Cseh, Sandor; Dorman, Gyorgy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-186</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A glutaminyl cyclase (QC) fragment library was in silico selected by disconnection of the structure of known QC inhibitors and by lead-like 2D virtual screening of the same set.  The resulting fragment library (204 compds.) was acquired from com. suppliers and pre-screened by differential scanning fluorimetry followed by functional in vitro assays.  In this way, 10 fragment hits were identified ( ∼ 5 % hit rate, best inhibitory activity: 16 μM).  The in vitro hits were then docked to the active site of QC, and the best scoring compds. were analyzed for binding interactions.  Two fragments bound to different regions in a complementary manner, and thus, linking those fragments offered a rational strategy to generate novel QC inhibitors.  Based on the structure of the virtual linked fragment, a 77-membered QC target focused library was selected from vendor databases and docked to the active site of QC.  A PubChem search confirmed that the best scoring analogs are novel, potential QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VdqwKUctWrVg90H21EOLACvtfcHk0ljZ54q4j6TL7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D&md5=1eb4a1423d7e0bc0cf4ea621848d4580</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs11030-016-9717-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-016-9717-4%26sid%3Dliteratum%253Aachs%26aulast%3DSzaszk%25C3%25B3%26aufirst%3DM.%26aulast%3DHajd%25C3%25BA%26aufirst%3DI.%26aulast%3DFlachner%26aufirst%3DB.%26aulast%3DDobi%26aufirst%3DK.%26aulast%3DMagyar%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DI.%26aulast%3DL%25C3%25B6rincz%26aufirst%3DZ.%26aulast%3DKapui%26aufirst%3DZ.%26aulast%3DP%25C3%25A1zm%25C3%25A1ny%26aufirst%3DT.%26aulast%3DCseh%26aufirst%3DS.%26aulast%3DDorm%25C3%25A1n%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520from%2520lead-like%2520libraries%2520by%2520in%2520silico%2520and%2520in%2520vitro%2520fragment-based%2520screening%26jtitle%3DMol.%2520Diversity%26date%3D2017%26volume%3D21%26spage%3D175%26epage%3D186%26doi%3D10.1007%2Fs11030-016-9717-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropog, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesada, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of [<sup>11</sup>C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer’s disease prior to amyloid β aggregation</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1039/C5MD00148J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1039%2FC5MD00148J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26101580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1065-1068&author=A.+F.+Brooksauthor=I.+M.+Jacksonauthor=X.+Shaoauthor=G.+W.+Kropogauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=P.+J.+H.+Scott&title=Synthesis+and+evaluation+of+%5B11C%5DPBD150%2C+a+radiolabeled+glutaminyl+cyclase+inhibitor+for+the+potential+detection+of+Alzheimer%E2%80%99s+disease+prior+to+amyloid+%CE%B2+aggregation&doi=10.1039%2FC5MD00148J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation</span></div><div class="casAuthors">Brooks, Allen F.; Jackson, Isaac M.; Shao, Xia; Kropog, George W.; Sherman, Phillip; Quesada, Carole A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-1068</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The hydroxy moiety of 1-[3-(1H-imidazol-1-yl)propyl]-3-(4-hydroxy-3-methoxyphenyl)thiourea was selectively carbon-11 labeled to generate [11C]PBD150 in 7.3% yield from [11C]methyl triflate (non-decay cor.; radiochem. purity ≥95%, specific activity = 5.7 Ci μmol-1, n = 5).  Evaluation of [11C]PBD150 by small animal PET imaging (mouse and rat) detd. that it did not permeate the blood brain barrier, indicating that a previously described therapeutic effect in transgenic mice was likely not the result of inhibiting central nervous system glutaminyl cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmg-DpdoFU-7Vg90H21EOLACvtfcHk0ljZ54q4j6TL7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D&md5=eaea24571848b33c06b92756ff873161</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC5MD00148J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00148J%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DJackson%26aufirst%3DI.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DKropog%26aufirst%3DG.%2BW.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B11C%255DPBD150%252C%2520a%2520radiolabeled%2520glutaminyl%2520cyclase%2520inhibitor%2520for%2520the%2520potential%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prior%2520to%2520amyloid%2520%25CE%25B2%2520aggregation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1065%26epage%3D1068%26doi%3D10.1039%2FC5MD00148J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent human glutaminyl cyclase inhibitors as anti-Alzheimer’s agents based on rational design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2573</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2573-2590&author=V.+H.+Hoangauthor=P.+T.+Tranauthor=M.+Cuiauthor=V.+T.+Ngoauthor=J.+Annauthor=J.+Parkauthor=J.+Leeauthor=K.+Choiauthor=H.+Choauthor=H.+Kimauthor=H.+J.+Haauthor=H.+S.+Hongauthor=S.+Choiauthor=Y.-H.+Kimauthor=J.+Lee&title=Discovery+of+potent+human+glutaminyl+cyclase+inhibitors+as+anti-Alzheimer%E2%80%99s+agents+based+on+rational+design&doi=10.1021%2Facs.jmedchem.7b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design</span></div><div class="casAuthors">Hoang, Van-Hai; Tran, Phuong-Thao; Cui, Minghua; Ngo, Van T. H.; Ann, Jihyae; Park, Jongmi; Lee, Jiyoun; Choi, Kwanghyun; Cho, Hanyang; Kim, Hee; Ha, Hee-Jin; Hong, Hyun-Seok; Choi, Sun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2573-2590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer's disease (AD).  The authors designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E-42.  An in vitro structure-activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor.  When tested in mouse models of AD, compd. 212 (I) significantly reduced the brain concns. of pyroform Aβ and total Aβ and restored cognitive functions.  This potent Aβ-lowering effect was achieved by incorporating an addnl. binding region into the authors' previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu 327 in the QC binding site.  The authors' study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqaMS-1r-2bVg90H21EOLACvtfcHk0ljUuubg-GZ7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D&md5=856a0159f8249b82f8b79d25ab162973</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00098%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DNgo%26aufirst%3DV.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.-H.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520based%2520on%2520rational%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2573%26epage%3D2590%26doi%3D10.1021%2Facs.jmedchem.7b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">12439</span>– <span class="NLM_lpage">12449</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-12449&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0ljUuubg-GZ7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D12449%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillaspy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefker, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hada, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoover, D. J.</span></span> <span> </span><span class="NLM_article-title">A simple method for the formation of cyclopropylamines: The first synthesis of tricyclopropylamine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">7399</span>– <span class="NLM_lpage">7402</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(95)01560-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2F0040-4039%2895%2901560-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK2MXoslOqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=7399-7402&author=M.+L.+Gillaspyauthor=B.+A.+Lefkerauthor=W.+A.+Hadaauthor=D.+J.+Hoover&title=A+simple+method+for+the+formation+of+cyclopropylamines%3A+The+first+synthesis+of+tricyclopropylamine&doi=10.1016%2F0040-4039%2895%2901560-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for the formation of cyclopropylamines: the first synthesis of tricyclopropylamine.</span></div><div class="casAuthors">Gillaspy, Melissa; Lefker, Bruce A.; Hada, William A.; Hoover, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7399-402</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Treatment of a variety of secondary and primary amines with [(1-ethoxycyclopropyl)oxy]trimethylsilane and NaBH3CN in MeOH gave mono- and dicyclopropylamines in 41-91% yield.  Sterically hindered di- and tricyclopropylamines, including tricyclopropylamine, were prepd.  The pKas of some mono-, di- and tricyclopropylamines were measured showing a redn. of ∼1-2 pKa unit per added cyclopropyl group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBHlBQO9wq2LVg90H21EOLACvtfcHk0ljUuubg-GZ7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslOqu70%253D&md5=03d4a4010d1b5b4a9bf075b24fdc3b1d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2901560-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252901560-4%26sid%3Dliteratum%253Aachs%26aulast%3DGillaspy%26aufirst%3DM.%2BL.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DHada%26aufirst%3DW.%2BA.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26atitle%3DA%2520simple%2520method%2520for%2520the%2520formation%2520of%2520cyclopropylamines%253A%2520The%2520first%2520synthesis%2520of%2520tricyclopropylamine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D7399%26epage%3D7402%26doi%3D10.1016%2F0040-4039%2895%2901560-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinick, F.</span></span> <span> </span><span class="NLM_article-title">The mechanism of the Robinson-Gabriel synthesis of oxazoles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2407</span>– <span class="NLM_lpage">2408</span>, <span class="refDoi"> DOI: 10.1021/jo00953a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00953a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaE3sXksVWmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=2407-2408&author=H.+H.+Wassermanauthor=F.+Vinick&title=The+mechanism+of+the+Robinson-Gabriel+synthesis+of+oxazoles&doi=10.1021%2Fjo00953a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the Robinson-Gabriel synthesis of oxazoles</span></div><div class="casAuthors">Wasserman, Harry H.; Vinick, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2407-8</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The mechanism of the Robinson-Gabriel synthesis of oxazoles from α-acylamino ketones was elucidated.  The reaction takes  place by incorporation of the oxygen of the amide group and elimination of the ketone oxygen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkDjrXlwu56bVg90H21EOLACvtfcHk0lg_BNlmF19Mnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXksVWmu70%253D&md5=c22a1b17ba838f26ea937892232f6d3f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo00953a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00953a028%26sid%3Dliteratum%253Aachs%26aulast%3DWasserman%26aufirst%3DH.%2BH.%26aulast%3DVinick%26aufirst%3DF.%26atitle%3DThe%2520mechanism%2520of%2520the%2520Robinson-Gabriel%2520synthesis%2520of%2520oxazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D2407%26epage%3D2408%26doi%3D10.1021%2Fjo00953a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fukuyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jow, C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, M.</span></span> <span> </span><span class="NLM_article-title">2- and 4-Nitrobenzenesulfonamides: Exceptionally versatile means for preparation of secondary amines and protection of amines</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">6373</span>– <span class="NLM_lpage">6374</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(95)01316-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2F0040-4039%2895%2901316-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFCmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=6373-6374&author=T.+Fukuyamaauthor=C.-K.+Jowauthor=M.+Cheung&title=2-+and+4-Nitrobenzenesulfonamides%3A+Exceptionally+versatile+means+for+preparation+of+secondary+amines+and+protection+of+amines&doi=10.1016%2F0040-4039%2895%2901316-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">2- and 4-nitrobenzenesulfonamides: exceptionally versatile means for preparation of secondary amines and protection of amines</span></div><div class="casAuthors">Fukuyama, Tohru; Jow, Chung-Kuang; Cheung, Mui</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">6373-4</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">2- And 4-nitrobenzenesulfonamides I (R = Y = H, X = NO2; R = X = H, Y = NO2) , readily prepd. from primary amines, undergo smooth alkylation by Mitsunobu reaction or by conventional methods to give N-alkylated sulfonamides I (R = PhCH2, Pr, PhCH2CH2, CHMeCO2Et) in near quant. yields.  These sulfonamides could be deprotected readily via Meisenheimer complexes upon treatment with thiolates in DMF at room temp., giving secondary amines RNHCH2C6H4OMe-4 in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70dPXo4L1urVg90H21EOLACvtfcHk0lg_BNlmF19Mnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFCmu7k%253D&md5=eb9ffe1b2070a87db41962623495139c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2901316-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252901316-A%26sid%3Dliteratum%253Aachs%26aulast%3DFukuyama%26aufirst%3DT.%26aulast%3DJow%26aufirst%3DC.-K.%26aulast%3DCheung%26aufirst%3DM.%26atitle%3D2-%2520and%25204-Nitrobenzenesulfonamides%253A%2520Exceptionally%2520versatile%2520means%2520for%2520preparation%2520of%2520secondary%2520amines%2520and%2520protection%2520of%2520amines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D6373%26epage%3D6374%26doi%3D10.1016%2F0040-4039%2895%2901316-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goddard-Borger, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stick, R. V.</span></span> <span> </span><span class="NLM_article-title">An efficient, inexpensive, and shelf-stable diazotransfer reagent: Imidazole-1-sulfonyl azide hydrochloride</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3797</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.1021/ol701581g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol701581g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3797-3800&author=E.+D.+Goddard-Borgerauthor=R.+V.+Stick&title=An+efficient%2C+inexpensive%2C+and+shelf-stable+diazotransfer+reagent%3A+Imidazole-1-sulfonyl+azide+hydrochloride&doi=10.1021%2Fol701581g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient, Inexpensive, and Shelf-Stable Diazotransfer Reagent: Imidazole-1-sulfonyl Azide Hydrochloride</span></div><div class="casAuthors">Goddard-Borger, Ethan D.; Stick, Robert V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3797-3800</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of a new diazotransfer reagent, imidazole-1-sulfonyl azide hydrochloride, are reported.  This reagent has proven to equal triflyl azide in its ability to act as a "diazo donor" in the conversion of both primary amines into azides and activated methylene substrates into diazo compds.  Crucially, this reagent can be prepd. in a one-pot reaction on a large scale from inexpensive materials, is shelf-stable, and is conveniently cryst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp47A7S4vCoO7Vg90H21EOLACvtfcHk0lg_BNlmF19Mnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D&md5=f664d543b21303c0101ddedd9cc37744</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fol701581g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol701581g%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard-Borger%26aufirst%3DE.%2BD.%26aulast%3DStick%26aufirst%3DR.%2BV.%26atitle%3DAn%2520efficient%252C%2520inexpensive%252C%2520and%2520shelf-stable%2520diazotransfer%2520reagent%253A%2520Imidazole-1-sulfonyl%2520azide%2520hydrochloride%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3797%26epage%3D3800%26doi%3D10.1021%2Fol701581g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubiales, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Santos, J. M.</span></span> <span> </span><span class="NLM_article-title">The aza-Wittig reaction: an efficient tool for the construction of carbon-nitrogen double bonds</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1016%2Fj.tet.2006.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlagtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=523-575&author=F.+Palaciosauthor=C.+Alonsoauthor=D.+Aparicioauthor=G.+Rubialesauthor=J.+M.+de+los+Santos&title=The+aza-Wittig+reaction%3A+an+efficient+tool+for+the+construction+of+carbon-nitrogen+double+bonds&doi=10.1016%2Fj.tet.2006.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The aza-Wittig reaction. An efficient tool for the construction of carbon-nitrogen double bonds</span></div><div class="casAuthors">Palacios, Francisco; Alonso, Concepcion; Aparicio, Domitila; Rubiales, Gloria; de los Santos, Jesus M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">523-575</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the aza-Wittig reaction of phosphazene derivs. with several carbonyl compds. are reviewed.  Phosphazenes afford inter- and intramol. aza-Wittig reactions with different compds. such as aldehydes, ketones, esters, thioesters, amides, anhydrides, and sulfimides.  One of the most important applications of this reaction is the synthesis of a wide range of acyclic and heterocyclic compds., ranging from simple monocyclic compds. to complex polycyclic and macrocyclic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Jq_OhMZNQLVg90H21EOLACvtfcHk0liKfcOguddZPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlagtr3P&md5=9da0a948b7d1275dbcb9d15edb76a404</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DF.%26aulast%3DAlonso%26aufirst%3DC.%26aulast%3DAparicio%26aufirst%3DD.%26aulast%3DRubiales%26aufirst%3DG.%26aulast%3Dde%2Blos%2BSantos%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520aza-Wittig%2520reaction%253A%2520an%2520efficient%2520tool%2520for%2520the%2520construction%2520of%2520carbon-nitrogen%2520double%2520bonds%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D523%26epage%3D575%26doi%3D10.1016%2Fj.tet.2006.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Continuous spectrometric assays for glutaminyl cyclase activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1006/abio.2001.5560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1006%2Fabio.2001.5560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=11906150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=49-56&author=S.+Schillingauthor=T.+Hoffmannauthor=M.+Wermannauthor=U.+Heiserauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Continuous+spectrometric+assays+for+glutaminyl+cyclase+activity&doi=10.1006%2Fabio.2001.5560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Spectrometric Assays for Glutaminyl Cyclase Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Wermann, Michael; Heiser, Ulrich; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The enzymic conversion of one chromogenic substrate, L-glutamine-p-nitroanilide, and two fluorogenic substrates, L-glutaminyl-2-naphthylamide and L-glutaminyl-4-methylcoumarinylamide, into their resp. pyroglutamic acid derivs. by glutaminyl cyclase (QC) was estd. by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme.  For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-Bu ester.  The assay can be performed in the presence of ammonia up to a concn. of 50 mM.  Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymic activity of about 20%.  This is the first report of a fast, continuous, and reliable detn. of QC activity, even in the presence of ammonium ions, during the course of protein purifn. and enzymic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQW4L1wwLqbVg90H21EOLACvtfcHk0liKfcOguddZPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D&md5=18509903cf5017f855c3c3ea68dc9915</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5560%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DContinuous%2520spectrometric%2520assays%2520for%2520glutaminyl%2520cyclase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2002%26volume%3D303%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.2001.5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plank, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>397</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1515%2Fhsz-2015-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=26351917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=45-55&author=A.+Beckerauthor=R.+Eichentopfauthor=R.+Sedlmeierauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=A.+Stephanauthor=C.+Bauscherauthor=S.+Kohlmannauthor=T.+Hoffmannauthor=A.+Kehlenauthor=S.+Bergauthor=E.+J.+Freyseauthor=A.+Osmandauthor=A.+C.+Plankauthor=S.+Rossnerauthor=S.+von+Horstenauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=S.+Schilling&title=IsoQC+%28QPCTL%29+knock-out+mice+suggest+differential+substrate+conversion+by+glutaminyl+cyclase+isoenzymes&doi=10.1515%2Fhsz-2015-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span></div><div class="casAuthors">Becker, Andreas; Eichentopf, Rico; Sedlmeier, Reinhard; Waniek, Alexander; Cynis, Holger; Koch, Birgit; Stephan, Anett; Baeuscher, Christoph; Kohlmann, Stephanie; Hoffmann, Torsten; Kehlen, Astrid; Berg, Sabine; Freyse, Ernst-Joachim; Osmand, Alexander; Plank, Anne-Christine; Rossner, Steffen; von Hoersten, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Secretory peptides and proteins are frequently modified by pyroglutamic acid (pE, pGlu) at their N-terminus.  This modification is catalyzed by the glutaminyl cyclases QC and isoQC.  Here, we decipher the roles of the isoenzymes by characterization of IsoQC-/- mice.  These mice show a significant redn. of glutaminyl cyclase activity in brain and peripheral tissue, suggesting ubiquitous expression of the isoQC enzyme.  An assay of substrate conversion in vivo reveals impaired generation of the pGlu-modified C-C chemokine ligand 2 (CCL2, MCP-1) in isoQC-/- mice.  The pGlu-formation was also impaired in primary neurons, which express significant levels of QC.  Interestingly, however, the formation of the neuropeptide hormone TSH-releasing hormone (TRH), assessed by immunohistochem. and hormonal anal. of hypothalamic-pituitary-thyroid axis, was not affected in isoQC-/-, which contrasts to QC-/-.  Thus, the results reveal differential functions of isoQC and QC in the formation of the pGlu-peptides CCL2 and TRH.  Substrates requiring extensive prohormone processing in secretory granules, such as TRH, are primarily converted by QC.  In contrast, protein substrates such as CCL2 appear to be primarily converted by isoQC.  The results provide a new example, how subtle differences in subcellular localization of enzymes and substrate precursor maturation might influence pGlu-product formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6FvRmQrpJjbVg90H21EOLACvtfcHk0liKfcOguddZPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN&md5=d49367e240255a8fa1546bae79865508</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0192%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DOsmand%26aufirst%3DA.%26aulast%3DPlank%26aufirst%3DA.%2BC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsoQC%2520%2528QPCTL%2529%2520knock-out%2520mice%2520suggest%2520differential%2520substrate%2520conversion%2520by%2520glutaminyl%2520cyclase%2520isoenzymes%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26spage%3D45%26epage%3D55%26doi%3D10.1515%2Fhsz-2015-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate Aβ formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">4460</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-4460&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%CE%B2+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0lhFZ9auTlUDaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%25CE%25B2%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D4460%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaupp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">On the seeding and oligomerization of pGlu-amyloid peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12393</span>– <span class="NLM_lpage">12399</span>, <span class="refDoi"> DOI: 10.1021/bi0612667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0612667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=12393-12399&author=S.+Schillingauthor=T.+Lauberauthor=M.+Schauppauthor=S.+Manhartauthor=E.+Scheelauthor=G.+B%C3%B6hmauthor=H.-U.+Demuth&title=On+the+seeding+and+oligomerization+of+pGlu-amyloid+peptides&doi=10.1021%2Fbi0612667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">On the Seeding and Oligomerization of pGlu-Amyloid Peptides (in vitro)</span></div><div class="casAuthors">Schilling, Stephan; Lauber, Thomas; Schaupp, Michael; Manhart, Susanne; Scheel, Eike; Boehm, Gerald; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12393-12399</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligomerization of amyloid β (Aβ) peptides is the decisive event in the development of Alzheimer's disease (AD), the most common neuro-generative disorder in developed countries.  Recent evidence links this conformation-driven process to primary- and secondary-structure modifications of Aβ.  The N and C terminus of deposited Aβ has been shown to possess conspicuous heterogeneity.  While the C-terminally longer form of Aβ, i.e., Aβ (42), is considered more amyloidogenic, the role of the N-terminal modifications, e.g., truncation and glutamate cyclization accounting for the majority of the deposited peptides, is less understood.  In the present study, we characterized the oligomerization and seeding capacity of pGlu-amyloid peptides using two unrelated techniques based on flow cytometry or fluorescence dye binding.  Under different conditions and irresp. of the C terminus of Aβ, i.e., Aβ40 or 42, pGlu-modified peptides displayed an up to 250-fold accelerated initial formation of aggregates compared to unmodified Aβ.  The accelerated seed formation is accompanied by a change in the oligomerization kinetics because of N-terminal pGlu formation.  Furthermore, the formation of mixed aggregates consisting of either pGlu-Aβ (3-42) or ADan or ABri and Aβ (1-42) was investigated by Aβ fluorescence labeling in flow cytometry.  The results suggest that pGlu-modified peptides are potential seeding species of aggregate formation in vivo.  The data presented here and the abundance of pGlu peptides in amyloidoses, such as FBD and AD, suggest pGlu-amyloid peptides as a species with biophys. characteristics that might be in particular crucial for the initiation of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6CurUnBcAULVg90H21EOLACvtfcHk0lhFZ9auTlUDaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D&md5=3c41f4ad0b1cbe27a9dbc55bab2be8f4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbi0612667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0612667%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DLauber%26aufirst%3DT.%26aulast%3DSchaupp%26aufirst%3DM.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DScheel%26aufirst%3DE.%26aulast%3DB%25C3%25B6hm%26aufirst%3DG.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DOn%2520the%2520seeding%2520and%2520oligomerization%2520of%2520pGlu-amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D12393%26epage%3D12399%26doi%3D10.1021%2Fbi0612667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase ameliorates amyloid pathology in an animal model of Alzheimer’s disease via the modulation of γ-secretase activity</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.3233/JAD-141356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;key=10.3233%2FJAD-141356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=797-807&author=H.+Songauthor=Y.+J.+Changauthor=M.+Moonauthor=S.+K.+Parkauthor=P.-T.+Tranauthor=V.-H.+Hoangauthor=J.+Leeauthor=I.+Mook-Jung&title=Inhibition+of+glutaminyl+cyclase+ameliorates+amyloid+pathology+in+an+animal+model+of+Alzheimer%E2%80%99s+disease+via+the+modulation+of+%CE%B3-secretase+activity&doi=10.3233%2FJAD-141356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3233%2FJAD-141356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141356%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DTran%26aufirst%3DP.-T.%26aulast%3DHoang%26aufirst%3DV.-H.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520ameliorates%2520amyloid%2520pathology%2520in%2520an%2520animal%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520via%2520the%2520modulation%2520of%2520%25CE%25B3-secretase%2520activity%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2014%26volume%3D43%26spage%3D797%26epage%3D807%26doi%3D10.3233%2FJAD-141356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB','PDB','3PBB'); return false;">PDB: 3PBB</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i111"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00751">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11706"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00751">10.1021/acs.jmedchem.9b00751</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic procedure and characterization details of intermediates; the purities of all final compounds; docking study of compound <b>84</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_001.pdf">jm9b00751_si_001.pdf (315.08 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00751/suppl_file/jm9b00751_si_002.csv">jm9b00751_si_002.csv (3.54 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-17%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00751%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00751" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c8465d3c24c7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
